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ABSTRACT 
The development of healthy gametes is paramount to the health of 
progeny and to the survival of a species. Epigenetic information contained within 
gametic DNA in the form of DNA methylation is essential for germ cell and 
embryo development. DNA methylation is a genome-wide phenomenon involved 
in the control of gene expression and chromosome structure and stability. During 
germ line development, patterns of DNA methylation are established in a sex-
and sequence-specific manner. The primary goal of the work presented in this 
the sis is to gain an understanding of the nature of the genome-wide pattern of 
DNA methylation in germ cells and to study its progression during germ cell 
development. The complexity of male germ cell development has been weil 
studied in mice and th us makes an excellent system in which to study germ cell 
DNA methylation. Firstly, genome-wide patterns of DNA methylation in adult 
male germ cells were determined using a variety of techniques. Results from 
these studies demonstrate that the DNA methylation pattern in male germ cells is 
highly distinct from that of somatic cells. The reorganization of the germ cell 
pattern is associated with chromosomal features such as the chromosomal 
banding pattern and regional GC content. Secondly, by examining purified 
populations of male germ cells, we have determined that patterns of DNA 
methylation are being acquired during spermatogenesis. De novo methylation 
and demethylation events occur in a sequence-specific manner prior to the 
meiotic phase of germ cell development. Finally, the stability of these patterns 
was studied by perturbing DNA methyltransferase activity. The study of germ 
cells lacking a functional Dnmt3L gene demonstrates that the abnormalities 
displayed in these cells are associated with a failure to acquire normal levels of 
DNA methylation. In addition, the treatment of mice with the hypomethylating 
agent, 5-aza-2'-deoxycytidine, results in adverse effects on sperm function and is 
associated with sequence-specific hypomethylation. Collectively, these studies 
have uncovered several novel aspects of DNA methylation in male germ cells 
and contribute to our understanding of the role(s) for epigenetic phenomena in 
the development and maintenance of healthy gametes. 
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RÉSUMÉ 
La formation de gamètes sains est cruciale au bon développement de la 
progéniture et à la survie de l'espèce. L'information épigénétique contenue dans 
l'ADN des gamètes, sous la forme d'ADN méthylé, est essentielle au 
développement des cellules germinales et de l'embryon. La méthylation de 
l'ADN est un phénomène qui s'étend à l'ensemble du génome et qui est impliqué 
dans le contrôle de l'expression des gènes tout en contribuant à la stabilité et à la 
structure des chromosomes. Les patrons de méthylation sont établis durant le 
développement des cellules germinales en fonction du genre de l'organisme et 
de la nature des séquences étudiées. Le but principal des travaux présentés 
dans cette thèse était d'approfondir notre compréhension de la nature des 
patrons de méthylation de l'ADN de la cellule germinale ainsi que d'étudier 
comment ces patrons sont modifiés durant le développement du gamète chez la 
souris. Comme le développement des cellules germinales mâles a été bien 
étudié, nous avons choisi d'utiliser ce système pour nos études. Premièrement, 
nous avons déterminé les patrons génomiques de méthylation de l'ADN du 
spermatozoïde en utilisant diverses techniques. Ces études ont démontré que le 
patron de méthylation des cellules germinales mâles est hautement distinct de 
celui des cellules somatiques. La réorganisation du patron gamétique est 
associée avec des caractéristiques chromosomiques telles que le patron des 
bandes chromosomiques ainsi que le contenu régional en Ge. Deuxièmement, 
en examinant diverses populations de cellules germinales purifiées, nous avons 
déterminé que les patrons de méthylation sont acquis au cours de la 
spermatogenèse. Des évènements de méthylation de novo et de déméthylation 
se produisent avant la méiose. Finalement, nous avons étudié la stabilité de ces 
patrons en perturbant l'activité des ADN méthyltransférases, les enzymes 
responsables de l'établissement des patrons de méthylation. L'étude de cellules 
germinales ne comprenant pas de gène Dnmt3L fonctionnel a démontré que le 
phénotype adverse présenté par ces cellules était du à leur incapacité à acquérir 
des taux de méthylation normaux. Aussi, le traitement de souris avec l'agent 
hypométhylant 5-aza-2' -deoxycytidine a résulté en des conséquences adverses 
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sur la fonction du spermatozoïde et fut associé avec l'hypométhylation de 
séquences spécifiques. Ensemble, ces études mettent en lumière plusieurs 
nouveaux aspects de la méthylation de l'ADN chez le gamète mâle et contribuent 
à notre compréhension du rôle des phénomènes épigénétiques dans le 
développement de gamètes sains. 
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CHAPTER 1 
INTRODUCTION 
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Germ cells provide the essential link between generations. They are the 
only cells that naturally carry out the process of transmitting genetic information, 
making them of paramount importance to the survival and evolution of a species. 
Germ cells have highly specialized characteristics that allow for this process to 
reliably take place; yet, from two single cells, the myriad of ce II-types that make 
up an individual are derived. It is in this sense that germ cells embody the 
potential for cellular totipotency and a species' immortality. 
The birth of a healthy child is the successful result of an exceedingly 
complex set of genetically-driven interactions that occur in precise time and 
space within the developing embryo. As the knowledge of the genes involved in 
this process move forward, it has become clear that there are components to the 
genetic mate rial that are contributed by both parents that go beyond the 
underlying genetic sequence. This emerging component is termed 'epigenetic' 
and can be considered as the next frontier in genetics. Over the past decade, an 
appreciation has been growing for a vast role for epigenetics in the control of 
many aspects of development and disease. It has been widely accepted that, 
unlike genetic information, epigenetic information is highly dynamic in defined 
periods of our lifecycle. Specifically, it is within male and female germ cells 
where a critical period of epigenetic reprogramming takes place, establishing 
epigenetic marks that can persist for the life of an individual supporting both 
normal development and contributing to overall health. It is the exploration of the 
nature of the epigenetic program in male germ cells, its acquisition and stability 
during adult life, with which the theme of this thesis is concerned. 
1 Statement of Investigation 
The mechanisms that underlie epigenetic phenomena relate to how local 
chromatin structure influences the expression of genes. These mechanisms 
include an array of covalent modifications to core histone proteins, interactions 
with small RNA molecules, and DNA methylation. Recent work has shown that 
these phenomena work closely together to stabilize chromatin states. Disruption 
of various aspects of these mechanisms has been shown to be related to the 
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abnormal gene expression patterns seen in many types of cancer and other 
diseases. To date, DNA methylation remains the best studied of these 
mechanisms. 
DNA methylation is present in many types of plants and vertebrate animais 
(Tweedie et aL, 1997; Vanyushin, 2006). It is present in a non-random fashion in 
the genomes of mammals. The mouse is an excellent model to understand 
various aspects of the biology of DNA methylation and has been intensively 
studied. Mice possess homologs of ail of the known human DNA 
methyltransferase enzymes. The organization and ove rail amount of DNA 
methylation is vastly similar between mice and humans. Recently, it was 
concluded that syntenic chromosomal regions retain a pattern of DNA 
methylation that is highly concordant between the two species (Eckhardt et al., 
2006). Furthermore, in the mouse, it is possible to extend our knowledge with 
interventional studies which procure important information through genetic 
ablation and drug treatment approaches that are not possible in humans. 
The findings of many of these studies point to a critical aspect that sets 
epigenetics apart from classical genetics - reversibility. The labile nature of DNA 
methylation versus genetic sequence information makes it a fascinating 
candidate for acquired diseases and raises hope for pharmacological and other 
approaches for prevention and intervention. There are time points in 
development where DNA methylation patterns are reset, giving ail progeny a 
"clean epigenetic slate" to begin life. One of these reprogramming events 
happens in early embryonic development where somatic patterns are set, the 
other occurs in germ cells (Figure 1.1). Continuai reprogramming with each 
generation raises the possibility of the occurrence of 'epimutations' in these 
critical developmental widows. Furthermore, some acquired epigenetic states 
can escape reprogramming of DNA methylation patterns and be passed on to 
progeny, in what is called 'epigenetic inheritance' (Morgan et aL, 1999; Rakyan et 
aL, 2003). Clearly, a fundamental understanding of DNA methylation in germ 
cells is paramount to the understanding of these very important processes. 
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Previous work in looking at DNA methylation in germ cells, particularly the 
male, has hinted that DNA methylation patterns are unique in these cells. Due to 
the larger number of germ cells produced in the male th an in the female, their 
greater accessibility and their continuai renewal, most germ cell studies focus on 
spermatozoa and testicular tissues. Various techniques have been used for 
these studies; however, no study has provided a non-biased genome-wide 
picture of the status of methylation in germ cells. 1 have employed a technique 
called restriction landmark genomic scanning (RLGS) to accomplish this. 
Chapter Il describes the development and evaluation of a technique that works in 
concert with RLGS. This technique was a necessary component to achieve this 
goal of a comprehensive analysis of DNA methylation patterns in male germ 
cells, the focus of chapter III. As mentioned earlier, previous studies have found 
that, during a defined window in pre-natal development, patterns of DNA 
methylation are reset; however, it is not known if patterns continue to be acquired 
outside of this window. Data presented in chapter IV addresses the question of 
whether or not patterns of DNA methylation continue to be acquired in post-natal 
life, in a particular period of gametogenesis called spermatogenesis. After 
defining the nature of DNA methylation during spermatogenesis, chapter V 
explores the relationship between DNA methyltransferases and DNA methylation 
in this period by perturbing their function bya pharmacological intervention. 
This introductory chapter will provide an overview of the aspects of male 
germ cell biology and DNA methylation that are relevant to the work presented in 
this thesis. As the work presented in this thesis relates solely to male germ cells, 
less emphasis will be placed on female germ cells. This chapter will begin with 
the origins and development of male germ cells in both pre- and post-natal 
developmental windows. Next, 1 will discuss aspects of DNA methylation in 
mammals, and, finally, what is known about DNA methylation in male germ cells 
and approaches that can be taken to study DNA methylation in these cells. 
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1.1 Gametogenesis 
1.1.1 Embryonic Origins of Germ Cells 
The germ line is defined as the continuous lineage of cells that perpetuate 
the lifecycle of a species. Other than a brief period after fertilization and 
persisting into the early stages of embryonic development, germ cells carry the 
germ line in mammals. In the mouse, identifiable germ cells first appear around 
6.5 dpc (days post-coitum) as a cluster of a few cells that arises out of the 
embryonic endoderm and are termed primordial germ cells (PGCs) (Figure 1.1). 
These cells migrate out of this compartment, through the developing embryo and 
arrive a few days later to colonize the genital ridges around 10.5 dpc. These 
cells will mitotically divide during the period of migration and after colonization of 
the genital ridges, creating a population of approximately 25,000 germ cells by 
13.5 dpc (Donovan et al., 1987; Tam and Snow, 1981). 
1.1.2 Female Germ Cell Development 
The appearance and behavior of PGCs from their appearance to the 
colonization of the genital ridge are indistinguishable between male and female 
(McLaren, 1995). The gonads acquire a sexually-dimorphic appearance around 
12.5 dpc as germ cells are organized into cord structures in the male but not in 
the female (Hogan et al., 1986). Early female fetal germ cells, termed 'oogonia', 
stop mitotic divisions and enter meiosis as early as 14 dpc (Wasserman and 
Albertini, 1994). Pairing and recombination of homologous chromosomes occur 
until the time of birth where oogonia are found to be arrested in meiosis (Bakken 
and McClanahan, 1978). These cells, now called non-growing oocytes, will 
remain arrested until puberty (which occurs shortly after birth in mice) where 
some are recruited into the oocyte growth phase by hormonal signais. During 
this period, many non-growing oocytes will degenerate by atresia. In the oocyte 
growth period, oocytes will increase their diameter from 10-20 IJm to 80 IJm and 
undergo other ultra-structural changes. The completion of oocyte development 
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prior to the ovulation of a fully-grown oocyte occurs in the meiotic maturation 
period where meiosis resumes and is completed upon fertilization. 
1.1.3 Male Germ Cell Development 
1.1.3.1 Male Pre-Natal Germ Cell Development 
There is a striking dimorphism of germ cell development between male 
and female. After the initial spermatogenic cord formation begins to occur around 
12.5 dpc specifically in the male, male PGCs continue to divide mitotically until 
being arrested around 14.5 dpc, but do not enter meiosis (Nagano et al., 2000; 
Vergouwen et al., 1991). PGCs will resume their mitotic activity immediately after 
birth (Coffigny et al., 1999). Over the next few days of post-natal life, the male 
germ cells will migrate towards the basement membrane of the spermatogenic 
cords. These cells will give rise to both the first spermatogonia and a population 
of self-renewing spermatogonial stem cells that will continually produce germ 
cells for the life of the animal (Orwig et aL, 2002). 
1.1.3.2 Male Post-natal Germ Cell Development 
Much literature has been composed that describes many of the intricate 
details of the male reproductive system in the adult. Much work has been done 
to characterize the kinetics, regulation, molecular mechanisms and pathologyof 
spermatogenesis (Clermont, 1972; Cooke and Saunders, 2002; Dadoune et aL, 
2004; de Rooij and Russell, 2000; Ewing et aL, 1980; Grootegoed et aL, 2000; 
Hecht, 1998; Russell et aL, 1990). Therefore, only an overview of the specifie 
aspects that are relevant to this thesis will be discussed. 
Testis Structure 
The testis of the adult animal is organized as an array of seminiferous 
tubules encapsulated by the testicular tunica (reviewed by Russell et al. 1990) 
(Figure 1.2). Intervening between the tubules are small interstitial spaces 
comprised of somatic cells, such as the testosterone-producing Leydig cells, as 
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weil as myoid, epithelial and blood-borne cells. Germ cells are housed within the 
seminiferous tubules that are surrounded by the basal lamina. Spermatogenesis 
occurs within the tubule in a highly organized histological structure called the 
seminiferous epithelium (Figure 1.2). Spermatogonial stem cells occupy the 
basal compartment of the tubule and germ cells of increasing maturity are found 
as they migrate towards the tubular lumen. The only somatic cell type found 
within the tubules is the Sertoli cells. These non-proliferative cells nurse the 
developing germ cells by providing factors necessary for and removing cellular 
waste and debris created by developing germ cells (Griswold; 1995; Mruk and 
Cheng, 2004; Sharpe, 1994). The nuclei of Sertoli cells are distributed along the 
basal lamina of the tubule and the cytoplasmic projections of each cell contact 
30-50 germ cells throughout the tubule and at various stages of development (Siu 
and Cheng, 2004). Tight junctions between adjacent Sertoli cells form the blood-
testis barrier separating the basal and adluminal compartments of the 
seminiferous epithelium. ... . . 
The timing of the phases of spermatogenesis is highly precise and 
constant. These kinetics result in a predictable architecture of the seminiferous 
epithelium where specific ce Il types within each of the phases of 
spermatogenesis are found grouped together. These groups are defin~d as 
particular stages of spermatogenesis (reviewed by Russell et al., 1990). In the 
mouse, cross sections of seminiferous tubules can be grouped into 12 stages . 
that are arbitrarily defined by cellular features that are identifiable by Hght 
microscopy. This allows for precise histological identification of ail germ cells 
within the various phases of spermatogenesis. 
Spermatogenesis 
Spermatogenesis is a very complex process whereby haploid 
spermatozoa are produced from diploid spermatogonial stem cells. In a 
continuous process that lasts for the lifespan of the male, spermatogenesis 
achieves the processes of genetic recombination, a dramatic morphological 
remodeling of the nucleus and ce Il body, while managing·.· to . produce 
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approximately ten million sperm per gram of testis tissue a day (Amann and 
Howards, 1980). This is achieved by a highly regulated process that can be 
broken down into three distinct phases: the proliferative phase, the meiotic 
phase, and spermiogenesis (Figure 1.3). These phases are also referred to as 
pre-meiotic or spermatogonial, meiotic or spermatocyte and post-meiotic or 
spermatid spermatogenic phases. Each phase involves distinct processes and 
germ cel! types (Bellvé et al., 1977b). 
ln the proliferative phase, diploid spermatogonial stem cells mitotically 
divide to produce the first undifferentiated spermatogonia. Like the stem cells of 
other tissues, one daughter cell is destined for differentiation, the other for self-
renewal. Although differing theories of the kinetics of spermatogonial stem cell 
renewal have been proposed (Clermont and Bustos-Obregon, 1968; Huckins, 
1971; Oakberg, 1971), both proposed mechanisms involve the existence of stem 
cells. Cells that are not destined for self-renewal are termed primitive type A 
spermatogoniâ and continue to divide several times which amplifies the numbers 
of germ cells before they begin to differentiate. Ali germ cells that arise from a 
single stem cell are connected throughout the duration of spermatogenesis by 
cytoplasmic bridges that arise from incomplete cytokinesis. Type A 
spermatogonia divide and differentiate into intermediate spermatogonia, then into 
type B spermatogonia before exiting the proliferative phase. Commitment to the 
differentiation into intermediate and type B spermatogonia is associated with 
visible changes to the nuclear architecture, most notably is the accumulation of 
heterochromatin in the periphery of the nuclear envelope. 
ln the meiotic phase, spermatocytes (germ cells of the meiotic phase) will 
become tetraploid, synapse homo logo us chromosomes, undergo recombination 
and reduce their genetic content to haploid. This phase begins with one final 
mitotic cell division that generates preleptotene spermatocytes from type-B 
spermatogonia. Preleptotene cells will endo-reduplicate their DNA (DNA 
replication without cell division) to form the tetraploid leptotene spermatocytes. It 
is in this stage and the next stage, zygonema, where homologous chromosomes 
are paired in preparation for recombination. In the lengthy pachytene stage that 
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folIows, a phase that requires approximately a week to complete, homologous 
chromosomes undergo genetic recombination. The first reductive division occurs 
to produce secondary (diploid) spermatocytes from diplotene spermatocytes, 
which quickly divide in the second meiotic reduction to produce haploid 
spermatids. 
Spermiogenesis is the spermatogenic phase where spermatids undergo 
dramatic morphological changes to both the cytoplasm and nucleus of the cell. 
Spermatids can be grouped generally by their morphology into round spermatids 
followed by the elongating spermatid stage (Figure 1.3). Nuclear changes 
include extensive chromatin remodeling that replaces histones with transition 
proteins and eventually protamines. (Dadoune et aL, 2004; Sassone-Corsi, 
2002). Protamines are small basic proteins that coil DNA into a compact 
structure and condense the chromatin by disulfide bonding. Cytoplasmic 
changes include the formation of an acrosome, elongation and eventual removal 
of most of the cytoplasm and the development of a motile flagellum. Cytoplasmic 
bridges are pinched off in the final stages of spermiogenesis before spermatozoa 
are released from the testicular epithelium in a process called 'spermiation'. 
At which point spermatogenesis is complete; however, additional 
processes are further required to produce spermatozoa that are motile and are 
capable of natural fertilization. Spermatozoa that are liberated into the testicular 
lumen are transported into the caput of the epididymis where the final nuclear 
compaction and disulfide linkages between protamines are completed. A small 
amount of additional cytoplasm is shed from the spermatozoa during transit from 
the caput to the cauda of the epididymis that is important for their motility, and 
extensive changes occur in the lipid and protein composition of the . sperm 
membrane. Finally, mature spermatozoa are stored in the cauda of the 
epididymis before being mixed into semen and ejaculated. 
During spermatogenesis, severa 1 processes necessitate highly ordered, 
germ cell-specific chromatin states, both during meiotic stages and 
spermiogenesis. The accomplishment of this is made possible by the 
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developmentally regulated expression of a large array of germ cell-specific genes 
(Shima et aL, 2004). Although the mechanisms that underlie the establishment of 
germ ce II-specifie chromatin states and how the genes that control these 
processes are regulated are unclear, a large body of evidence from other 
systems implicates the phenomenon of DNA methylation as being intricately 
involved in the regulation of chromatin states that can influence both gene 
expression and chromatin structure. 
1.2 DNA Methylation 
DNA methylation is an important component of a general mechanism that 
allows for additional information to be encoded into chromatin in addition to the 
underlying genetic sequence. These modifications are termed 'epigenetic' and 
involve an extensive array of modifications to histone proteins (Jenuwein and 
Allis, 2001) and small, non-coding RNA molecules (Bayne and Alishire, 2005). 
As ail the data in presented in this thesis relates only to DNA methylation, these 
other related phenomena will not be discussed further. 
Although the vast majority of DNA of ail organisms is made up of the four 
native deoxynucleotides (adenine, cytosine, guanine, and thymine), many 
organisms modify a small proportion of these molecules. In mammalian DNA, 
the primary modification occurs to cytosine, via the transfer of a methyl group 
from S-adenosylmethionine (SAM) to the 5th carbon of the cytosine ring to form 5-
methylcytosine (5mC) (Figure 1.4). 5mC accounts for approximately 5% of the 
total cytosine content of DNA, or 1-2% of the ove ra Il DNA content in most tissues. 
ln mammals and other organisms, 5mC is found in palindromic 5'-CG-3' 
sequences within DNA (termed CpG dinucleotides). Approximately 60-80% of 
CpG dinucleotides in the mammalian genome are methylated (Bestor et aL, 
1984; Bird, 1980). 
A key feature of DNA methylation is that information can be either stably 
inherited from mother to daughter cells or can be erased and re-established 
without altering the underlying sequence. It has been weil demonstrated that 
5mC can be added and removed in specifie periods of genomic reprogramming 
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(Reik et aL, 2001). DNA methyltransferase enzymes (DNMTs) methylate 
cytosine residues, white, although less extensively described, demethylation Gan 
occur via a growing number of potential mechanisms that include direct removal 
of the methyl group (Bhattacharya et aL, 1999) and base excision and repair by 
glycosylase and DNA repair enzymes (Jost and Jost, 1995; Walsh and Xu, 2006). 
1.2.1 Biological Roles of DNA methylation 
Most roles that have been assigned to 5mC involve the creation of an 
additional layer of information in the genome. This information is interpreted as a 
signal to format the surrounding sequence as condensed heterochromatin versus 
less-condensed euchromatin (Vermaak et aL, 2003). DNA methylation is a key 
component of an array of different phenomena that work together to establish 
and maintain a heterochromatic state. 
DNA methylation has been theorized to behave both on a genome-wide 
scale (Bestor and Tycko, 1996), as weil as on a gene-specific level (Ballestar and 
Wolffe, 2001). On a genome-wide scale, 5mC promotes chromatin stability and 
is theorized to constrain the effective size of the genome through the selective 
exposure of regulatory sequences versus non-regulatory sequences. Generally, 
it has been shown that the presence of 5mC, particularly in 5' regions, by 
promoting the formation of local heterochromatin, will down-regulate 
transcriptional activity. 
1.2.1.1 Regulation of Gene Expression 
There are severa 1 proposed mechanisms that link DNA methylation to the 
modulation of gene expression via direct interactions with proteins that modulate 
chromatin structure (Klose and Bird, 2006). On a local level, small changes to 
the methylation of DNA in key positions (mainly thought to be 5' regions of genes) 
have been shown to change the ability of transcription-factors to associate with 
DNA. The simplest mechanism involves a direct physical change that results 
from the addition of 5mC to a particular sequence. DNA methylation can alter the 
conformation of DNA (Mclntosh et aL, 1983) and may result in changed 
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associations with various regulatory proteins. DNA methylation of key residues 
also physically biocks binding of proteins that promote transcription (De Smet et 
aL, 1996; Griswold and Kim, 2001; Santoro and Grummt, 2001). More generally, 
it is believed that DNA methylation plays a role in the regulation of genes by 
mainly influencing regional chromatin states. There are several members of a 
methyl-CpG-binding domain (MBD) protein family that promote repressive states 
in chromatin by specifically recognizing the methylated state of DNA. These 
include Kaiso, MeCP2 and four MBD proteins (MBD1-4). Commonly, these 
proteins promote transcriptional repression by complexing proteins that retain 
histone deacetylase (HDAC) activity that changes the potential of DNA-histone 
association by modifying the histone's electrical charge. DNA methyltransferase 
enzymes are able to interact with HDAC proteins and promote repression through 
this association (Burgers et aL, 2002). 
A considerable amount of information has been produced by investigating 
aberrant DNA methylation in disease, mainly cancer (Feinberg, 2004; Robertson, 
2005). Many studies have focused on the relationship between gene-specifie 
hypermethylation in tumors and cancer cell lines and loss of expression. Many of 
these repressed genes that are associated with hypermethylation can be 
reactivated via the use of 5-azacytidine, a drug that promotes demethylation in 
replicating cells. These studies provide a considerable amount of information 
that supports the causative association between hypermethylation and gene 
repression. 
1.2.1.2 Imprinting and X Chromosome Inactivation 
Regions of the genome that display allele-specific expression are often 
differentially methylated (Reik and Walter, 2001). These regions are termed 
'imprinted regions' and/or 'imprinted genes'. In most cases, differentially 
methylated states between alleles observed in offspring are acquired during germ 
cell development in either parent in a sex-specific manner. Several regions of the 
genome are imprinted; however, most marks are acquired in the female germ line 
as opposed to the male. The reason(s) for this dichotomy are unclear; however, 
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the existence of imprinted regions has been ascribed to the desire of either sex ta 
control the growth potential of the offspring (Moore, 2001). The female takes a 
more pro-active stance because offspring'overgrowth will have a greater effect on 
her than on the father. 
Another role of DNA methylation involves the inactivation of X 
chromosome in females. X-Linked gene dosage compensation in females is 
achieved by repression of the genes on the X chromosome during development 
(Sado and Ferguson-Smith, 2005). It has been shown that many genes on the 
inactive X chromosome are methylated (Park and Chapman, 1994). In addition, 
methylation contributes to the regulation of the master switch gene that controls 
the inactivation of the X chromosome, Tsix (Sado et al., 2004). 
1.2.1.3 Relationship to Genome Organization 
Analysis of the mouse and human genomic sequences reveal that there 
are approximately 20 and 27 million CpG dinucleotides in the two species, 
respectively (Fazzari and Greally, 2004). Each CpG dinucleotide is a potential 
target for DNA methylation. Total genomic sequence can be divided into two 
broad classes: those sequences that belong to interspersed transposable 
elements (TEs) and those that do not. In the mouse, approximately 40% of the 
total number of CpG dinucleotides is composed of TE-derived DNA, which 
include short and long interspersed transposable elements (SINEs and UNEs, 
respectively), and many types of long terminal repeat (L TR) retroviral elements. 
(Figure 1.5). The remaining approximately 60% of the total number of CpGs are 
found in unique sequence which include non-repetitive exonic, intronic and 
intergenic sequences. CpG dinucleotides are divided between these genomic 
compartments in proportion to the amount of underlying sequence. Also, the 
proportion of sequence in each compartment and the CpG distribution is similar 
between mice and humans, with somewhat more CpGs found in TEs in humans. 
One very interesting feature of the genomic sequence of mammals and 
other species are CpG islands (CGls). While the genomes of mammals are 
ove ra Il relatively devoid of CpG dinucleotides, short sequences of high CpG 
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density are found throughout their genomes. Originally defined based mainly on 
CpG and G+C density (Gardiner-Garden and Frommer, 1987), definition of higher 
stringency (Takai and Jones, 2002) has been more widely-adopted for CGls 
(G+C ~ 55%, CpG obs/exp ~ 0.6, length ~ 500bp). CGls account for less than 
1 % of the overall genomic sequence; however, account for 6-7% of ail CpGs 
(Figure 1.5). CGls are of special interest because they are commonly associated 
with the 5' regions of genes and their methylation status has been shown 
generally to be inversely correlated with gene expression levels. Greater th an 
half of ail mammalian genes are associated with CGls (Ioshikhes and Zhang, 
2000), many of which pertorm house-keeping functions. Another interesting 
feature of CGls is that they are generally found to be unmethylated in ail tissues. 
A recent study in humans found that only 9% of assayed CGI were methylated in 
any of the 12 different tissues studied, and ail methylated CGls were of lower 
CpG density (Eckhardt et aL, 2006). The unmethylated nature of CGls and their 
high frequency of association with the 5' regulatory regions of housekeeping 
genes suggest that the func1ion of CGls is to provide a constitutively open 
chromatin state that is permissive for the expression of highly expressed genes. 
Unlike CGls, it is generally believed that non-CGI sequences are highly 
methylated in mammals. High levels of methylation in TEs are thought to 
promote overall chromosome stability by repressing their transcription (Yoder et 
aL, 1997b). Also, stable heterochromatic states may mask homologous regions 
on non-homologous chromosomes that are represented by TE sequences and 
repress somatic recombination events. It has been shown that in cancer cells, 
genomic DNA is hypomethylated and genomic instability is a hallmark of the 
genomes of many tumors and cancer cell lines (Ehrlich, 2006). Current genomic 
sequence builds do not include centromeric and telomeric regions of 
chromosomes, which are mostly composed of tandemly repeated satellite and 
telomeric repeat sequences. Studies using Southem blot analysis have 
demonstrated that these regions are highly methylated in somatic tissues 
(Gaillard et aL, 1981; Sanford et aL, 1984). Non-repetitive, non-CGI sequences 
are thought to contain high levels of DNA methylation as weil; however, they 
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have been the subject of much less direct interrogation. The purpose(s) of 
methylation in the non-CGI unique sequence compartment is unknown, despite 
the majority of the genome belonging to this compartment. 
DNA methylation functions in genome organization by promoting the 
formation of heterochromatin. The chromosomallandscape of higher eukaryotes 
is heterogeneous with respect to heterochromatin versus euchromatin. 
Heterogeneity within chromosomes was first visuatized by Caspersson 
(Caspersson et aL, 1968), which was later improved by using the Giemsa dye 
(Devet al., 1972). At the Iight microscopy level, the staining of metaphase 
chromosomes readily reveals a chromosome-specifie pattern of alternating dark 
(Giemsa- or G-) and Iight (reverse- or R-) bands. G- and R-bands generally 
define chromosomal regions of heterochromatin versus euchromatin, 
respectively. These regions are associated with differences in sequence 
features. G-bands contain fewer genes, longer introns, fewer CGls, replicate 
later and have a lower rate of meiotic recombination versus R-bands (Fazzari and 
Greally, 2004). While TEs and unique sequence are defined as occupying 
genomic 'compartments', the interspersed nature of TEs causes these 
compartments to be scattered throughout the genome. However, the distribution 
of specifie sequences is not random and is associated with higher order ultra-
structural features of chromosomes. The proportion of TEs to unique sequence 
and the distribution of various TEs have been shown to be related to the 
distribution of heterochromatin. G-bands also contain proportionally more total 
repetitive sequence, including satellite repeats, more UNEs, yet, surprisingly, 
fewer SINEs. Another sequence-based feature of the chromosomal banding 
pattern is that G-bands contain below-average and R-bands aboye-average G+C 
nucleotide content (Saccone et aL, 1993). Defined regions of chromosomes 
contain high and low GC content (usually several Mb in size) and are defined as 
isochores (Bernardi et al., 1985). Recently, it has been concluded that this is the 
defining feature of the banding pattern (Costantini et aL, 2006), demonstrating a 
clear connection between heterochromatin to chromosomal regions of low GC 
content. 
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The basis for the linear heterogeneity of GC content is thought to be the 
result of the association of DNA methylation to heterochromatin. 5-
Methylcytosine is relatively unstable compared to cytosine and the other 
nucleotides and will spontaneously deaminate to form thymine (Shen et aL, 
1994). Improperly repaired G nucleotides in T/G mismatches would result in the 
original 5mC/G being replaced with a T/A base pair. This existence of a 5mC-
dependent mutational mechanism operating in the germ line of a species over 
many generations would cause any methylated sequence to gradually lose GC 
content. The existence of CGls is explained by this mechanism and due to their 
property of being consistently unmethylated, thus resistant to 5mC-dependent 
mutation. This mechanism has also been proposed as a key aspect of genome 
defense, as targeting 5mC to TEs would not only cause transcriptional 
inactivation, but mutations would render them nonfunctional over time. 
The relationship between heterochromatin and DNA methylation combined 
with the fact that there are specific sequence features associated with 
heterochromatin, opens the door to a multitude of possible functions for DNA 
methylation. As DNA methylation promotes heterochromatin formation, functions 
may include genomic defense against parasitic elements, long-range interactions 
influencing gene expression and regulation of mitosis (Talbert and Henikoff, 
2006). It has been postulated that by supporting the maintenance of 
heterochromatin, DNA methylation allows regions containing regulatory 
sequences and genes to be preferentially available (Bestor and Tycko, 1996). A 
role for DNA methylation in this process is supported by the fact that 5mC is a 
universal feature of large-genome eukaryotes that contribute to the C-value 
paradox (Thomas, Jr., 1971); defined as genome size scalingindependent of 
gene number, while many eukaryotes with genome sizes <5 x 10(8) bp do not 
methylate their DNA (Kidwell, 2002). As a more detailed knowledge of the 
functions of these sequences evolves, additional roles of DNA methylation will 
undoubtedly be uncovered. 
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1.2.2 DNA Methyltransferases 
The f1exibility of DNA methylation (stability vs. reversibility) is facilitated by 
different activities attributed to various members of the DNMT family of enzymes. 
During the S-phase of cell cycle, patterns of DNA methylation are faithfully copied 
from the existing DNA strand to the newly synthesized strand in an activity 
termed 'maintenance methylation'. The palindromic nature of the CpG 
dinucleotide sequence allows for maintenance methylation activity to result in the 
duplication of the genomic methylation pattern. The other activity attributed to 
DNMT proteins is the establishment of newly methylated cytosines, termed 'de 
novo methylation'. CpG dinucleotides are thought to be primary targets of de 
nova methylation; however, non-CpG methylation may also occur during periods 
of DNA methylation establishment (Imamura et aL, 2005; Ramsahoye et aL, 
2000). 
ln mammals, there are three subfamilies of DNMTs that are classified 
according to sequence similarities (Goll and Bestor, 2005) (Figure 1.6). The 
primary and initially characterized DNA methyltransferase is DNMT1 (Bestor et 
aL, 1988). Subsequent studies showed that DNMT1 has a greater preference for 
hemimethylated DNA (Hsieh, 2005; Li et aL, 1992; Yoder et aL, 1997a) causing it 
to be assigned the function of maintenance methylation. Further strengthening 
this classification, DNMT1 is upregulated during the S-phase of the cell cycle 
(Szyf et aL, 1991), unlike other DNMTs (Robertson et al., 2000), and associates 
with DNA replication machinery (Rountree et aL, 2000). However, as DNMT1 
has also been shown to have de novo activity in vitro (Okano et aL, 1999), it 
remains unclear if DNMT1 performs this function in vivo. 
The essential nature of DNA methylation was first demonstrated by the 
targeted disruption of DNMT1 (Lei et aL, 1996; Li et aL, 1992). Disruption of 
catalytic activity of the protein results in mid-gestational embryonic lethality and a 
decrease in overall methylation levels to -5% of normal. Many phenomena 
associated with DNA methylation were shown to be disrupted, including gene 
imprinting (Li et aL, 1993), X-chromosome inactivation (Panning and Jaenisch, 
1996), and transposon silencing (Walsh et aL, 1998). 
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Although DNMT2 is the most conserved DNMT protein between 
organisms, disruption of this gene results in no decrease of DNA methylation in 
mouse cells (Okano et aL, 1998). Recently, it has been shown that DNMT2 
functions as an RNA methyltransferase in mammals (Goll et aL, 2006), consistent 
with the fact that DNMT2 is found in lower organisms that lack detectible 
quantities of DNA methylation. 
The DNMT3 subfamily consists of two catalytically-active members, 
DNMT3a and DNMT3b, and a homologous protein, DNMT3L (DNA 
methyltransferase 3-like), which lacks catalytic activity. DNMT3a and DNMT3b 
are encoded by separate genes and are postulated to function primarily as de 
nove methyltransferases (Okano et aL, 1999). Regulation of these genes is 
complex, as evidenced by the large number of alternative splicing variants that 
are produced (Aoki et aL, 2001; Chen et aL, 2002; Ishida et aL, 2003; Okano et 
aL, 1999; Weisenberger et aL, 2002; Weisenberger et aL, 2004). Of interest, a 
catalytically-functional splice variant of DNMT3a, DNMT3a2 is the predominant 
protein in germ cells (Chen et aL, 2002). 
Targeted disruption of both of DNMT3a and DNMT3b further underscores 
the essential nature of DNMT activity and DNA methylation in normal 
development. DNMT3a-deficient mice die 3-4 weeks after birth despite having 
normal levels of global methylation (Okano et aL, 1999). Targeted deletion of 
DNMT3b results in embryonic lethality occurring in mid gestation and causes 
demethylation of centromeric satellite sequences (Okano et aL, 1999). Mice 
engineered to have a double deletion of DNMT3a/3b die earlier during embryonic 
development and have globally hypomethylated genomes (Okano et aL, 1999). 
Similar effects of perturbing DNA methylation have been found· in studies on 
embryonic stem cells. In these studies, targeted deletion of DNMT3a or DNMT3b 
alone has little or no effect on genome-wide methylation, whereas double 
deletion results in extensive hypomethylation at multiple genomic loci, similar to 
levels seen in DNMT1-deficient cells (Hattori et aL, 2004). DNMT3b is the only 
DNMT to be associated with a human disease. Various mutations in this gene 
cause ICF (immunodeficiency, centromeric instability and facial anomalies) 
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syndrome, a disease associated with cytogenic abnormalities resulting from 
demethylation of centromeric regions of certain chromosomes (Xu et aL, 1999). 
Together, these studies indicate that DNMT3a and DNMT3b perform shared and 
separate functions. 
Although lacking sorne amino acids that confer catalytic activity, DNMT3L 
is similar to other DNMT3 family members in both its N- and C-terminal domains 
(Aapola et aL, 2000). DNMT3L is also of interest because its expression is 
predominant in the germ cells of both sexes (Aapola et al., 2001). It is important 
for the establishment of DNA methylation in both male and female germ cells 
(Bourc'his et aL, 2001; Bourc'his and Bestor, 2004; Hata et aL, 2002; Webster et 
al., 2005). Studies showing interactions between DNMT3L and DNMT3a and/or 
DNMT3b suggests that DNTM3L may function as a cofactor and stimulate de 
novo methylase activity (Chedin et aL, 2002; Hata et aL, 2002; Nimura et aL, 
2006; Suetake et aL, 2004; Suetake et aL, 2006). Consistent with its selective 
expression in germ cells, targeted disruption of this gene results in no observable 
somatic phenotype, but mice of both sexes are infertile (Bourc'his et aL, 2001; 
Hata et aL, 2002; Webster et aL, 2005). (A more comprehensive review of the 
germ ce II-specifie effects can be found in the subsequent section of the 
introduction, DNA Methyltransferases in Male Germ Ce Ils) 
1.3 DNA Methylation in Germ Ce Ils 
1.3.1 Tissue-Specifie DNA Methylation 
The reversible nature of DNA methylation led to the postulation that DNA 
methylation could be involved in the establishment of tissue-specifie expression 
patterns (Holliday and Pugh, 1975; Riggs, 1975). Different tissues acquire 
differential gene expression patterns although they arose from the same 
precursor cells during development. The role of DNA methylation as a director of 
this process is controversial (Bestor and Tycko, 1996), as direct evidence 
demonstrating causality is elusive. Studies have shown that as early as post-
43 
implantation embryonic development, tissue-specific methylation has occurred, 
evidenced by ail tissues of extra-embryonic origin containing methylation patterns 
distinct to that of the embryo proper (Chapman et al., 1984; Rossant et aL, 1986). 
More recently, studies have demonstrated that different tissues from within the 
same adult individual possess differential methylation patterns. Restriction 
land mark genomic scanning (RLGS), a technique that can visualize several 
thousand unique loci located throughout the genome simultaneously, has been 
used to demonstrate that ail tissues studied possess unique patterns of 
methylation to varying degrees (Shiota et aL, 2002), and the tissue-specific 
methylation status of sorne gene-specific loci correlate with levels of tissue-
specific expression (Song et aL, 2005). Recently, a study of severa 1 tissues in 
humans has reported similar results, where differences in methylation range 
between 5-20% between various cell types and tissues (Eckhardt et aL, 2006). 
1.3.2 Male Germ Cell-Specific DNA Methylation 
Although genome-wide patterns of DNA methylation are established de 
novo in early embryos, germ cells undergo a second period of reprogramming 
that occurs later in embryonic development (Reik et aL, 2001). Data from studies 
on imprinted genes, repeat sequences and germ-cell specific genes (Hajkova et 
aL, 2002; Lees-Murdock et al., 2003; Maatouk et aL, 2006) demonstrate that 
before and upon arrivai to the genital ridges around 10.5-11.5 dpc, migrating 
PGCs possess a pattern of DNA methylation that is somatic in nature. As PGCs 
colonize the genital ridges, patterns of DNA methylation in PGCs are erased. 
Germ cell patterns are re-established at a later stage in development in a sex-
specific manner. Due to the small numbers of germ cells at the se stages, the full 
extent and sequence specificity of the reprogramming is largely unknown. In the 
case of imprinted genes, the sequences and the timing of the acquisition of DNA 
methylation are sex-specific. In female PGCs, DNA methylation of maternally-
methylated imprinted DMRs is acquired after birth during the oocyte growth 
phase (Lucifero et aL, 2004). In males, PGCs begin to re-acquire DNA 
methylation between 15.5-17.5 dpc, a period much earlier th an in the female 
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(Hajkova et aL, 2002). Repeat sequences such as the intracisternal A particle 
(IAP), long interspersed transposable elements (UNEs) and satellite sequences 
show a similar timing of erasure and establishment (Hajkova et aL, 2002; Lees-
Murdock et aL, 2003; Walsh et aL, 1998). However, unlike imprinted genes, 
methylation is not fully erased at repeat sequences. The timing of the acquisition 
of DNA methylation coincides with high levels of the germ cell-specific protein 
Dnmt3L in both sexes (Bourc'his et aL, 2001; La Salle et aL, 2004), as weil as a 
sharp increase in the antigenicity of germ cells for an antibody directed against 
5mC in the male (Coffigny et aL, 1999). 
There are several possibilities that have been suggested to explain the 
necessity of germ cell-specific reprogramming, which include the regulation of 
germ cell-specific gene expression, the setting of genomic imprints and the 
establishment of chromatin structure. Although the primary purpose of germ cell 
reprogramming is unclear, there ate sorne studies that hint that the pattern of 
DNA methylation that is acquired as a result of this reprogramming event is 
distinct from other cells. 
1.3.2.1 Methylation and Testis-Specific Gene Expression 
The germ cells of the testis display the most unique tissue-specific global 
transcriptional profile of any tissue or cell type examined in both mouse and 
human (Shima et al., 2004; Su et al., 2004). The high number of genes 
expressed in the testis is presumably a requirement of the specialized processes 
of meiosis and spermiogenesis. A few of thesegenes have been shown to 
display testis-specific methylation states (MacLean and Wilkinson, 2005). 
Included in these are the transition protein genes, Tp1& Tp2, and the protamine 
genes, Prm1 & Prm2, that are expressed during spermatid development to 
facilitate nuclear remodeling (Trasler et aL, 1990). Pdha2 and Pgk2 are 
autosomal homologs of the X-linked genes whose activation is required when XV 
body formation silences the X chromosome during spermatocyte development 
(Ariel et aL, 1991; lannello et aL, 1997). Most testis-specific genes that display a 
testis-specific methylation state are hypomethylated in their 5' regions, reflecting 
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their activated status. However, the Prm1, Prm2 and Tp2 exist as a single gene 
cluster and, curiously, this region is specifically hyperrnethylated in the testis 
despite being the exclusive tissue of expression (Trasler et aL, 1990). Another 
gene, the human cyclin A gene, CCNA 1, is methylated in gerrn cells of the testis 
and hypomethylated in other tissues, even though the testis is its preferential site 
of expression (Muller-Tidow et aL, 2001). Although the number of testis-specific 
genes that have been shown to be associated with altered methylation pales in 
comparison to the total number of genes with unique levels of expression in the 
testis, it is likely that methylation plays a role in the control of these few 
examples. Why the numerous other testis-specific genes do not show this 
association and how sorne testis-specific genes are highly expressed despite 
being hyperrnethylated specifically in the testis is unclear and casts doubt on the 
hypothesis that gene regulation is the primary purpose for testis-specific DNA 
methylation. 
1.3.2.2 Genomic Imprinting in Male Germ Cells 
A second function of gerrn cell reprogramming is the setting down of 
genomic imprints. Imprinted genes are methylated on either the maternai or 
paternal allele, resulting in an overall 50% level of methylation in adult somatic 
tissues. Depending on the parental nature of the imprint, these loci will be either 
fully methylated or unmethylated in the gerrn cells of the testis resulting in a 
methylation state distinct to somatic tissue. There is an extreme dichotomy 
between the proportion of imprinted regions known to be methylated on paternal 
versus maternai alleles (Bourc'his and Bestor, 2006). Only three regions have 
been described to be methylated in sperrn versus oocytes. These three 
paternally-methylated DMRs are found in the H19-lgf2 region (Tremblay et aL, 
1995), the Dlk1-Gt/2 region (Takada et aL, 2002) and upstream of the Rasgrf1 
gene (Yoon et aL, 2002). The regions marked by paternally-methylated imprints 
are different from those that are associated with testis-specific genes. Paternally-
methylated DMRs tend to be found in intergenic regions that are several 
kilo bases away from the genes that they control, whereas altered methylation 
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found in testis-specific genes are directly associated. In addition, the methylation 
of paternally-imprinted DMRs seems to function by blocking access to distant 
enhancer sequences instead of directly influencing the function of proximal 
promoter regions (Bourc'his and Bestor, 2006). Although methylation occurs 
mostly on maternai alleles for imprinted genes, correct levels of expression of 
imprinted genes in offspring depends on the cumulative methylation state of both 
parental alleles. Abnormal expression of gametic imprints has been associated 
with several human disease syndromes, including Prad er-Will i, Beckwith-
Wiedemann and Angelman syndromes (Robertson, 2005). 
1.3.2.3 Repetitive Elements 
It has been shown that gametic reprogramming results in a difference in 
the methylation status of sorne repetitive sequences between somatic and germ 
ceUs. Centromeric repeat sequences, particularly the major and minor satellite 
sequences, are distinctly hypomethylated in the germ cells of both sexes in 
humans and mice (Gama-Sosa et aL, 1983; Sanford et aL, 1984). This is in 
contrast to findings on other repeats of mainly interspersed transposable element 
origin. IAP, UNE and major urinary protein (MUP) sequences are methylated in 
mature sperm (Sanford et aL, 1984; Walsh et aL, 1998). However, in humans 
and primates, Alu repeat sequences are hypomethylated in sperm relative to 
somatic tissues (Hellmann-Blumberg et aL, 1993; Kochanek et aL, 1993; Liu et 
aL, 1994). Methylation of centromeric repeats are thought to provide mainly a 
structural function to chromosomes (O'Neill et aL, 1998; Viegas-Pequignot and 
Dutrillaux, 1976; Xu et aL, 1999); although the purpose of their hypomethylation 
in germ cells is not clear, it may represent a modified chromosome structure 
requirement of germ ce II-specifie processes, such as meiosis. 
A more complete picture of DNA methylation patterns in male germ cells 
has not been produced. Many repetitive sequences and most non-CGI unique 
sequences, despite composing a majority of the entire genome, have not been 
interrogated. Due to the involvement of DNA methylation in the development of 
male germ cells, it has been postulated that DNA methylation may play a role in 
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male infertility although very little work has been done to' support this hypothesis 
(Cisneros, 2004). The purpose(s) of the germ cell reprogramming and DNA 
methylation in germ cells will become clearer once a comprehensive germ cell 
pattern of DNA methylation is established. 
1.3.3 Acquisition of DNA Methylation during Spermatogenesis 
Although it has been established that the acquisition of DNA methylation 
begins during fetal germ cell development, few studies have investigated the 
changes in DNA methylation during spermatogenesis. Spermatogenesis begins 
a few days after birth in the mouse, when germ cells resume the cell cycle to 
produce a pool of undifferentiated type A spermatogonia (Reviewed by Russell et 
aL, 1990). Around 8 dpp, germ cells differentiate into type B spermatogonia and 
enter meiosis around 10 dpp. For testis-specific genes, the hypomethylated state 
is fully established prior to spermatogenesis (Kafri et al., 1992; Maatouk et al., 
2006). The methylation status of Pgk2, has been weil studied in various stages 
of spermatogenesis and is found to remain unmethylated through meiotic and 
spermiogenic phases (Geyer et aL, 2004). Repetitive elements, such as IAP and 
LlNE-1, are fully methylated in spermatozoa and have acquired this state by 17.5 
days of gestation (Lees-Murdock et aL, 2003; Walsh et al., 1998). Although the 
major and minor satellite centromeric repeàt sequences are partially methylated 
in germ cells, their status remains unchanged during spermatogenesis (Sanford 
et aL, 1984). Interestingly, studies on imprinted genes have shown that complete 
acquisition of methylation does not occur until after birth. H19, a paternally-
methylated imprinted gene, initially acquires methylation before birth; however, 
complete levels of DNA methylation are not achieved until the pachytene 
spermatocyte phase of spermatogenesis (Davis et aL, 1999). The late 
acquisition was shown to occur specifically on the allele of maternai origin, 
indicating the involvement of other epigenetic factors in genomic reprogramming. 
The two other known paternally methylated imprinted genes, Rasgrf1 and Gt/2, 
similarly acquire most of their DNA methylation in the pre-natal window, but have 
yet to acquire the levels found in spermatozoa (Li et al., 2004). Although limited 
48 
data point to the acquisition of DNA methylation patterns beyond the fetal 
development window, a comprehensive study of the timing and sequence-types 
that may be involved has not been done. 
1.3.4 DNA Methyltransferases in Male Germ Cells 
The importance of DNA methylation in male germ cells has been 
highlighted by studies investigating the roles for the DNMT family of enzymes. Ali 
known members of the DNMT family are expressed in male germ cells and are 
expressed in a developmentally regulated fashion to varying degrees, (La Salle et 
aL, 2004; La Salle and Trasler, 2006a; Shima et aL, 2004). In addition, sorne are 
expressed as alternative transcripts that are only found in germ cells (La Salle 
and Trasler, 2006b). For example, the expression of Dnmt1 in male pachytene 
spermatocytes is marked by the inclusion of an alternative 5' exon that prevents 
translation of the transcript despite an enrichment of the protein in 
leptotene/zygotene spermatocytes (Jue et aL, 1995). 
Knock-out studies have highlighted a role for several Dnmts in various 
stages of germ cell development (Bourc'his et aL, 2001; Bourc'his and Bestor, 
2004; Kaneda et aL, 2004). The germ ce II-specifie gene, Dnmt3L, although 
lacking catalytic activity, is highly expressed in PGCs beginning at 15.5-18.5 dpc 
(Bourc'his et aL, 2001) and not in somatic tissues (Aapola et aL, 2001). Males 
lacking a functional Dnmt3L gene are infertile as a result of a complete lack of 
germ cells in the adult testes (Bourc'his et aL, 2001). Their infertility is a result of 
a structural failure of meiotic chromosomes to properly synapse which 
presumably leads to apoptosis via the activation of the pachytene checkpoint 
(Bourc'his and Bestor, 2004). Intriguingly, a failure to establish normal genomic 
levels of DNA methylation in spermatocytes isolated from Dnmt3L (-1-) animais is 
observed, including severa 1 types of interspersed repeat sequences, such as 
LlNE-1 and IAP. Various paternally-methylated imprinted DMRs are 
• undermethylated including H19 (Bourc'his and Bestor, 2004; Kaneda et aL, 2004; 
Webster et aL, 2005) and Rasgrf1 (Webster et aL, 2005). Further studies have 
revealed that the fa il ure to acquire DNA methylation extends to the imprinted 
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intergenic DMR, Dlk1-Gt/2, and to widespread non-repetitive loci (La Salle et aL, 
2007). 
Other DNMT enzymes are ubiquitously expressed, thus the dissection of 
a germ ce II-specifie effect in the whole-animal knock out models is difficult. 
Although the germ cell-specific conditional targeted disruption of Dnmf1 has not 
been done, Dnmf3a and Dnmf3b have been conditionally disrupted in germ cells. 
The conditional disruption of the Dnmf3a gene in germ cells leads to a similar 
phenotype of infertility due to a complete loss of germ cells in the adult testis 
(Kaneda et aL, 2004). Spermatogonia isolated from Dnmf3a(-I-) animais show 
defects in methylation at imprinted genes but not at repeat sequences (Kaneda et 
al., 2004). Conditional disruption of the Dnmf3b gene had no detectible effect on 
germ cell viability, emphasizing that the roles for these proteins are distinct. The 
developmental regulation and requirement of various DNMTs during 
spermatogenesis highlights the importance of DNA methylation for the proper 
development of fertile male germ cells. 
1.3.5 Effect of 5-Aza-2'Deoxycytidine in Male Germ Ce Ils 
The disruption of spermatogenesis and lack of fertile germ cells in DNMT 
knock-out animal models makes the study of germ cells in later stages of 
development impossible and negates the ability to measure fertility effects. An 
alternate strategy to perturb DNMT function is the use of the cytidine analog, 5-
aza-2'-deoxycytidine (5-azaCdR). 5-azaCdR is currently used as an anti-cancer 
agent for myelodysplastic syndromes and other types of cancer, due to its ability 
to cause demethylation and cytotoxicity. Upon interaction with 5-azaCdR that 
has been incorporated into DNA, DNMT eniymes become irreversibly bound to 
DNA as a covalent adduct (Gabbara and Bhagwat, 1995; Santi et aL, 1984; 
Taylor and Jones, 1982). Hypomethylation occurs during subsequent rounds of 
DNA replication due to the depletion of the cellular pool of DNMTs. Adducts are 
cytotoxic and induce apoptosis in a p53-dependent manner (Juttermann et aL, 
1994; Schneider-Stock et aL, 2005). Notably, decreases in methylation can 
occur at non-cytotoxic concentrations of 5-azaCdR that do not significantly impair 
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DNA synthesis (Glazer and Knode, 1984; Mondai and Heidelberger, 1980). Use 
of 5-azaCdR offers an advantage as this agent inhibits both known 
(Weisenberger et aL, 2004) and potentially unknown methyltransferases. 
5-AzaCdR has been used in a series of experiments that further highlights 
the importance of DNA methylation in male germ cells. Male mice treated with 
the drug during the entire developmental window of spermatogenesis display 
considerable adverse effects to their reproductive physiology (Kelly et aL, 2003). 
Male rats treated with an analogous drug, 5-azacytidine, show similar effects 
(Doerksen et aL, 2000; Doerksen and Trasler, 1996). Effects include 
abnormalities in testicular histology leading to significant reductions in testis 
weight and reduced sperm counts. Litters sired by treated males are smaller, 
owing to an increase in pre-implantation embryo loss. These reproductive effects 
occur at doses that do not affect the overall health of the animais. Interestingly, 
mice that are heterozygous for a loss-of-function mutation in the catalytic domain 
of the DNMT1 protein (Lei et aL, 1996) are partially protected from the adverse 
effects of the drug. In both rodent studies, abnormalities were associated with 
dose-dependent global reductions in DNA methylation. These studies further 
support the importance of DNA methylation to the proper development of male 
germ cells; however, effects caused by the cytotoxic properties of the drugs 
cannot be excluded. 
1.4 Approaches to the Study of DNA Methylation 
There are many techniques that have been developed for the study of 
DNA methylation. A summary and comparison of severa 1 commonly used 
methods and the methods used in this thesis is displayed in table 1 .1. Until 
recently, the study of DNA methylation has been largely restricted to investigating 
individual sequences. Frequently used techniques such as bisulfite sequencing 
and Southern blotting allow for the analysis of methylation of either unique-copy 
sequences or a particular repeat. While these approaches have generated useful 
and informative data, the size and complexity of mammalian genomes makes any 
study based on a focused number of loci limited in its overall interpretative power. 
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Global techniques also are available that measure total cytosine content 
(generally done using high-performance liquid chromatography) or overall 
methylation at CCGG sites (done using thin-layer chromatography). These 
techniques are limited because they have low sensitivity and fail to identify 
sequences affected. Non-biased, genome-wide approaches that allow for the 
investigation of various sequence types simultaneously have recently been 
developed. These techniques allow for DNA methylation to be analyzed in more 
depth and to determine the specificity of alterations in DNA methylation between 
samples. 
1.4.1 Restriction landmark Genomic Scanning 
Restriction land mark genomic scanning (RLGS) is a technique that allows 
for the investigation of a relatively large number of loci simultaneously. The 
technique was pioneered by Hayashizaki et al. (Hayashizaki et al., 1993) and is 
in current use in laboratories around the world. Using RLGS, the methylation 
status of approximately 3000 individual CpG sites in unique-copy and low-copy 
number sequences across the genome are revealed by digestion of genomic 
DNA using the methylation sensitive restriction enzyme, Notl (Figure 1.7). DNA 
fragment ends are then radiolabeled and separated by 2-dimensional 
electrophoresis producing an array of spots, with each spot corresponding to an 
individual CpG site located randomly in the genome. The relative intensity of 
each spot is inversely proportional to the percentage of methylation at that locus. 
RLGS has been very useful in the study of cancer (Rush and Plass, 2002) and 
other diseases related to DNA methylation (Kondo et al., 2000). 
1.4.1.1 Virtual RlGS 
An early drawback of the RLGS technique was the difficulty involved in 
identifying the genomic loci associated with spots of interest. This was initially 
overcome by the production of RLGS spot cloning libraries; a bacterial plasmid 
library containing individual RLGS DNA fragments that could be used to identify 
RLGS spots (Smiraglia et al., 1999; Yu et al., 2004). Although effective, spot 
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identification using the RLGS library is fairly laborious and inefficient. The 
usefulness of the RLGS technique has been increased substantially as a result of 
the recent development of a virtual RLGS (vRLGS) resource. In combination with 
the sequencing of the human and mouse genomes, vRLGS produces a 
computer-generated spot pattern that closely resembles the actual RLGS profile 
of a given species. Total genomic sequence is digested 'in silico' and carefully 
formulated migration algorithms predict spot positions in two-dimensions (Figure 
1.8) (O. Smiraglia, unpublished). This allows for hastened spot identification by 
identifying candidate loci (virtual spots that are in close proximity to the spot of 
interest on overlapping virtual and actual profiles). The correct candidate locus is 
identified by obtaining plasmid or bacterial artificial chromosome (BAC) clones 
that contain each candidate locus and mixing clone DNA with genomic DNA as 
background. Virtual RLGS analysis also allows for determination of the subset of 
sequences that are visible on actual RLGS profiles. .Due to the high GC content 
of the Notl recognition sequence (GCGGCCGC), approximately 70% of the loci 
visualized by RLGS correspond to CpG islands, despite CGls encompassing less 
than 1 % of the genomic sequence (Fazzari and Greally, 2004). Because CGls 
are mostly associated with genes, the total dataset generated by RLGS is gene-
centric. Approximately 15% of the analyzable loci are found in interspersed 
transposable elements. Specifically, 240 and 60 Notl sites are found in the 
internai regions and LTRs of the IAP and early transposon (ETn) interspersed 
repeats, respectively. Due to their repetitive nature, their 'migration' produces a 
highly discernable pattern on vRLGS gels. However, they are rarely observed on 
actual RLGS profiles due to their constitutively hypermethylated nature. The 
remaining 15% of the loci analyzed result from Notl sites that are found randomly 
in unique sequences, mostly in intronic and intergenic sequences. 
1.4.2 Tiling Arrays 
An emerging approach to investigate genome-wide patterns of DNA 
methylation is the use of tiling array technology. Tiling arrays are constructed to 
contain thousands to millions of individual DNA fragments (features), which are 
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attached to a solid support. Tiling arrays can be designed to analyze parts of the 
genome (Le. individual chromosomes) and/or specifie classes of sequences (Le. 
promoters). Individual array features can be larger (-1 kb) (Lippman et aL, 2004) 
and result in low resolution analysis or can be designed using oligonucleoties of 
20-50 nucleotides in length (high resolution) (Schumacher et aL, 2006). DNA is 
prepared by either immunoprecipitation using an antibody to 5mC or digestion 
using methylation sensitive restriction enzymes followed by dual fluorescent 
labeling. Although the promise of this technology is high, it is currently expensive 
to design and manufacture the a rra ys , making analysis of numerous 
samples/conditions not feasible. Data that are generated using this technique 
are non-quantitative making the investigation of partial - yet potentially 
biologically important changes in DNA methylation that may occur at a particular 
locus difficult to interpret. In addition, because the length of individual tiles on an 
array is relatively short, interpretation of interspersed repetitive loci is problematic 
due to cross hybridization. This leaves approximately 40% of the total sequence 
of the mammalian genome uninvestigated using this method. Altematively, 
because RLGS fragment sizes are relatively large, the methylation status of a 
single interspersed repetitive element located in a unique genomic position can 
be interrogated. 
1.4.3 Quantitative Analysis of Unique Loci 
The investigation of DNA methylation using RLGS generates information 
on multiple single CpGs located in numerous loci across the genome. 
Confirmation of the RLGS findings and further investigation of the methylation 
status of additional CpGs at these and other loCi presents a formidable challenge. 
A suitable technique for this purpose would have to satisfy two major 
requirements: firstly, it would need to be flexible and rapid enough to handle 
numerous individual genomic regions, and, secondly, be quantitative so that 
partial changes in DNA methylation could be reproducibly detected. 
There are many techniques that have been developed that can assess 
methylation with single CpG resolution (for review see (Tollefsbol, 2004). This 
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was initially done by digesting DNA using methylation-sensitive restriction 
enzymes followed by sequence detection using Southem blotting. Since then, 
several additional techniques have been developed; however, most do not 
produce a quantitative assessment. Of the methods that are quantitative, the 
bisulfite sequencing technique is the most widely used. Bisulfite sequencing 
generates methylation information by initially treating the DNA with sodium 
bisulfite which selectively converts non-methylated cytosines to uracil while 
leaving methylated cytosine resides unaffected (Clark et al., 1994). Following 
conversion, CpGs of interest are f1anked by primers and PCR amplified. DNA 
fragments are sub-cloned and sequenced. Although this technique is unmatched 
by ail other techniques because ail CpGs in a small region are analyzed, the 
primary drawback is the length of time required for bisulflte conversion and 
subsequent sub-cloning and sequencing steps. There have recently been 
techniques that are quantitative and avoid lengthy cloning ·steps including QMSP 
(Lo et al., 1999), QAMA (Zeschnigk et al., 2004), Bio-CORE (Brena et al., 2006); 
however, these techniques still involve the use of sodium bisulfite. Further 
drawbacks of the use of bisulfite include high rates of sample loss (Grunau et al., 
2001), instability of bisulfite-treated DNA, PCR amplification bias and artifacts 
that result from incomplete conversion of cytosines to uracil. 
Chapter Il of this thesis describes in detail the development and evaluation 
of an approach that avoids the drawbacks of the use of bisulfite, while taking 
advantage of the speed and accuracy of real-time PCR technology. 
1.5 Rationale for Thesis Studies 
As our understanding grows about the nature of genes and how their 
behavior is related to the chromosomal environ ment in which they function, so is 
our appreciation of the influence of epigenetics and DNA methylation. The links 
between abnormalities in DNA methylation and broad disease states, such as 
cancer, and natural phenomena, such as aging, are undeniable. The fact that 
DNA methylation represents an adaptable, essential piece of our genetic makeup 
that is acquired in every individual of each generation speaks to its importance. It 
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is within our germ cells that the epigenetic patterns are established that support 
healthy embryonic development and the health of our offspring. Alterations in 
germ cell acquired patterns of methylation are most likely the cause of imprinting-
related disease syndromes and may be related to infertility. Furthermore, genes 
that are normally restricted to germ cells are commonly found erroneously in 
tumors and associated with abnormal states of DNA methylation (Simpson et al., 
2005). A clear appreciation of the genome-wide nature of the germ cell 
epigenetic program, its- acquisition, and its stability is paramount to the 
understanding of these very important processes and how they may contribute to 
human disease. 
As discussed previously, there are several lines of evidence that 
demonstrate that DNA methylation and germ cell function/viability are linked. The 
important members of the DNMT family of enzymes are highly regulated during 
pre-natal development and spermatogenesis. Germ cell-specific disruption of 
DNMTs results in cell death and alterations in DNA methylation in germ cells. 
Treatment of mice with 5-aza-2'-deoxycytidine results in decreased 
spermatogenesis and abnormal embryo outcomes. 
Due to the strong association between DNA methylation and several 
aspects of germ œil biology, it is very likely that distinct properties of DNA 
methylation are playing key roles in male germ cells. The purpose of this 
dissertation is to ad vance our current understanding of DNA methylation in male 
germ cells. To address this, the following questions were asked: 
1. What is the pattern of DNA methylation of male germ cells of the adult? 
How does this pattern differ from that of other cells? 
2. Are patterns of DNA methylation acquired during spermatogenesis? 
3. Is it possible to perturb patterns of DNA methylation in male germ cells 
by altering DNMT function during spermatogenesis? How does this effect 
germ cell quality? 
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To ask these questions, we employed the RLGS technique, due to its 
ability to determine methylation at multiple sequences on a genome-wide scale. 
ln order to fully employ the RLGS technique to it fullest extent, it was necessary 
to develop a technique that could be used in concert with RLGS to verity and 
expand upon the RLGS findings. This newly developed technique, termed 
quantitative analysis of DNA methylation using real-time PCR (qAMP), was 
extensively tested in its ability to accurately assess site specifie levels of 
methylation determined by RLGS. The technique was further evaluated against 
other sites of known methylation, including imprinted genes, and by using bisulfite 
sequencing, the widely-accepted go Id standard of DNA methylation analysis. 
The use of RLGS and qAMP in combination with other standard 
techniques for DNA methylation analysis has allowed for the studies presented in 
this thesis to assess DNA methylation in male germ cells in a scope and level of 
detail not accomplished previously. The results of the se studies have important 
implications for understanding the roles of DNA methylation in germ cells and 
many other biological systems. 
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Table 1.1: A comparison of methods for DNA methylation analysis: 
Method 
Southern 
Siotting 
HPLC 
Tiling Arrays 
RLGS 
Sisulfite 
Sequencing 
MSP 
Bisulfite-
Based? 
N 
N 
YIN 
N 
Y 
Y 
Scope 
genome-wide 
genome-wide 
genome-widel 
loci-specifie 
genome-widel 
loci-specifie 
loci-specifie 
Accuracy 
quantitative 
quantitative 
semi-
quantitative 
quantitative 
Sensitivity 
low 
low 
low 
low 
Processing 
Time, Cost 
5-6 days, 
low 
1 day, 
low 
1-2 days, 
Very high 
7-14 days, 
high 
semi- 5-7 days, 
quantitative high high 
non- 2-4 days, loci-specifie high quantitative low 
qAMP N loci-specifie quantitative medium-high ~~~~m 
HPLC, high-performance liquid chromatography; RLGS, restriction landmark genomic scanning; 
qAMP, quantitative analysis of DNA methylation by real-time PCR; MSP, methylation-specific 
PCR 
Figure 1.1: Diagram of epigenetic reprogramming events that occur in the 
male germ line. At fertilization and during the preimplantation stages of 
embryonic development, gametic patterns of DNA methylation are erased. At 
-3.5 dpc, the inner cell mass cells of the blastocyst, cells that are the progenitor 
cells of ail of the embryonic cell lineages, establish a new pattern of DNA 
methylation. This pattern is the foundation for ail of the somatic cell lineages. 
Germ cells are specified -6.5-7.5 dpc from the proximal epiblast and migrate 
through the developing embryo to arrive at the g.enital ridges at -10.5-11.5 dpc. 
Germ cells arrive at the genital ridges with a somatic pattern of DNA methylation. 
Around this time, the somatic pattern is erased, and, in the male, a new germ cell 
pattern is established beginning -13.5 dpc which continues to be established 
during fetal development. 
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Figure 1.2: Schematic representation of seminiferous tubules within the 
testis. Germ cel! populations are shown in the context of their localization in the 
tubule, with immature spermatogonia Iying along the basement membrane and 
spermatids near the lumen. The basal and adluminal compartments of the testis 
are also shown. Adapted fram (Gilbert, 2000) and reprinted with permission fram 
Sinauer Associates, Inc. 
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Figure 1.3: Schematic representation of spermatogenesis. A) The 
development of mature spermatozoa results from germ cells passing through 
three phases: proliferation, meiosis and spermiogenesis. Mitotic diploid 
spermatogonia divide and differentiate before entry into meiosis. T etraploid 
spermatocytes pair homologous chromosomes, undergo recombination and 
divide twice without DNA replication to yield haploid spermatids. Spermatids 
undergo the process of spermiogenesis which results in the formation of mature 
spermatozoa. 
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Figure 1.4: Schematic representation of the conversion of cytosine to 5-
methylcytosine by DNA methyltransferases. DNMTs catalyze the transfer of a 
methyl group trom the cofactor S-adenosylmethionine (SAM) to the position 5' of 
the cytosine ring, creating 5-methylcytosine (5mC) and S-adenosylhomocysteine 
(SAH). 
Cytosine 5-methylcytosine 
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Figure 1.5: The distribution of CpG dinucleotides in the human and mouse 
genomes. The proportion of CpG dinucleotides located in unique sequence 
(right hait) and transposable element (Ieft hait) compartments of the genomes of 
mouse and human are shown. The proportion of total CpGs found in CpG 
islands is shown in green. CpG islands are exclusively made up of non-
transposable element sequence. Data obtained from Fazzari and Greally (2004) . 
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Figure 1.6: Organization of known mammalian DNA methyltransferases. 
Specifie motifs are represented by black boxes; five of the important amino acid 
motifs involved in catalytic activity are iIIustrated to demonstrate homology in the 
catalytic domain (adapted from Bestor (2000) Hum Mol Gen. 9:2395). The 
primary methylation activity ascribed to each protein is indicated (Goli and Bestor, 
2005). 
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Figure 1.7: Schematic diagram of the RLGS method. Notl sites in genomic 
DNA are c1eaved only if they are unmethylated. Both 5' and 3' ends are labeled 
by a fill-in reaction with radioactive nucleotides. Notl-Notl DNA fragments are 
reduced to smaller sizes with the EcoRV restriction enzyme which is not sensitive 
to DNA methylation. These DNA fragments are run in an aga rose tube gel (1 st 
dimension electrophoresis). The gel is extracted from the tubular sheath and 
while the fragments remain within the gel, they are digested in situ with another 
methylation insensitive enzyme, HinFI. The aga rose tube gel is then connected 
to a polyacrylamide gel and the fragments are run in the second dimension. 
Spots visible on RLGS profiles represent hypomethylated loci, whereas spots that 
are missing in comparison to others are hypermethylated. 
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Figure 1.8: Virtual and actual RLGS profiles. Virtual RLGS profiles are 
generated by in silico digestion of an entire genomic sequence using the same 
recognition sequences cleaved by restriction enzymes used in the generation of 
actual profiles. An algorithm that predicts two-dimensional fragment migration 
based on fragment length, curvature and rigidity is used to produce the virtual 
spot pattern. Virtual RLGS can very accurately predict the positions of actual 
spots; differences arise trom missing sequence in current genomic builds or 
hypermethylation of Not! sites in actual RLGS profiles. 
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CHAPTER Il 
Evaluation of a Quantitative DNA Methylation Analysis Technique using 
Methylation-Sensitive/Dependent Restriction Enzymes and Real-Time PCR 
Christopher C. Oakes, Sophie La Salle, Bernard Robaire & Jacquetta M. Trasler 
Epigenetics (2006) 1: 146-152 
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ABSTRACT 
DNA methylation in mammals has been shown to play many important 
roles in diverse biological phenomena. Several methods have been developed 
for the measurement of region-specifie levels of DNA methylation. We sought a 
technique that cou Id be used to quantitatively evaluate multiple independent loci 
in several tissues in a quick and cost-effective manner. Recently, a few 
quantitative techniques have been developed by employing the use of real-time 
PCR, though they require the additional step of sodium bisulfite conversion. Here 
we evaluate a technique that involves the digestion of non-sodium bisulfite-
treated genomic DNA using methylation-sensitive and methylation-dependent 
restriction enzymes followed by real-time PCR. The utility of this method is 
tested by analyzing seventeen genomic regions of known tissue-specifie levels of 
DNA methylation including three imprinted genes. We find that this approach 
generates rapid, reproducible and accu rate results (range= ±5%) without the 
additional time required for bisulfite conversion. This approach is also adaptable 
for use with smaller amounts of starting material. We propose this method as a 
rapid, quantitative method for the analysis of DNA methylation at single sites or 
within small regions of DNA. 
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INTRODUCTION 
ln the genomes of mammals, the majority of cytosine molecules within the 
CpG dinucleotide sequence are methylated at the fifth carbon of the cytosine 
ring. DNA methylation is involved in normal biological phenomena such as X 
chromosome inactivation (Avner and Heard, 2001) and genomic imprinting (da 
Rocha and Ferguson-Smith, 2004). Modifications of DNA methylation patterns 
have been found to occur in cancer (Robertson, 2005) and aging (Issa, 2000) 
Restriction landmark genomic scanning (RLGS) is a useful method that 
generates information on the DNA methylation status of multiple unique genomic 
loci from a single DNA sample. We sought a technique that could be used in 
concert with RLGS to confirm and further evaluate the DNA methylation status of 
the many loci that are explored by this method. To be efficient for this purpose, 
we required a rapid, flexible assay, yet one that could quantitatively measure a 
full range of DNA methylation. 
A variety of techniques have been used to detect site-specific levels of 
DNA methylation (Tollefsbol, 2004). The bisulfite genomic sequencing method is 
unmatched in its ability to determine methylation at ail CpG dinucleotides within a 
small region of DNA providing the highest level of resolution and information. 
However, this method is not appropriate for the investigation of large numbers of 
loci because of the costs and time requirements involved. Novel quantitative 
techniques that investigate a smaller number of CpG dinucleotides by using 
sodium bisulfite-conversion, such as Ms-SNuPE (Gonzalgo and Jones, 1997) 
and Bio-COBRA (Brena et aL, 2006), are useful because they are faster, but the 
analysis requires gel electrophoresis followed by densitometry. QMSP (Lo et aL, 
1999) and QAMA (Zeschnigk et aL, 2004) employ time-saving real-time PCR 
technology, but still require the additional step of bisulfite conversion. Other 
drawbacks of the use of sodium bisulfite include incomplete conversion and loss 
of the DNA sample (Grunau et aL, 2001). 
Here we describe an alternative technique that can be used to rapidly 
profile the DNA methylation status of numerous loci without the use of sodium 
bisulfite. This technique has three basic steps: 1) the digestion of a DNA sample 
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of interest with several methylation-sensitive enzymes (MSREs) and a 
methylation-dependent restriction enzyme (MDRE); 2) the designing of primers to 
specific genomic regions; 3) a real-time PCR amplification reaction to monitor the 
formation of the PCR product. A similar strategy combining a MS RE and MDRE 
has been successfully used previously (Yamada et al., 2004); however, the 
method was limited to a non-quantitative assessment. Although this strategy 
investigates fewer CpGs than the bisulfite-sequencing technique, by generating 
data in a single day this method is substantially faster and more economical. 
There are also several additional advantages over other bisulfite-based 
quantitative techniques that include a simplified oligonucleotide design strategy, 
no standard curve measurements and increased template stability. 
ln this study, we evaluate the ability of this technique to accurately assess 
site- and region-specific differences of DNA methylation between tissues with 
known levels of DNA methylation, including three imprinted genes. The results of 
these experiments demonstrate that this assay is a rapid and accu rate way of 
determining levels of DNA methylation. We find that this method, termed here as 
quantitative analysis of DNA methylation using real-time PCR (qAMP), is a 
valuable analytical tool suitable for the investigation of site- and region-specific 
levels of DNA methylation. 
MATERIALS & METHODS: 
DNA Isolation 
Adult male C57BU6 mice were obtained from Charles River Laboratories 
(St-Constant, Ouebec). Ali animal studies were conducted in accordance with 
the principles and procedures outlined in the Guide to the Gare and Use of 
Experimental Animais prepared by the Ganadian Gouncil on Animal Gare. 
Genomic DNA was isolated from liver, intestine, brain and testis using either 
proteinase K and phenol followed by dialysis (Okazaki et al., 1995) or the 
DNeasy Tissue Kit from Oiagen (Germantown, MD, USA). 
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Preparation of DNA templates 
First, a set of PCR templates is created for each DNA sample; each set is 
composed of separate tubes of DNA of equal concentration that have been 
digested with a single restriction enzyme (Figure 2.1). Restriction enzyme 
digests include three groups: 1) a mock digestion with no enzyme (sham); 2) 
MSRE digests which cleave the DNA strand if the restriction site(s) are 
unmethylated; 3) a MD RE digest using the homing endonuclease, McrBC which 
cleaves the DNA strand only if it is methylated. 
Each DNA sample is homogenized and sheared by repeatedly passing the 
sample through a 27% gauge needle attached to a 1 ml syringe resulting in an 
average fragment size of -4-5 kb. The DNA is th en distributed equally to as 
many tubes as required for the desired number of individual digestions. Here we 
used amounts of DNA starting mate rial ranging from 2 I-Ig - 2 ng for each 
digestion reaction. For the template set using 2 I-Ig per digestion, DNA was 
diluted to 50 ng/l-ll, distributed to separate tubes and digested in a volume of 50 1-11 
with 25 units of Notl, Hpall, Hhal, McrBC, or no enzyme for 4-5 hours according 
to the manufacturer's suggested conditions. Notl and Hpall were purchased from 
Invitrogen (Carlsbad, CA, USA) and Hhal and McrBC were purchased from New 
England Biolabs (Ipswich, MA, USA). After digestion, each PCR template was 
diluted 8-fold in water and incubated at 65° for 30 minutes to inactivate the 
enzyme. For DNA amounts of 200 ng, 20 ng, and 2 ng digestions were done in a 
volume of 10 1-11 with 5 units of enzyme for 2 h, 40 min, and 20 min, respectively. 
Templates were kept at 4° for short-term usage and at -80° for long-term storage. 
Primer Design 
Primer design involves the placement of primer pairs that flank both the 
region of interest and a control region. The control primers are designed to a 
region that is devoid of any of the restriction sites of the enzymes used in the 
design of the experiment. This region can be located in unique (single-copy) 
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sequence anywhere in the genome. The other pair of primers is chosen to flank 
both MSRE and MDRE restriction sites. 
PCR primers were chosen to flank specific regions based on the presence 
of informative restriction sites within the PCR amplified region with careful 
consideration of the special enzymatic properties of McrBC. McrBC recognizes 
two half-sites of 5'-G/AmC-3,13. In mammalian DNA, this sequence must be 
followed by a G to make a CpG dinucleotide. The recognition sequence is a non-
palindrome, thus, along with 5'-GmCG-3' and 5'-AmCG-3', McrBC will also 
recognize the sequences 5,_mCGC-3' and 5,_mCGT-3' (complementary to the 
recognition sequence). Optimal separation of the two ha If-sites is 55-103 bp and 
the enzyme cleaves the DNA in between the two sites approximately 30 bp from 
either site (Stewart et al., 2000). Best results are obtained when McrBC sites are 
separated by the optimal distance and located towards the center of the product 
so that both of the potential cut sites fall within the tlanked region and complete 
cleavage can occur. MSRE sites should be between the primer annealing 
sequences. Primers were designed using the Primer3 software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) according to the 
standard principles for successful quantitative PCR outlined in the QuantiTect'M 
SYBR® Green PCR Handbook from Qiagen. Product sizes range from 100-200 
bp. Genomic sequence data was obtained from the University of California at 
Santa Cruz Genome Browser, version mm6 (http://www.genome.ucsc.edu).AII 
primer pairs were tested to identify the annealing temperature for optimal 
efficiency and to check for the formation of non-specific products. Primer 
sequences and genomic loci are listed in Table 2.1. 
Quantitative PCR 
Cycle threshold (Ct) values are obtained by real-time PCR amplification of 
the various templates. PCR amplification is initially done on each PCR template 
within a given set using the control primers to ensure that the templates are of 
equal concentration and that non-specific cleavage of the DNA sample has not 
occurred. Each PCR reaction for both control and experimental reactions is done 
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in triplicate. Acceptable variability in mean template Ct values range from +/-0.3 
cycles. Once it has been confirmed that ail of the templates in a set fall within the 
acceptable range, Ct values are then obtained using the primers designed to the 
region of interest. Changes in the Ct values (~Ct) of the digested templates are 
expressed relative to the sham digested template within a given set. Quantitative 
PCR was done using the QuantiTect™ SYBR® Green PCR Kit (Qiagen) according 
to the manufacturer's suggested conditions for use with the Mx3000P PCR 
machine from Stratagene (La Jolla, CA, USA). Reactions were mixed in a total 
volume of 20 1-11 with 2 1-11 of template DNA. Different templates from the same set 
were always run together in the same PCR run. Ct values were calculated using 
the MxPro v3.00 software (Stratagene) and expressed relative to ROX, a passive 
dye. Non-specific amplification was monitored by melting curve analysis of each 
reaction. 
The percentage of methylation of a given site is determined from the 
change in Ct value by using the basic principle that each successive round of 
PCR amplification results in approximately a 2-fold increase in the amount of 
product. Thus, a ~Ct of 1.0 indicates that 50% of the template has been cleaved, 
2.0 equals 75% cleavage, etc. For MSREs, the relationship of ~Ct to percent 
methylation can then be described using the formula percent methylation=100(2-
~Ct); for MOREs, the relationship follows the inverse function, percent 
methylation=1 00(1-Z~Ct). Non-linear regression analysis was done using 
SigmaStat v3.0 software (SPSS). 
RLGS and Bisulfite Sequencing 
The identification of differentially methylated sites for use in the evaluation 
of the technique was done using RLGS (Okazaki et al., 1995). Densitometry of 
RLGS spots was done by exposing the RLGS gel to a phosphorimager screen 
from Kodak (Rochester, NY, USA). Images were analyzed using the 
ImageQuant v5.1 software from GE Healthcare (Piscataway, NJ, USA). Spot 
density values were obtained by comparing a spot of interest to approximately 
10-15 surrounding spots of unchanged intensity. The identities of spots of 
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interest were determined by using a RLGS cloning library as described previously 
(Yu et aL, 2004). Bisulfite sequencing was done as described previously 
(Warnecke et aL, 1998). Primers used to amplify the region of the U2af1-rs1 
gene from bisulfite-converted DNA were S'-GTATAGGTTAGTTGTGTTAT/S'-
ACCTACCTAAACAATCACCC as described previously (Zhang et aL, 2006). 
RESULTS 
Identification of Differentially Methylated Sites 
The evaluation of the qAMP method was done by comparing methylation 
levels in liver, intestine, brain and testis determined by RLGS. RLGS is a 
methylation-sensitive technique that reveals site-specifie levels of DNA 
methylation of multiple genomic loci simultaneously, thus providing a system to 
test a variety of sequences. Initially, three RLGS spots demonstrating tissue-
specifie spot intensity were mapped to single Notl restriction sites within the 
genomic regions of the estrogen receptor-a (Esr1 J, Gata-4, and the imprinted 
gene U2af1-rs1 (Figure 2.2). Using a phosphorimager, the densities of these 
spots were measured relative to surrounding fully unmethylated spots that did not 
change. The relative spot density is inversely proportional to the percent of DNA 
methylation of the Notl site. 
Analysis of Differentially Methylated Sites 
Figure 2.3 depicts the DNA methylation analysis of the imprinted gene 
U2af1-rs 1 in liver and testis. Surrounding the differentially methylated Notl site 
visualized in Figure 2.2 are Hhal and McrBC restriction sites (Figure 2.3a). 
Amplification of this region results in different Ct values for templates digested 
with different enzymes, whereas control primers amplify at similar values (Figure 
2.3b,c). A digestion curve ranging from ±S-fold the amount of enzyme does not 
result in a significant alteration in Ct values indicating that the DNA digestion is 
complete with the amounts of enzyme used (Figure 2.4). 
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To calculate the percentage of methylation from the ~Ct values, it was first 
necessary to test if the theoretical relationship (outlined in materials and 
methods) holds true in our experimental system. Approximately one-hundred 
measurements comparing RLGS spot density to ~Ct values using each of the two 
enzymes, Notl and McrBC, were done by designing primers that flank twelve 
additional differentially methylated sites found in the four different tissues in two 
animais (Figure 2.5 & Table 2.1). Spots were chosen to include a full range of 
methylation. A non-linear regression analysis of the total data set produces a 
curve that closely approximates the relationship for Notl (Figure 2.5a). The 
McrBC data set approximates the MORE relationship, but deviates from the curve 
(Figure 2.5b). This occurs because although the Notl site also serves as a 
McrBC site, the resulting ~Ct is representative of an integrated value from 
multiple McrBC sites due to the high frequency of such sites in virtually ail regions 
tested. The ~Ct value will be different if heterogeneity in the methylation state of 
neighboring sites exists within the region flanked by the primers. Furthermore, 
the value of the standard error estimate for both Notl and McrBC results, in part, 
from errors associated with RLGS densitometry. 
To test the accuracy of the method, equal concentrations of brain and 
sperm ONA were mixed in a range of ratios (100:0, 90:10, 75:25, 50:50, 25:75, 
10:90 & 0:100). Primers that flank a Notl site and several McrBC sites in the 
AK142239 gene, which is methylated in brain and unmethylated in sperm ONA, 
were used to compare the percent methylation (calculated from ~Ct values using 
the relationship) to the expected values predicted from the ratios (Figure 2.5c). 
The %methylation values for the MSRE, Notl, closely coincide with the expected 
percentage in the range from 0-75%, but are less accurate in determining values 
between 75-100%. The inverse is true for the MORE, McrBC. This loss of 
precision is observed in these defined ranges because of the nature of the curved 
relationship (Figures 2.5a,b). In these ranges, small variations in Ct values will 
result in a noticeable effect in % methylation. This demonstrates that by using 
both classes of enzymes, a full range of methylation can be accurately 
determined. 
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The imprinted nature of U2af1-rs 1 produces an ove rail methylation value 
of approximately fifty percent in somatic tissues within its differentially methylated 
region (DMR) (Shibata et al., 1996; Zhang et al., 2006). Using the established 
relationship, calculation of the percentage of methylation from the ~Ct values 
results in numbers very close to fifty percent (49-60%) for both MSREs and 
McrBC in ail three somatic tissues tested (Figure 2.6a). Because U2af1-rs1 is a 
maternally-methylated imprinted gene, the level of methylation within the male 
germ cells of the testis is very low. Somatic cells comprise only a sm ail fraction 
of the adult testis cell population «15%) (Bellve et al., 1977a), therefore, results 
in the range of 6-20% are expected. The findings also closely match the values 
determined by RLGS densitometry (Figure 2.2). 
To further demonstrate the value of the qAMP method, the commonly 
used bisulfite sequencing technique was used to analyze the same region of the 
U2af1-rs1 gene (Figure 2.6b). Bisulfite sequencing reveals the anticipated low 
levels of methylation in the testis and approximate 50% methylation in liver due to 
the imprinted nature of the region. Although more methylated than unmethylated 
strands were sequenced for liver, it is not statistically different from 50% (p=0.3) 
and previous evaluation of this region has determined the methylation to be 
specific to the maternai allele (Zhang et al., 2006). To appropriately compare the 
results, the low level of methylation in the testis is most accurately determined by 
MSREs. In the analyzed region there are three Hhal sites and one Notl site. Ali 
three Hhal sites must be methylated for amplification to occur. Bisulfite 
sequencing reveals that one strand in twenty is methylated at ail three sites, 
which is equivalent to the qAMP result of 6%. Bisulfite sequencing also reveals a 
low amount of sporadically methylated CpGs, which substantiates the slightly 
increased level of methylation that is detected at the single Notl site. These 
results show that the percentage of methylation ascertained using qAMP is highly 
comparable to the proportion of methylated to unmethylated CpGs within the 
assayed restriction sites determined by the bisulfite sequencing method. 
Futhermore, at this locus, the level of methylation at the restriction enzyme sites 
is representative of the overall methylation level of the region. 
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Reproducibility and Sensitivity 
The primers designed ta the U2af1-rs1 gene were also used ta test the 
reproducibility and the sensitivity of the assay. Re-digestion of the same four 
DNA samples using the same amount of starting material (2 I1g per digestion) 
results in very similar values (±5%) for ail four tissues using Hhal and MerBC 
(Figure 2.6e). The sensitivity of the assay using lower amounts of starting 
material was tested by decreasing the amount of DNA ta 200 ng, 20 ng and 2 ng 
per digestion. The results obtained demonstrate that the assay ean aecurately 
determine methylation levels down ta 20 ng of DNA with an average range of 
values obtained for four experiments (ail other than 2 ng) in ail tissues was 
determined ta be ±3.6% for Hhal and ±6.1 % for MerBC. At 2 ng (roughly 
equivalent ta the DNA content of 340 diploid cells), range values inerease ta 
±6.3% for Hhal and ±12.4% for MerBC. 
Analysis of CpG Island Methylation 
Analysis of two other differentially methylated sites found within the CpG 
islands of Gata4 and Esr1 also reveal tissue-specifie methylation levels by using 
this method (Figure 2.7b,e). The Notl sites found within each of the CpG islands 
(marked by 'N'in Figures 2.7b,c) are hypermethylated in liver ta differing degrees 
(Figure 2.1). Primer design in CpG islands can be problematic due ta the high 
GC content, however, a multitude of restriction sites within CpG islands provide 
many alternative design strategies. Although the flanked regions for Gata4 and 
Esr1 are approximately 150bp away from the Notl site, levels of methylation 
determined by this method for ail MS REs are very similar ta RLGS findings for 
bath genes. MerBC values for liver also refleet the RLGS result; however, they 
are generally higher for other tissues and may refleet heterogeneous methylation 
in these regions. 
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Analysis of Other Imprinted Loci and Optimization of Primer Design 
The method was also tested using primers designed to the previously 
established DMRs of the imprinted genes Snrpn (Shemer et al., 1997)and H19 
(Tremblay et al., 1995). Snrpn, like U2af1-rs1, is a maternally-methylated 
imprinted gene and displays the expected result using both MSREs in ail tissues 
(Figure 2.8a). The paternally-methylated imprinted gene H19 was chosen to 
demonstrate the effect of primer placement because of the lower McrBC site 
density found within the DMR (Figure 2.8b). H19 is 50% methylated in somatic 
tissues and is expected to be approximately 90% methylated in whole testis. 
Using primer pair 1, Hhal and Hpall digests produce the expected result in the 
testis, however, the level is lower (74%) than expected for McrBC. Although 
there are two McrBC half-sites within the flanked region, they are closer th an the 
optimal distance apart. Other half-sites of the optimal distance are outside the 
region flanked by primer pair 1, and if methylated, some cleavage would then be 
expected to occur outside the region. Primer pair 2 was designed to flank these 
adjacent sites and corrects the percentage of methylation to 90% as detected by 
the McrBC digest. 
DISCUSSION 
Our data show that the qAMP method can generate fast and accurate 
results without the use of sodium bisulfite. In addition to avoiding the drawbacks 
of using bisulfite, qAMP has several advantages over other methods that 
quantitatively assay region- and site-specifie levels of DNA methylation. 
Compared to techniques that depend on densitometry for quantitative evaluation, 
such as Ms-SNuPE and Southern blotting, the use of real-time PCR greatly 
reduces the processing time and eliminates the need for the use of 
radionucleotides. In comparison to quantitative techniques that employ real-time 
PCR, these methods necessitate the design of two sets of oligonucleotides 
(whether they be primers or probes) because bisulfite-conversion creates both 
converted (unmethylated) and unconverted (methylated) template DNA. The use 
79 
of different oligonucleotides for the purpose of a quantitative measurement 
requires that differences in amplification/binding efficiencies be controlled for by 
producing standard curves for each region investigated. Instead, the qAMP 
assay uses the same primer pair to amplify ail DNA templates, thus eliminating 
the need to relate measurements to constructed standard curve values which 
increases the accuracy and the throughput of the assay. Secondly, 
oligonucleotides are not as accu rate in discerning methylation as are restriction 
enzymes. Oligonucleotide binding can occur despite a single nucleotide 
mismatch making detection of single CpGs problematic. Also, oligonucleotides 
designed to multiple methylated or unmethylated CpGs will not efficiently bind to 
heterogeneously methylated templates. The use of different MS REs that assay 
individual CpGs is a much better strategy to investigate single and multiple CpGs 
within a region. Thirdly, by using both MSREs and McrBC, the qAMP assay 
produces two inde pendent and complementary measurements that are derived 
from both the methylated and unmethylated DNA strands. This allows for an 
accu rate assessment of a full range of DNA methylation and greatly improves the 
reliability of the results. In contrast, values obtained for unmethylated and 
methylated templates are expressed as a single ratio in bisulfite-based assays. 
Finally, the single-stranded nature of bisulfite-treated DNA greatly reduces 
template stability, whereas, in the qAMP assay, digested DNA used remains 
double stranded, which is much more conducive for long term usage. 
One of the useful advantages of this assay is the ability to examine many 
candidate loci in a rapid, cost-effective manner. Once loci of interest have been 
determined, the more thorough bisulfite sequencing method could be used. For 
screening purposes, inspecting the precise methylation state of every CpG in a 
given region is not necessary in the majority of cases. Thirty to fort Y percent of 
ail CpGs in mammalian DNA can be surveyed by using 3-5 relatively inexpensive 
MSREs, respectively (Schumacher et al., 2006). This tactic would be greatly 
more efficient to manage large numbers of loci. Specifically, the investigation of 
a single locus using the bisulfite sequencing method, with sequencing 15 clones 
to obtain a se mi-quantitative measurement, costs an estimated 5-fold more th an 
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the qAMP method as described here using a four-enzyme digest with each 
template run in triplicate. In addition, processing times are reduced from 5 days 
to 1 by avoiding lengthy cloning and sequencing steps. Furthermore, once the 
digestions have been done, the digested ONA can conveniently serve as 
templates for many PCR reactions. For example, high quality results can be 
obtained with 1 I-/g of digested ONA diluted into 1000 1-/1, enough for 500 
individual reactions (166 loci do ne in triplicate). Once the ONA has been 
digested, the processing time to re-use the same template to explore additional 
loci is only 2-3 hrs, whereas it is still -4 days for re-use of bisulfite-converted ONA 
with the bisulfite sequencing method. 
ln order to fully interpret the data generated by this assay, a few caveats 
must be considered. Firstly, the overall accuracy of the assay is dependent upon 
the range of ONA methylation of the region. Because of the nature of the curved 
relationship between the percentage of methylation and changes in the Ct value, 
MSREs are more sensitive to changes in methylation in the lower percent range, 
whereas MOREs are more sensitive in the higher percent range (Figure 2.5). 
Although ail PCR reactions are run in triplicate, small variations in mean Ct 
values of +/-0.3 cycles can occur, which can result in a significant change in the 
calculated level of methylation. For example, if a ONA region is 90% methylated, 
a 0.3 Ct variation will result in an error of 17% for MSREs, however the same 
variation will result in an error of only 2% for MOREs. Clearly, to evaluate a full 
range of methylation, a combination of data from both classes of enzymes must 
be considered. If the methylation level of the region is fifty percent, the added 
MSRE and MORE ~Ct value is at its minimum possible value, making this range 
the most sensitive to Ct variation. For this reason, the analysis of imprinted 
genes within somatic tissue was chosen as the most appropriate test of the 
accuracy of the assay. 
Another important aspect in the interpretation of the results is the 
consideration of the number of restriction sites for each enzyme within the 
amplified region. The percentage of methylation is a reflection of the integrated 
value of ail the sites and is interpreted differently for the two classes of enzymes. 
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The McrBC enzyme only requires two half-sites that are methylated within the 
amplified region to cleave the DNA strand. As a result, the percentage of 
methylation is truly representative of the percent of DNA strands that are 
methylated at two or more sites, or inversely, the opposite of the total percentage 
of unmethylated strands. For MSREs, if there are multiple sites for the same 
enzyme, the percentage of methylation is representative of the percent of DNA 
strands that are methylated at ail of the sites. Incongruent results from the two 
classes of enzymes reflect heterogeneity in the methylation state between 
neighboring restriction sites. In the case of U2af1-rs1, the values for both Not! 
and Hhal are similar although there are three Hhal sites compared to one Notl 
site. Because ail the Hhal sites have to be fifty percent methylated for this result 
to occur, it would indicate that there is a low level of site to site variation within 
this region which is supported by bisulfite sequencing of the region. In this 
condition, the McrBC result exactly reflects the MS RE result. However, in the 
cases of Gata4 and Esr1, where the MSREs produce similar results to the RLGS 
but McrBC is slightly higher especially in the testis, tissue-specifie 
hypermethylation of a few of the McrBC sites could explain the discrepancy. If a 
higher level of accuracy is required in these particular cases where heterogeneity 
is suspected, use of the bisulfite genomic sequencing technique would be most 
appropriate. 
The data presented here clearly demonstrate the utility of the qAMP 
method to determine quantitative levels of DNA methylation in a variety of 
sequences. Single sites or small regions of DNA can be analyzed without the 
use of bisulfite conversion while using relatively small amounts of source DNA. 
Primers can be designed to analyze virtually any restriction site(s) found in non-
repetitive sequences. With the added convenience of being able to use the sa me 
templates to assay many different regions, this assay provides quality results 
requiring a modest investment of material and time. 
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Figure 2.1: Schematic diagram outlining the qAMP procedure. 
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Figure 2.2: Enlargements of RLGS autoradiographs showing tissue-specifie 
spot intensity. Arrows point to three identified spots within different regions of 
the two-dimensional RLGS gel. Individual spots represent a single Notl site 
found in a unique copy sequence. Spot densities were measured using 
phosphorimager screens and compared relative to the intensities of surrounding 
spots that do not display tissue-dependent changes in intensity. 
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Figure 2.3: Analysis of the DMR region within the U2af1-rs1 gene. (a) The 
Notl RLGS landmark (N) is found within the 5' region of the single exon and is 
surrounded by Hhal (Hh) and McrBC (M) restriction sites. Primers are designed 
to flank the DMR region as weil as a second pair to a sequence devoid of Notl, 
Hhal, or McrBC restriction sites found elsewhere in the genome. (b) Liver and 
testis genomic DNA digested with either no enzyme (sham) or Notl, Hhal, or 
McrBC are used as templates for real-time PCR using either primer pair. (c) 
Restriction digests result in little or no change in the Ct values using the control 
primers, whereas differences are observed using the DMR region primers. A 
shift in the Ct value relative to the sham-digested template reflects a difference in 
the levels of DNA methylation between liver and testis. For clarity, in (b) only 
single values are shown, whereas values in (c) are means of three replicates. 
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Figure 2.4: Effect of digestion conditions on the shift in Ct value. 
Decreased (5-fold less) and increased (2.5-fold more) amounts relative to the 
normal amount of enzyme used do not significantly change the results indicating 
that under- or over-digestion does not occur using 20 U of enzyme. Not more 
than 50 U are used in the reaction to ensure that the amount of glycerol does not 
exceed the maximum recommended level of 5% in the reaction. Increased 
digestion time also does not alter the shift in Ct value. Results presented as 
mean +/-8D for three replicates. 
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Figure 2.5: The correlation between the shift in Ct value and RLGS spot 
density. Thirteen genomic loci in liver, intestine, brain and testis digested with 
Notl (a) and McrBC (b). 80lid black lines represent a non-linear regression 
comparing differentially methylated sites in various tissues totaling ninety-nine 
individual measurements each run in triplicate. The dotted curve represents the 
theoretical relationship between differences in Ct value and %methylation for two 
classes of restriction enzymes. (c) Comparison of %methylation determined by 
qAMP versus expected values. Notl and McrBC sites in the AK142239 gene are 
hypermethylated in brain and unmethylated in sperm ONA. A primer pair that 
flanks these sites was used to amplify ONA mixed in the ratios 100:0, 90: 1 0, 
75:25,50:50,25:75, 10:90 & 0:100. The expected value curve is adjusted for a 
small amount of residual methylation in sperm ONA at this locus. ONA 
methylation values closely coincide with the expected values for both enzymes 
except where an enzyme class-specific decrease in accuracy is predicted to 
occur. Results presented as mean +/-80 for four replicates. 
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Figure 2.6: Calculation of the percent methylation of the U2af1-rs1 gene. (a) 
Percent methylation was calculated from the ~Ct value for Notl, Hhal, and McrBC 
using the established relationship. (b) Analysis of the U2af1-rs1 gene from the 
same DNA samples using the bisulfite sequencing technique. The methylation 
status of ail CpGs in the amplified region is shown as either methylated (black 
circles) or unmethylated (open circles). The CpGs that are assayed by the 
various restriction enzymes used in the qAMP assay as weil as the qAMP primer 
binding sites are shown. (c) Reproducibility and sensitivity of the assay. 
Digestion of the same DNA samples from ail four tissues were repeated using 2 
I-Ig, 200 ng, 20 ng and 2 ng of DNA for each of the sham, Hhal and McrBC 
digests followed by PCR amplification using the U2af1-rs 1 primers. 
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Figure 2.7: Analysis of differentially methylated sites in CpG islands. Gata-
4 (a) and Esr1 (b) were analyzed using Hpall and Hhal as methylation-sensitive 
enzymes. The regions of amplification as weil as the locations of the Notl RLG8 
landmarks (N) within the genes are shown. Other mapped restriction sites 
include Hpall (Hp), Hhal (Hh), and McrBC (M). The percent methylation for each 
tissue is calculated by using the established i1Ct vs %methylation relationship for 
each class of enzyme. Results presented as mean +/-8D for three replicates. 
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Figure 2.8: Analysis of established DMR regions of two known imprinted 
genes. The percent of DNA methylation was measured for a maternally-
methylated gene, Snrpn (a), and the paternally-methylated H19 gene (b). The 
results for two different primer design strategies are shown for H19. Results 
presented as mean +/-8D for three replicates. N, Notl; Hp, Hpall; Hh, Hhal; M, 
McrBC. 
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Table 2.1: Primers used for qAMP analysis 
Sequence Genomic Location (mm6) Forward Primer (5'-3') Reverse Primer (5'-3') 
U2af1-rs1 chr11 :22,866,725 GGCCGTACCACAGATAACCA GCGCAGTTATCCGTCTATCCA 
Gata4 chr14:57,770,881 GGCTCAAGGCCCTAAGGTAA AGCCCCTACCCAGCCTACAT 
Esr1 chr10:5,791,650 CTGCCAAAGAATCCTTTCTGAC GCCCTACTACCTGGAGAACGA 
Snrpn chr7:53,781,658 CTCCTCAGAACCAAGCGTCT ATTCCGGTCAGAGGGACAGA 
H19 chr7:136,993,942 AAAAGCAGAAGGCAGGACAC CTTTGGCTGTCTCTGGAACAT 
AK016529 chr16_random:14, 160, 131 CTGGCAAGCTGTCCGATAGT CCGAGATCTTACGCAGGAGATA 
AK045080 chr18:47,714,811 TGATTAGCACTCGTTGGACA CTTTGGAAACGTCTGCGATTA 
4933401 N24Rik chr12:87,099,316 TGCCAACTGCTTTTCCAGAT TAAAGCATCCCAGTGGCAGT 
intergenic chr14:95,005,924 CATCAACCCAGGTACGAAGA GGAAGAGGAGGAGCCACAGT 
intergenic chr4:113,607,322 GCGCTCCCAAATGAAGGTTA AGCGACAAGCTCCATTCTCT 
AK142239 chr1 :135,952,219 GAAGAGCATCACGATCAGCA AATGCCACTAGCCCAAGGT 
intergenic chr4:52,412,674 GAGAGAGAGACTGTCACCCTGTTA TTCAGGGTTGCAGCTAAAGA 
Adcy5 chr16:34,013,972 AAGCAGGAAGTTGGCGTTTA CTTCCTCCTCCTGCTTCCA 
S76657 chr2:73,984,368 TCTGCAATAAGGGGCTGAAC AAAGTGGCTTGTGAGGCATT 
intergenic chr15:85,727,534 TTAGGGCTGCCAGGAGTAAG ACCCACGAGCATCTTTCG 
AK136359 chr4:58,946,140 TAGTCCTGCGTGTGGACTGT GCGTTGCTAGGAGAGAAGGA 
6130401J04Rik chr1 :16,803,660 CCCTTTCTTCCCCCTAAGC GAGACGAGGTGAGCGTCTG 
control1 chr18:47,713,995 GCAATCAGGCTTGTAGCAGTT CATATGCACCATGTGTCTTGG 
control2 chr16_random:14,159,508 TCTGATCCCATGTTCCCTGT TGGGAGGAGAAGCAAATGTC 
CONNECTING TEXT 
The genome-wide, locus-specifie nature of the data generated by the 
RLGS technique necessitates that any technique used for follow-up studies to 
confirm and expand on RLGS results must be rapid and flexible enough to 
manage a large number of loci. The studies in chapter Il also demonstrate that 
tissue-specifie differences in DNA methylation often occur as partial differences in 
methylation; thus, the ability to perform measurements quantitatively is of great 
importance. The studies described in chapter Il make the quantitative 
measurement of locus-specifie DNA methylation possible on the scale necessary 
for further investigation in connection with the RLGS technique. In chapter III, we 
employ the RLGS technique to analyze tissue-specifie patterns of DNA 
methylation on a genome wide scale. The qAMP technique is a tool that is 
extensively used in these studies. 
CHAPTER III 
A Unique Configuration of Genome-Wide DNA Methylation Patterns in the 
Testis 
Christopher C. Oakes, Sophie La Salle, Dominic J. Smiraglia, Bernard Robaire, & 
Jacquetta M. Trasler 
Proceedings of the National Academy of Sciences (2007) 1 04( 1) :228-33 
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ABSTRACT 
ln the mammalian lifecycle, the two periods of genome-wide epigenetic 
reprogramming are in the early embryo, when somatic patterns are set, and 
during germ cell development. Although some differences between the 
reprogrammed states of somatic and germ cells have been reported, overall 
patterns of genomic methylation are considered to be similar. Using restriction 
landmark genomic scanning (RLGS) to examine approximately 2600 loci 
distributed randomly throughout the genome, we find that the methylation status 
of testicular DNA is highly distinct, displaying eight-fold the number of 
hypomethylated loci relative to somatic tissues. Identification and analysis of 
more than 300 loci show that these regions are generally located within non-
repetitive sequences that are away from CpG islands and 5' regions of genes. 
We show that a contributing factor for these differences is that the methylation 
state of non-CpG island DNA is correlated with the regional level of GC content 
within chromosomes, and that this relationship is inverted between the testis and 
somatic tissues. We also show that in Dnmt3L-deficient mice, which exhibit 
infertility associated with abnormal chromosomal structures in germ cells, this 
unique testicular DNA methylation pattern is not established. These special 
properties of testicular DNA point to a broad, distinct epigenetic state that may be 
involved in maintaining a unique chromosomal structure in male germ cells. 
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INTRODUCTION 
Although germ cells faithfully carry parental genetic information to the next 
generation, they edit the epigenetic information that they inherit. Epigenetic 
marks in the form of DNA methylation are erased in primordial germ cells in favor 
of the establishment of a sex-specific, de novo epigenetic program (Reik et aL, 
2001). This initial programming is not only important for gametogenesis 
(Bourc'his and Bestor, 2004; Hayashi et aL, 2005; Kaneda et aL, 2004), but also 
provides the basis for genomic imprinting (Ferguson-Smith and Surani, 2001), as 
some sex-specific marks persist following a second wave of demethylation that 
occurs during early embryogenesis. Furthermore, it has been shown recently 
that some epigenetic marks can pass from one generation to the next by 
avoiding both periods of reprogramming in what is termed 'epigenetic inheritance' 
(Morgan et aL, 1999; Rakyan et aL, 2003). A clear appreciation of the genome-
wide nature of the germ cell epigenetic program is paramount to the 
understanding of these important processes. 
DNA methylation in mammals occurs at cytosine residues in CpG 
dinucleotides. CpG islands are generally thought to be devoid of methylation, 
while the rest of the genome is highly methylated in non-developing tissues(Reik 
et al., 2001). A recent study in humans confirmed that CpG islands represent the 
only major unmethylated genomic compartment in somatic (brain) DNA and 
implied that germ cells were similar, but this was not tested directly(Rollins et aL, 
2006). Although DNA methyltransferases are differentially regulated and 
essential during germ cell development (La Salle et aL, 2004; La Salle and 
Trasler, 2006b), few studies to date have directly examined germ cell genome-
wide DNA methylation patterns. Due to the larger number of germ cells produced 
in the male than in the female, their greater accessibility and their continuai 
renewal, most germ cell studies focus on spermatozoa and testicular tissues. In 
the adult, the testis is composed of over 80% germ cells, mainly in the meiotic 
and post-meiotic phases of spermatogenesis (Bellve et aL, 1977a), and thus will 
be referred to in this study as non-somatic. Although the data are limited, 
imprinted loci(Ferguson-Smith and Surani, 2001), some repetitive sequences 
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(Sanford et aL, 1984) and tissue-specifie genes (MacLean and Wilkinson, 2005), 
point to a unique state of DNA methylation in the testis. Previous studies using 
RLGS have found methylation differences between the testis and other tissues 
(Shiota et aL, 2002; Song et aL, 2005), but these studies either did not identify 
the sequences or the analysis was restricted to tissue-specifie genes. In this 
study, we have used RLGS as weil as other techniques to explore, in a non-
biased fashion, the DNA methylation pattern in the testis. 
RESUL TS AND DISCUSSION 
RLGS was used to survey approximately 2600 genomic Not! restriction 
sites that are mostly found in CpG islands, but also in non-coding unique and 
repetitive sequences not within CpG islands. Analysis of testis, liver, intestine 
and brain from adult mice revealed 241 spots that display tissue-specifie intensity 
(Figure 3.1). Although each tissue demonstrates a unique spot profile, more th an 
one-half of ail differentially methylated spots are specifie to the testis. The testis 
displays 8-fold the number of exclusively hypomethylated spots compared to the 
average of the somatic tissues. A comparison of adult testis and mature sperm 
isolated from the cauda of the epididymis display identical RLGS patterns, 
consistent with the fact that the adult testis is composed of a majority of mature 
germ cells (Figure 3.2). 
Using a combination of the mou se RLGS spot cloning library (Yu et aL, 
2004), and the virtual RLGS method (Smiraglia et aL, 2007), we identified the 
genomic location of approximately half (125) of the differentially methylated spots 
(Figure 3.3 & Table 3.2). We further identified the genomic locations of 48 
'absent' spots that correspond to unchanged methylated Not! sites, and, 
combining 89 spots identified previously (Yu et aL, 2004), 186 unchanged 
unmethylated spots. Over 90% of loci that are unmethylated and unchanged in 
ail tissues are found in CpG islands and within the 5' region of genes; unchanged 
methylated loci are found in regions of low CpG content and away from 5' regions 
(Figure 3.4). Interestingly, differentially methylated (DM) loci are found in 
sequences of diverse CpG content and in various locations within and outside of 
100 
known genes. Focusing on the loci that are either DM between testis and 
somatic tissue (testis-specific DM) or DM between different somatic tissues 
(somatic-specific DM) reveals that testis-specific DM loci are less likely to be 
located in 5' regions of genes or to be found in strong CpG islands than are 
somatic-specific DM loci. Only 20% of testis-specific DM loci are within CpG 
islands and include genes that are previously known to be differentially 
methylated, such as imprinted genes (Cdkn1c, U2af1-rs1, and Nap1/5) and 
testis-specific genes (Ddx4 and Hspa 1~, whereas the remaining 80% (non-CpG 
island) represent novel DM loci. 
Seventy-five percent of Not! sites are found within CpG islands (Fazzari 
and Greally, 2004). Due to this bias, by using RLGS we would expect to find a 
majority of DM loci in CpG islands if they are located randomly. The high 
proportion of DM loci being found in non-CpG islands is highly significant for both 
testis and somatic tissues (P<1x10-17 and P<1x10-7 , respectively) clearly 
demonstrating that a unique state of DNA methylation exists outside of CpG 
island sequences, especially in the testis. This also implies that the numbers of 
testis-specific DM loci that are found away from CpG islands are vastly 
underrepresented on RLGS profiles. 
ln the mouse, Not! sites are found within some interspersed repetitive 
elements, predominantly in the internai sequence of intracisternal-A particle (IAP) 
and in the long-terminal repeats (LTRs) of early transposon (Etn) and other L TR-
containing families of repeat sequences (Aota et al., 1987; Baust et al., 2003; 
Jurka et al., 2005). Ali unchanged unmethylated loci were found solely within 
non-repetitive sequences, whereas approximately one-half of the unchanged 
methylated loci were found to be within various interspersed repeats, particularly 
IAP (Table 3.1). An analysis of 240 and 60 Not! sites (present on vRLGS 
profiles) within IAP and Etn repeats, respectively, revealed consistent 
hypermethylation in ail tissues tested, as revealed by absence on actual RLGS 
profiles (Figure 3.5). Despite the high level of methylation of repetitive DNA, a 
limited number of full-Iength L TR-containing repeats were found to be 
unmethylated in somatic tissues. Interestingly, ail these repeats were methylated 
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in the testis. We did find several repetitive elements to be hypomethylated in the 
testis that are specifie to solitary L TR fragments belonging to ERVK (class Il) and 
MaLR (class III) of the L TR family of repeats. The differential methylation state of 
longer-Iength L TRs versus solitary L TRs demonstrates that some sm ail repetitive 
sequences are not targets for methylation in the testis. Transcripts derived from 
these specifie subfamilies of repetitive elements are present and are 
developmentally regulated in female germ cells and early embryos (Peaston et 
al., 2004). These sequences may serve a functional role in germ cells (Shapiro, 
2005), or may not be of sufficient length and/or are too divergent to be targeted 
by the methylation machinery. 
The germ cells of the testis have a highly unique global transcriptional 
profile owing to the vast number of different gene products that are produced 
during meiosis and spermiogenesis (Shima et al., 2004). Although testis-specific 
DM loci are generally not found in typical promoter regions, hypomethylation of 
loci found in or near to genes could be related to increased gene activity. Of the 
72 DM loci found within expressed sequences, tissue-specifie expression levels 
are known for 62 in the GNF SymAtlas database. Of these, only 2/21 loci found 
in 5' regions, Ddx4 and Cdkn 1 C, and 1/44 non-5' loci, Hspa 11, demonstrated a 
correlation in ail four tissues of increased expression with hypomethylation 
(Figure 3.4c). Only nine additional loci showed a correlation in three of four 
tissues. The poor correlation with expression, cou pied with the fact that 
approximately a third of ail DM loci are not found associated with known 
expressed sequences and many are within repetitive sequences, suggests that in 
addition to its role as a transcriptional regulator, DNA methylation has additional 
functions, especially outside of 5' regions. 
The majority of loci that are found to be differentially methylated in this 
study occur within non-CpG island sequences in the testis. As a potential 
explanation, we observed that those loci that are hypermethylated in the testis 
are significantly more commonly located within R (reverse)-type bands on 
chromosomal ideograms, and that loci hypomethylated in the testis are 
commonly located in G (Giemsa) bands (Figure 3.6a and Figure 3.7). 
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Heterogeneous ban ding patterns reveal regional differences in chromosomal 
structure and are related to the disparity in the long-range G+C nucleotide 
composition that occurs along chromosomes (Bernardi et al., 1985). R-Bands 
generally contain above-average and G-bands below-average GC content. We 
tested if the sequence that surrounds each locus in these two groups differs in 
overall GC content. We found that loci that are hypomethylated specifically in the 
testis are found in regions of lower GC content (Figure 3.7). Consistent with the 
banding pattern results, loci that are hypomethylated in somatic tissue are 
located in regions of higher GC content, opposite to what is found in the testis. 
T 0 further compare the differential nature of the relationship between methylation 
and GC content between testis and somatic tissues, the level of methylation of ail 
identified non-CpG island hypomethylated loci in each tissue was compared to its 
regional GC content. In ail somatic tissues, there is a significant negative 
relationship between the level of methylation and GC content demonstrating that 
lower GC content regions are more likely to be hypermethylated (Figure 3.6b). In 
the testis, this relationship is inverted, iIIustrating that lower GC content regions 
are specifically hypomethylated. 
Due to the GC rich nature of the Notl recognition site (GCGGCCGC), 
RLGS sites are relatively rare in non-CpG island DNA and are biased towards 
sequences of higher GC content. To avoid this bias and the potential influence of 
nearby genes and repeat elements on DNA methylation, we focused on Hhal, 
Hpall, and McrBC sites in non-S', non-CpG island, and non-repetitive sequences 
using the qAMP assay (Oakes et al., 2006). A survey of 104 small amplified 
regions evenly spaced along chromosomes 4, 10, 17 and X in liver and testis 
shows striking differences in the pattern of DNA methylation between the two 
tissues (Figure 3.8a and Figure 3.9). Consistent with the RLGS findings, lower 
levels of methylation are generally found in the testis (Figure 3.8b). In liver, non-
CpG island sequences are generally highly methylated in GC-poor regions while 
lower levels are observed in some GC-rich regions. In the testis, the methylation 
status of these sites is again found to be inverted using this alternate approach. 
A comparison of the regional GC content with the difference in methylation 
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between the two tissues reveals a significant correlation between lower Ge 
content and hypomethylation on these four chromosomes in the testis (Figure 
3.8c). 
These data show that by taking into account broad regional characteristics 
of chromosomes, we are able to explain a significant proportion of the ditferences 
of DNA methylation that occur at single sites or sma" regions in non-CpG island 
sequences at both a whole-chromosome and a genome-wide scale. Because 
these ditferences occur broadly, are more likely to occur away from regulatory 
regions of genes and correlate with broad attributes of chromosomes, it raises 
the possibility that the testicular DNA methylation pattern may have a role in 
maintaining a unique chromosomal state that is capable of undergoing germ ce"-
specific processes, such as meiosis. The Dnmt3L gene is highly expressed 
during the perinatal period of reprogramming in male germ ce"s; yet, the primary 
defect that results from the disruption of the Dnmt3L gene is observed after birth 
in meiotic germ ce"s in which highly abnormal chromosomal structures are seen 
(Bourc'his and Bestor, 2004). If the testis-specific methylation patterns we 
describe for non-CpG island sequences have a role in chromosome structure or 
meiosis in germ ce"s, we would predict they might be altered in the germ ce"s of 
Dnmt3L-j- mice. To address this, spermatogonia were isolated from Dnmt3L-j-
mice and the methylation levels at various DM loci determined by RLGS were 
analyzed using qAMP (Figure 3.10). In the spermatogonia from Dnmt3L-j- mice, 
a" loci examined that were hypermethylated in the testis failed to gain the normal 
levels of methylation found in wild-type spermatogonia and testis. Other DM loci 
are also hypomethylated. Testis-specific hypomethylated loci remained normal, 
indicating that the primary influence of Dnmt3L is to promote DNA methylation. 
Furthermore, levels of methylation in wild-type spermatogonia resemble the 
levels found in the adult testis demonstrating that the testis-specific pattern was 
acquired in early germ ce" development at these non-CpG island sequences. 
We have demonstrated the novel finding that male germ ce"s have highly 
unique patterns of DNA methylation with most of the hypomethylation found in 
non-repetitive, non-CpG island sequences. These hypomethylated sequences 
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do not correlate with expression patterns; this is consistent with the fa ct that they 
are generally not found in the regulatory regions of genes. Instead, they are 
correlated with regional chromosome features, such as banding patterns and GC 
content. Although a previous study inferred a paucity of non-CpG island 
hypomethylation in germ cells (Rollins et aL, 2006), experimental evidence in the 
present study indicates a prominent role for regulation of DNA methylation in this 
compartment of the testis genome. Because greater than half of the total 
genomic sequence and CpG dinucleotide content belongs to non-repetitive, non-
CpG island DNA (Fazzari and Greally, 2004), these modifications might be 
expected to have prevalent effects on the ove rail structure of chromosomes in the 
testis. We also find that in the spermatogonia of Dnmt3L-j- mice, a model that 
displays abnormal chromosomal structures, at the sites examined the unique 
testicular DNA methylation pattern is not established. We propose that the 
maintenance of a unique, germ cell-specific chromosomal structure may require a 
distinct configuration of DNA methylation patterns in non-CpG island DNA. 
MATERIALS AND METHODS 
RLGS and spot identification 
Adult male C57BU6 mice were from Charles River Laboratories (St-
Constant, Quebec). Genomic DNA was isolated from tissues using proteinase K 
followed by phenol extraction(Okazaki et aL, 1995). RLGS was done as 
described previously (Okazaki et aL, 1995). Three replicate RLGS profiles were 
generated for each tissue. Each spot was assessed a score between 0-4 based 
on its intensity relative to surrounding, fully unmethylated spots. An intensity 
score of 0, 1, 2, 3 & 4 is representative of 100, 75, 50, 25, & 0 percent 
methylation, respectively. Visual assessment of spot intensity was confirmed by 
densitometry. Ali DM spots were observed to be changed in ail three replicates. 
Spot identities were determined by using either the RLGS cloning library (Yu et 
aL, 2004) or the virtual RLGS method (Smiraglia et aL, 2007). Loci identified 
using virtual RLGS were confirmed by obtaining the corresponding BAC clone 
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(Roswell Park Microarray Core Facility, Buffalo, NY) and running RLGS mixing 
gels. The methylation status of 36 identified loci was confirmed by using the 
qAMP methylation assay (Oakes et aL, 2006). Briefly, DNA is digested with 
various methylation-sensitive and methylation-dependent restriction enzymes and 
amplified using real-time PCR. Changes in cycle threshold values were used to 
calculate the percentage of methylation at each restriction enzyme site. For the 
analysis of chromosomes 4, 10, 17 and X, the percentage of methylation of each 
locus was determined by averaging the values obtained for ail of the restriction 
enzyme sites analyzed within the amplified region. To obtain purified Dnmt3L-
deficient spermatogonia, heterozygous Dnmt3L-deficient mice (Bourc'his et aL, 
2001) were crossed with GOF18deltaPE-Oct4/GFP mice (Yoshimizu et al., 
1999), and spermatogonia were isolated from the testes of 6-dpp offspring using 
fluorescence-activated cell sorting, 3-5 mice were pooled in each group. Ali 
primers are listed in Tables 3.3 & 3.4, Supplementary Information. 
Data analysis 
Ali positional and sequence information was obtained from the UCSC 
genome browser (Kent et aL, 2002) Mouse August 2005 assembly, mm7 
(http://genome.ucsc.edu/). Chromosomal bands were defined as a G-band if 
they appear black or grey, and as an R-band if white on ideograms. CpG Islands 
were defined by the criteria of Takai and Jones (Takai and Jones, 2002) 
(G+C~55%, CpGobs/exp~0.6, ~500bp), 5'regions were defined as being within -3 
to +1 kb of the transcriptional start site. DM loci were divided into the sub-
categories of 'somatic-specific DM' and 'testis-specific DM' if the unique state of 
hyper- or hypomethylation occurred solely in a single somatic tissue or in the 
testis, respectively. SigmaStat v3.0 software (SPSS) was used for statistical 
analysis with p<0.05 considered to be significant. Gene expression data were 
obtained from the GNF SymAtlas v1.2.4 expression data base 
(http://symatlas.gnf.org/SymAtlas/) using the GNF1 M, geRMA dataset. 
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Figure 3.1: RLGS analysis of tissue-specifie DNA methylation. Two-
dimensional spot profiles are produced by digestion of genomic DNA with the 
methylation-sensitive restriction enzyme, Notl, followed by radioactive end-
labeling. A spot is produced if the site is unmethylated and absent if methylated. 
(a) Enlargements of liver, intestine, brain and testis RLGS profiles. Black and 
white arrowheads denote hyper- and hypomethylated spots, respectively. (b) 
Summary of RLGS spot data. A total of 1945 spots are visible over four tissues; 
241 display differential intensity between tissues. Consistent methylation of 
approximately 1/3 of ail spots is predicted by subtracting the total visible spots 
from the total number of spots calculated by virtual RLGS analysis of the mouse 
genome. (c) Tissue-specifie breakdown of differentially methylated (DM) spots. 
Hyper- and hypomethylated spots can occur either in one tissue or can be 
shared. More than half of ail observed DM spots are testis-specific. 
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Figure 3.2: Enlargements of RLGS profiles of testis and cauda epididymal 
sperm demonstrating identical spot patterns. 
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epididymal 
sperm 
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Figure 3.3: Identification and confirmation of the genomic locations of 
RLGS spots. (a) The identity of 260 unmethylated, methylated, or differentially 
methylated spots were established by observing enhanced spot intensity on 
RLGS gels produced by mixing plasmid or BAC clone DNA with genomic testis 
DNA as background. (b) Summary of identified spots and the corresponding loci. 
Fort Y spots were found to originate from the sa me Not! site as another spot and 
were removed from the dataset to ensure that each spot relates to a single locus. 
(c) Verification of the DNA methylation status of identified loci using the qAMP 
assay (Oakes et al., 2006). Real-time PCR amplification of the region after 
digestion with the methylation-sensitive enzymes Hhal(H) and Not!(N) and the 
methylation-dependent enzyme McrBC(M) confirms the testis-specific 
hypomethylation of the 4Bx2 locus using ail three enzymes. The methylation 
status of a total of 36 identified loci was verified using this method. 
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Figure 3.4: The positional distribution of a" identified loci with respect to 
CpG islands and 5' regions. (a,b) Ali identified loci were grouped aeeording to 
their DNA methylation pattern in different tissues as being either unmethylated, 
methylated or differentially methylated (DM). DM loci are sub-divided into 
somatie-specifie and testis-specifie DM loci. The percent of loci from eaeh group 
that are found in CpG islands and within 5' regions are shown. Proportionally 
fewer testis-specifie DM loci are within CpG islands and 5' regions (p<O.05). (c) 
The correlation of expression of known genes with tissue-specifie methylation of 
DM loci. Approximately 2/3 of ail DM loci are loeated within or near known 
genes. Relative levels of tissue-specifie expression are known for 66 of these 
genes in the GNF gene expression database. Tissue-specifie hypomethylation 
eorrelated with expression in only a minority of DM loci loeated in the vicinity of 
genes. 
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Figure 3.5: Absence of IAP and Etn repetitive element spots on RLGS 
profiles of liver, intestine, brain and testis. (a) Restriction maps showing Not1 
sites in the gag and L TR sequences of IAP and Etn, respectively. Vertical 
positions of RLGS fragments are dependent on the size of Not1-Hinff fragments. 
The sizes of the vertical RLGS fragments are shown corresponding to both the S' 
and 3' sides of the Not! cut site. Three of these fragments are of sufficient size to 
be visible on a RLGS profile and are labeled A, Band C. (b) There are -240 and 
-60 Not! sites visible by virtual RLGS in IAP and Etn repeats, respectively. The 
vertical positions of the repetitive fragments are apparent in the lower portion of 
the virtual RLGS gel. Spots are spread horizontally due to variation in the 
flanking sequence that generates the horizontal spot position (c) IAP and Etn 
spots are absent in RLGS profiles of ail four tissues indicating that these repeats 
are constitutively hypermethylated. 
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Figure 3.6: Analysis of non-CpG island hypomethylated loci. (a) The 
chromosomal locations of non-CpG island loci that are hypomethylated in testis, 
somatic tissues, or both (open, black & grey triangles, respectively) are shown. 
(b) Correlation analysis of ail hypomethylated non-CpG island loci comparing the 
%GC of 50 Kb of flan king sequence with the level of methylation as assessed by 
visu al inspection of each RLGS spot in different tissues. The relationship 
between methylation and GC content is inverted in testicular DNA. Ideograms 
adapted from the UCSC genome browser. 
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Figure 3.7: Chromosomal banding patterns and levels of GC content 
associated with non-CpG island loci. Chromosomal banding patterns and 
levels of GC content that are associated with differentially methylated loci that are 
hypomethylated in testis, somatic tissues or both. The percentage of loci in each 
group that are located in R-bands and the %GC of 50 Kb of sequence flan king 
each locus is shown. Loci that are hypomethylated in the testis are less likely to 
be found in R-bands and in regions of higher GC content. Statistical analysis 
done using land ANOV A, error bars represent +/-SEM. 
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Figure 3.8: DNA methylation analysis of non-CpG island DNA on 
chromosomes 4,10,17 and X using the qAMP assay. Primers were designed 
to flank McrBC and Hhal or Hpall restriction sites placed at roughly five Mb 
intervals along each chromosome. Amplified regions were chosen only on the 
basis of the sequence not being in the proximity of a CpG island, a known 5' 
region, or within a repetitive sequence. (a) Analysis of chromosome 4. The 
percent of DNA methylation of each amplified region in liver (black dash) and 
testis DNA (grey dash) is shown. Differences in methylation are shown by 
arrows. The ideogram and GC percent are shown as are the positions of hyper-
and hypomethylated loci identified using RLGS. (b) The average difference in 
%methylation of ail DM regions analyzed on each chromosome shows an ove rail 
decreased level of methylation in testis versus liver in 3 of 4 chromosomes. 
Unchanged regions «10% difference) were excluded. (c) The correlation 
between the difference in methylation in each region on ail three chromosomes 
and the GC percent of flan king sequence shows a lower relative level of 
methylation in the testis in sequences of lower GC content. Chromosome 4 
ideogram and %GC were obtained from the UCSC genome browser. 
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Figure 3.9: DNA methylation analysis of non-CpG island DNA on 
chromosomes 10, 17 and X using the qAMP assay. DNA methylation analysis 
of non-CpG island DNA on chromosomes was done as described for 
chromosome 4 in Figure 3.8. The positions of known testis-specific genes that 
are hypomethylated in the testis are shown. 
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Figure 3.10: Levels of DNA methylation in Dnmt3L-deficient spermatogonia 
and adult tissues. The percent methylation of DM RLGS loci that are (a) 
hypermethylated in testis, (b) hypomethylated in testis and (c) somatie-speeifie 
DM was determined using qAMP. Loci that are hypermethylated in the testis fail 
to gain normal levels of methylation in Dnmt3L-defieient spermatogonia. 
Analyzed loci were ail in non-5' regions. L, liver; l, intestine; B, brain; T,testis. 
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Table 3.1: The number and characterization of repetitive elements associated with identified RLGS loci 
classification of reEetitive elements: 
non-L TR-containing: L TR-containing (solitaIY L TR): 
DNA Methylation Pattern Total # repetitive hyper- hypo- ERVK MaLR 
of loci (%) methylated methylated SINE UNE IAP ETN RLTR MT 
unchanged unmethylated 161 0(0) 0 0 0 0 0 0 0 0 
unchanged methylated 47 23 (49) 23 0 1 3 11 3(1) 4(2) 1 (1) 
DM testis vs. somatic 60 22 (37) 3 19 0 0 18(17) 2(2) 
DM inter-somatic 26 3 (12) 0 3 0 0 0 3 0 0 
Table 3.2: Ali identified RLGS loci 
Notl site Notl site location RLGS spot intensity (methylation) 
RLGSIO position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
1cx1 chr1 : 130281590-130282590 intergenic \ LlKE RLTR44C 2 0 0 0 
3Gx3 chr1 : 135991532-135992532 L06234 body LlKE 4 0 0 0 
3038 chr1 : 156204026-156205026 intergenic \ N 2 3 3 2 
3ex3 chr1 :36370867-36371867 AK137601 5' N MTEa, MaLR 1 0 0 0 
3fx9 chr1 :8058492-8059492 intergenic \ N RLTRETN 0 0 1 0 
5dx4 chr1 :890011 09-890021 09 Sh3bp4 body LlKE RLTRETN 0 0 2 0 
4bx4 chr1 :91312941-91313941 AK006182 5' LlKE 1 0 0 0 
3fx6 chr2:116796001-116797001 intergenic \ LlKE 4 2 0.5 1 
4E73 chr2: 155482740-155483740 intergenic \ N 2 1 1 1 
4cx3 chr2: 155613723-155614723 2410003P15Rik body N 0 0 1 1 
1hx3 chr2:168061251-168062251 AK133086 5' Y 4 0 0 0 
2G75 chr2:19314558-19315558 Armc3 body LlKE RLTR44E 3 0 0 2 
5F49 chr2:26098731-26099731 Btbd14a 5' y 4 0 4 4 
4cx1 chr2:74130334-74131334 S76657 body LlKE 4 0 0 0 
5cx6 chr2:77255277 -77256277 Zfp533 3' LlKE 4 0 0 0 
3gx1 chr2:86342178-86343178 intergenic \ N RLTR10D 0.5 0 0 0 
4818 chr2:92335401-92336401 AK036400 5' LlKE 4 2 2 1 
2fx2 chr2:98070124-98071124 intergenic \ N RLTR44D 3 0 0 0 
3031 chr3: 1 0095927-10096927 BC060946 5' y 4 2 3 4 
5cx4 chr3:36012850-36013850 Acad9 body LlKE RLTR10D 4 0 0 0 
5gx1 chr3:45159893-45160893 intergenic \ N RLTR10D 4 1 1 1 
3dx3 chr4: 114024855-114025855 intergenic \ LlKE 4 4 1 3 
5cx3 chr4: 123797266-123798266 intergenic \ LlKE RLTRETN 0 0 1 0 
1027 chr4: 130 166729-130 167729 Matn1 body LlKE 0 4 4 4 
3027 chr4: 133538960-133539960 Ccdc21 body LlKE RLTR4 0 4 4 4 
5gx2 chr4: 136128890-136129890 Ephb2 body N 0 0 1 1 
5036 chr4:48065246-48066246 Nr4a3 S' Y 4 4 4 1 
4bx2 chr4:52510613-52511613 intergenic \ LlKE 4 0 0 0 
6fx2 chr4:54418300-54419300 intergenic \ LlKE RLTR10A 3 0 0 0 
----
126 
Notl site Notl site location RLGS spot intensity (methylation) 
RLGS ID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
6bx1 chr4:8037009-8038009 AK035064 body LlKE 2 0 0 0 
3022 chr4:88677758-88678758 Cdkn2a 3' LlKE UNE Lx3C 2 4 4 4 
4dx1 chr4:9701490-9702490 AK035353 body LlKE RLTR44E 3 0 0 0 
4E15 chr5:1 05630030-1 05631030 E 1303098 19Rik 3' Y 0 3 3 4 
4F43 chr5: 1 05632198-1 05638870 E130309819Rik 5' y 0 4 4 4 
4044 chr5:111294164-111295164 intergenic \ N 0 1 1 1 
2G63 chr5 :59593352-59593751 CG869761 5' y 4 4 4 1 
5052 chr5:71955036-71956036 Zar1 5' Y 3 2 3 2 
6fx4 chr5 :73043767 -73044 767 Spata18 body Y 3 0 0 3 
6G33 chr6: 146248423-146249423 Itpr2 body LlKE 3 0 0 0 
6gx2 chr6:24967030-24968030 intergenic \ LlKE RLTR44A 1 0 0 0 
3E09 chr6:588747 42-588757 42 Nap115 5' Y 1 4 4 7 
5dx1 chr6:6688292-6689292 intergenic \ LlKE 3 0 0 0 
2cx3 chr7:11557189-11558189 Zfp324 3' Y 4 0 0 0 
3G91 chr7: 139888309-139888708 Cdkn1c 5' y 4 2 2 2 
6ex1 chr7:17493013-17494013 8cl3 body LlKE 1 0 0 0 
2dx7 chr7:39442553-39443553 intergenic \ LlKE RLTR44E 2 0 0 0 
19x8 chr7:75332581-75333581 Polg 5' y 1 0 0 0 
6dx2 chr7:75332881-75333881 Polg 5' y 3 1 4 2 
6dx4 chr7:75334206-75335206 Polg 5' Y 2 1 4 2 
4C13 chr7:75376878-75377277 AK032343 body Y 1 2 2 0 
2ex4 chr8: 1 08647075-1 08648075 intergenic \ N RLTR44E 2 0 0 0 
4gx4 chr8: 118899502-118900502 CJ052809 body LlKE 0.5 4 4 2 
5cx1 chr8:68335566-68336566 Cilp2 3' Y 4 2 2 2 
2C28 chr8:68336816-68337816 Cilp2 3' Y 4 2 2 2 
3E61 chr8:76679487 -76680487 intergenic \ LlKE RLTRETN 0 1 1 1 
5F09 chr8:83198115-83199115 Cacna1a body N 0 2 2 2 
2gx1 chr9:118558574-118559574 Itga9 body LlKE 3 0 0 0 
5bx5 chr9: 15818207 -15819207 C0043424 body LlKE 4 0 0 2 
3ex8 chr9:85800273-85801273 Ibtk body LlKE 2 0 0 0 
2G35 chr10:33404605-33405605 A330019N05Rik 5' LlKE 4 4 2 4 
------
.... 
---- ---
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGSIO position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
2030 chr10:39978903-39979903 intergenic \ N 4 0.5 1 0.5 
2F21 chr10:5633569-5634569 Esr1 body Y 4 2 3 4 
2dx1 chr10:62180628-62181628 AK133671 body N MTE2b, MaLR 4 0.5 0.5 0.5 
2ex7 ch r1 0: 65580897 -65581897 intergenic \ N RLTR44B 1 0 0 0 
2dx4 ch r1 0:71 064227 -71 065227 intergenic \ LlKE RLTR44D 3 0 0 0 
3cx2 chr1 0: 7871549-7872549 intergenic \ N RLTR44D 4 0 0 0 
5dx6 chr1 0:81050933-81 051933 Matk body N 0 0 2 2 
4gx5 chr1 0: 85525697 -85526697 Bpil2 body LlKE 3 0 0 0 
4cx2 chr10:97306373-97307373 AK134882 body N RLTR44D 3 0 0 0 
2021 chr11 :102546032-1 02547032 Grn 3' Y 4 1 2 1 
3829 chr11 : 1 08023826-1 08024826 AK034065 5' Y 4 0.5 0.5 0.5 
3F01 chr11 :114789169-114790169 Ttyh2 body N 0 0 0 4 
5C43 chr11 : 115359508-115359907 Grin2c 3' Y 4 4 4 2 
2hx1 chr11 :115577931-115578931 SIc16a5 body LlKE 3 0 0 0 
4C01 chr11 : 115967838-115968838 intergenic \ y 4 4 3 3 
3E07 chr11 :22923940-22924940 U2af1-rs1 5' y 4 2 2 2 
2fx1 chr11 :59211978-59212978 OBSCN body N RLTR44E 0 0 1 2 
3030 chr11 :64005264-64005663 Hs3st3b1 5' y 4 1 3 3 
4fx2 chr11 :67206493-67207493 intergenic \ LlKE 4 0 0 0 
4002 chr11 :84834099-84835099 intergenic \ LlKE 4 2 2 4 
5F66 chr11 :88257584-88258584 Cuedc1 body LlKE 2 0 1 1 
2F08 chr12: 1 02025532-1 02026532 intergenic \ N 4 2 2 2 
2G48 chr12:1 08961612-1 08962612 Tnfaip2 5' y 4 0 4 4 
2cx2 chr12:29928868-29929868 intergenic \ LlKE RLTR44A 1 0 0 0.5 
3dx6 chr12:6239843-6240843 intergenic \ N RLTR44B 3 0 0 0 
5cx10 chr12:69261419-69262419 Dact1 3' y 3 0 0 0 
3dx1 chr12:82147883-82148883 BC038335 3' LlKE 4 0 0 0 
1fx6 chr12:89165037-89166037 4933401 N24Rik body N 0 1 2 2 
4G103 chr12_random:413547-414547 Cables2 5' y 4 2 2 3 
3bx5 chr13:1 09807817-1 09808817 Ddx4 5' y 4 0 0 0 
3dx5 chr13:23144133-23145139 intergenic \ LlKE RLTR31 4 0 0 0 
128 
Notl site Notl site location RLGS spot intensity (methylation) 
RLGS ID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
2bx1 chr13:8081558-8082558 Adarb2 5' LlKE 2 0 0 0 
2F64 chr14:581 04168-581 05168 Gata4 body Y 4 1 4 4 
2cx1 chr14:94881121-94882121 intergenic \ N 3 0 0 0 
3fx2 chr14:98136003-98137003 BC079866 3' LlKE 3 0 0 0 
1fx5 chr15:29903539-29904539 intergenic \ N RLTR44B 4 0 0 0 
3bx1 chr15:411 00483-411 01483 Zfpm2 3' LlKE 4 0 0 0 
1G05 chr15:79515671-79516670 Csnk1e body LlKE 0 1 0 1 
4cx4 chr15:85761255-85762255 intergenic \ N 1 2 4 4 
4ax1 chr15:99084619-99085619 2810451 A06Rik 5' N 3 3 2 0 
4C11 chr16: 1 0316403-1 0317403 AK016529 body LlKE 0 2 3 0 
3E60 chr16:18170194-18171194 Gp1bb 5' Y 4 4 2 4 
4C31 chr16:34905665-34906665 Adcy5 body N 0 2 4 0 
3ax1 chr16:63543509-63544509 Epha3 body N 4 0 0 0 
4F84 chr17:33074114-33075114 Hspa11 3' Y 4 1 0 0 
3G87 chr17:35098434-35099434 Rfn39 3' y 4 2 2 3 
6dx1 chr17:81582462-81583462 intergenic \ N 0 1 1 3 
6E36 chr18:38473730-384 74730 intergenic \ N 0 1 1 0 
3bx2 chr18:47870542-47871542 AK045080 3' N 1 3 0 0 
3G10 chr18:75074491-75075491 Myo5b body N 0 0 0 1 
3C21 chr19:6323488-6324488 Nrxn2 5' y 4 4 4 0 
UNCHANGED METHYLATED: 
4dx7 chr1: 191694316-191695316 intergenic \ N SINE B3-B2 family 0 0 0 0 
5fx3 chr1 :8051385-8052385 intergenic \ LlKE RLTRETN 0 0 0 0 
4fx4 chr1 :8054188-8055188 intergenic \ N RLTRETN 0 0 0 0 
2gx12 chr2: 1 09031686-1 09032686 Mett5d1 body N RLTR10D 0 0 0 0 
3gx7 chr2: 155627541-155628541 241 0003P 15Rik body N 0 0 0 0 
5fx4 chr2:25946146-25947146 Camsap1 body N 0 0 0 0 
3ex12 chr2:26469065-26470064 Notch1 body LlKE 0 0 0 0 
6cx3 chr2:26472365-26473364 Notch1 body LlKE 0 0 0 0 
1ex6 chr2:46, 704,677-46,705,677 intergenic \ N IAPLTR2 0 0 0 0 
---------
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGSID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
3bx6 chr2:5,519,825-5,520,825 Camk1d body N 0 0 0 0 
5fx5 chr2:86,345,247 -86,346,306 intergenic \ N RlTR10D 0 0 0 0 
4hx2 chr3: 103722382-103723382 Rsbn1 body N 0 0 0 0 
4fx6 chr3:43851799-43852799 BC099952 body N RlTR27 0 0 0 0 
2ex12 chr3:87,841 ,451-87,842,451 Arhgef11 body N 0 0 0 0 
2dx11 chr4: 124421742-124422742 intergenic \ N 0 0 0 0 
5ex8 chr4:155146333-155147333 intergenic \ N RlTR10D 0 0 0 0 
6fx8 chr4:59072485-59073463 intergenic \ N IAPlTR2 0 0 0 0 
19x3 chr4:8,241, 763-8,242, 763 intergenic \ LlKE MMERVK10C 0 0 0 0 
2cx6 chr5: 144,319,244-144,320,244 AA137378 3' N 0 0 0 0 
3fx11 chr6:920387 49-920397 49 intergenic \ LlKE RlTRETN 0 0 0 0 
2gx9 chr7:31 091264-31092264 Gpi1 3' N 0 0 0 0 
6fx7 chr8:4857718-4858718 intergenic \ N RlTRIAP1a 0 0 0 0 
2ex13 chr8:95,493,253-95,494,253 intergenic \ N RlTR27 0 0 0 0 
19x1 chr9:117,887,550-117,888,550 intergenic \ N MMERVK10C 0 0 0 0 
2ex10 chr9:122,589,894-122,590,894 BC042569 5' N SINE-B2 0 0 0 0 
4ex5 chr9: 15829320-15830294 C0043424 body N 0 0 0 0 
2fx7 chr9:48672841-48673841 Plzf body N 0 0 0 0 
4dx8 chr9:48741810-48742810 Plzf body N MTE2b MalR 0 0 0 0 
1ex5 chr10:37,632,522-37,633,522 intergenic \ N lAPEz 0 0 0 0 
2gx11 chr11 :116717090-116718090 Rhbd16 body N 0 0 0 0 
7fx1 chr11 :118782291-118783291 D11Bwg0517e body N 0 0 0 0 
1fx9 chr11 : 119, 175,699-119, 176,698 intergenic \ N 0 0 0 0 
4fx5 chr11 :119206448-119207447 intergenic \ N 0 0 0 0 
5dx9 chr11 :90617696-90618696 Stxbp4 body N RlTR27 0 0 0 0 
3fx12 chr12:108180863-108181863 Dnchc1 body LlKE 0 0 0 0 
4gx10 chr13:69052451-69053451 intergenic \ LlKE 0 0 0 0 
4fx3 chr13:99940745-99941745 AK090136 body N 0 0 0 0 
19x2 chr14: 108,593,648-108,594,643 intergenic \ N RlTR27 0 0 0 0 
5ex9 chr14:58585165-58586164 AY534252 body N 0 0 0 0 
4dx6 chr14:6857367 4-6857 467 4 intergenic \ N 0 0 0 0 
----- '------- ------ ~~ -
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGSIO position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
2dx10 chr15: 13,411,380-13,412,380 intergenic \ N RLTR44C 0 0 0 0 
2gx10 chr16:22096541-22097541 intergenic \ N 0 0 0 0 
2fx6 chr16:49829798-49830798 B130050K08 body N RLTR10D 0 0 0 0 
19x1 chr16:52,497,054-52,498,054 intergenic \ N IAPLTR2 0 0 0 0 
2ex11 chrX:96,244, 173-96,245, 173 Tex11 body N EtnERV2 0 0 0 0 
UNCHANGEO UNMETHYLATEO: 
3C06 chr1 :15469944-15470945 AW045422 5' y 4 4 4 4 
4G106 chr1 : 16807772-16808772 6130401 J04Rik 5' y 4 4 4 4 
3A10 chr1 : 191,690,179-191,691,178 Rcor3 5' Y 4 4 4 4 
1E05 chr1 :191690703-191691702 Rcor3 5' Y 4 4 4 4 
3F42 chr1 :4487556-4488556 Sox17 3' y 4 4 4 4 
5E65 chr1 :58220251-58221251 6530404F10Rik 5' Y 4 4 4 4 
4F09 chr1 :89,845,970-89,846,970 intergenic \ y 4 4 4 4 
3G72 chr2:102251170-102252170 Trimm44 5' y 4 4 4 4 
3C13 chr2: 1 05853654-1 05854654 Zcs13 5' y 4 4 4 4 
4G96 chr2:109768396-109769396 intergenic \ y 4 4 4 4 
6012 chr2: 135399882-135400882 AK020944 5' Y 4 4 4 4 
3F14 chr2: 140136204-140137204 AK013491 5' Y 4 4 4 4 
2819 chr2: 163222202-163223202 intergenic \ LlKE 4 4 4 4 
3G90 chr2: 173854485-173855485 Npepl1 5' Y 4 4 4 4 
2C15 chr2: 19722709-19723709 AK076525 5' Y 4 4 4 4 
2G81 chr2:30611927-30612927 Cstad body LlKE 4 4 4 4 
3003 chr2:64028398-64029398 Fign 5' Y 4 4 4 4 
3C27 chr2:7 4499025-7 4500025 Evx2 3' y 4 4 4 4 
5G39 chr2:7 4502334-7 4503333 Evx2 5' Y 4 4 4 4 
1F02 chr2:74511886-74512886 Hoxd13 5' Y 4 4 4 4 
3007 chr3: 138550339-138551339 Tspan5 5' y 4 4 4 4 
4E40 chr3:32516993-32517993 Actl6a 5' Y 4 4 4 4 
1014 chr3:34457260-34458260 Sox2 5' y 4 4 4 4 
3F09 chr3:45324156-45325156 Pcadh10 5' y 4 4 4 4 
_._-----
----- ----
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGS ID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
2C31 chr3:57976407 -57977 407 Pfn2 5' Y 4 4 4 4 
3G60 ch r3: 62482883-62483883 4631416L 12Rik 5' Y 4 4 4 4 
2006 chr3:68594659-68595659 Schip1 5' y 4 4 4 4 
5G16 chr3:84372431-84373431 AK079415 5' y 4 4 4 4 
2C37 chr3_random:-163-837 X59474 5' y 4 4 4 4 
5050 chr4: 11248741-11249741 AK144417\AK133116 5'\5' Y 4 4 4 4 
5H33 chr4: 120089377-120090377 intergenic \ y 4 4 4 4 
3067 chr4:131327548-131328548 Oprd1 3' y 4 4 4 4 
6020 chr4:141617289-141618289 9030409G11 Rik 5' Y 4 4 4 4 
4009 chr4:146091219-146092219 AK089842 body Y 4 4 4 4 
2F89 chr4:152471366-152472366 BE985330 5' Y 4 4 4 4 
2F39 chr4:54958381-54959381 CJ147550 5' y 4 4 4 4 
1G34 chr4:59044079-59045079 AK136359 5' Y 4 4 4 4 
5051 chr4:59667448-59668448 E130308A 19Rik 5' Y 4 4 4 4 
3G119 chr4:77615294-77616294 Ptprd 5' y 4 4 4 4 
5813 chr4:99043424-99044424 intergenic \ LlKE 4 4 4 4 
6C17 chr4:990501 03-990511 03 Foxd3 5' Y 4 4 4 4 
2C25 chr5:116586572-116587572 Wsb2 5' y 4 4 4 4 
1F08 chr5: 128257505-128258505 Ran 5' Y 4 4 4 4 
3019 chr5: 134364721-134365721 Pom121 5' y 4 4 4 4 
2G05 chr5: 148344808-148345808 63304061 15Rik 5' Y 4 4 4 4 
4058 chr5:271 03323-271 04323 Insig1 5' y 4 4 4 4 
3824 chr5:32883436-32884436 AK038286 5' Y 4 4 4 4 
5C23 chr5:47308516-47309516 SIit2 5' Y 4 4 4 4 
3G35 chr5:73613244-73614244 BC083068 5' Y 4 4 4 4 
4F84 chr6: 122,855,579-122,856,579 Foxj2 5' y 4 4 4 4 
2E10 chr6:24898170-24899170 6332401019Rik 5' Y 4 4 4 4 
3049 chr6:38229607 -38230607 B 130055L09Rik 5' y 4 4 4 4 
4027 chr6:52127185-52128185 Hoxa2 5' Y 4 4 4 4 
4E29 chr6:52138663-52139663 5730596B20Rik 5' Y 4 4 4 4 
2G95 chr6:55166342-55167342 C330043M08Rik 5' y 4 4 4 4 
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGS ID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
2C19 chr6:85541127-85542127 Egr4 5' Y 4 4 4 4 
4E47 chr6:91198541-91199541 Nup210 5' y 4 4 4 4 
lE27 chr6:92172168-92173168 AK157305 5' Y 4 4 4 4 
lG14 chr7:1 0561 8761-105619761 Bca3 5' Y 4 4 4 4 
4821 chr7:321 04130-321 05130 AK149337 5' Y 4 4 4 4 
6G67 chr7:60359386-60360386 Apba2 5' Y 4 4 4 4 
5G21 chr7:61228288-61229288 Tjp1 5' Y 4 4 4 4 
lG50 chr7:76559422-76560422 2610312F20Rik 5' Y 4 4 4 4 
5830 chr7 :96976931-96977931 CF723412 5' y 4 4 4 4 
3004 chr8: 105656289-105657289 Cog8 5' y 4 4 4 4 
lF14 chr8: 12370578-12371577 Sox1 5' Y 4 4 4 4 
1026 chr8:35013720-35014720 BF456945 5' Y 4 4 4 4 
4G73 chr8:90391925-90392925 Irx3 5' y 4 4 4 4 
4E58 chr8:91448223-91449223 A330042H22 5' y 4 4 4 4 
5G61 chr9:45387989-45388989 Dscaml1 5' Y 4 4 4 4 
5F59 chr9:47491453-47492453 Igsl4 5' y 4 4 4 4 
lG51 chr9:49773317-49774317 Ncam1 5' Y 4 4 4 4 
3Ell chr9:52146492-52147492 BC042784 3' y 4 4 4 4 
3029 chr1 0: 117355938-117356938 Rap1b 5' Y 4 4 4 4 
4026 chr1 0:18041 072-18042070 intergenic \ y 4 4 4 4 
6C25 chr10:27855268-27856268 Ptprk 5' y 4 4 4 4 
5827 chr1 0:28926887-28927887 6330407J23Rik 5' Y 4 4 4 4 
5E24 chr10:28927649-28928649 6330407J23Rik 5' Y 4 4 4 4 
2C51 chr10:53568628-53569626 AK015334 5' y 4 4 4 4 
3E44 chr10:60042860-60043860 Cdh23 body N 4 4 4 4 
5C16 chr10:62244082-62245082 AK028920 5' Y 4 4 4 4 
3E54 chr10:67138965-67139965 Egr2 5' Y 4 4 4 4 
6G41 chr10:80544550-80545550 Dot11 5' Y 4 4 4 4 
3F27 chr10:81243984-81244984 intergenic \ y 4 4 4 4 
2831 chr10:81276209-81277209 AK132321 5' Y 4 4 4 4 
4F21 chr10:81353485-81354485 Aes 5' y 4 4 4 4 
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGS ID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
2G09 chr1 0:9373956-9374956 E130306M17Rik 5' Y 4 4 4 4 
1F40 chr11 : 102425843-102426843 Ubtf 5' Y 4 4 4 4 
5G51 chr11:1 06721451-1 06722451 Tex2 5' Y 4 4 4 4 
4E72 chr11 :11637804-11638804 AK077815 5' Y 4 4 4 4 
5F63 chr11 :119146234-119147097 Cbx8 3' Y 4 4 4 4 
6816 chr11:119149258-119150257 Cbx8 5' Y 4 4 4 4 
2840 chr11 :119150132-119151131 Cbx8 5' Y 4 4 4 4 
4F28 chr11 :119161722-119162722 intergenic \ Y 4 4 4 4 
3F03 chr11 :119164598-119165597 intergenic \ Y 4 4 4 4 
5E61 chr11 :120051613-120052613 Baiap2 5' Y 4 4 4 4 
5812 chr11 :23207637-23208637 Xpo1 5' Y 4 4 4 4 
3827 chr11 :23208412-23209412 Xpo1 5' Y 4 4 4 4 
2823 chr11 :43393725-43394725 d11ertd730e body LlKE 4 4 4 4 
2F73 chr11 :59257728-59258728 Gja12 3' Y 4 4 4 4 
4819 chr11 :61489409-61490409 intergenic \ y 4 4 4 4 
2H54 chr11 :66606861-66607861 AK147504 5' Y 4 4 4 4 
4E24 chr11 :70295636-70296636 SIc16a11 5' Y 4 4 4 4 
1F30 chr11 :8576172-8577172 AK089717 body Y 4 4 4 4 
4F52 chr11 :90747059-90748058 Cox11 5' Y 4 4 4 4 
5G22 chr11 :96573227-96574227 AK037877 5' Y 4 4 4 4 
5H105 chr11 :99046635-99047635 Rara 5' Y 4 4 4 4 
3F61 chr12:20917137-20918137 LOC245297 5' Y 4 4 4 4 
2F61 chr12:33881603-33882603 Tspan13 5' Y 4 4 4 4 
3F56 chr12:47396880-47397880 Foxg1 5' Y 4 4 4 4 
4G54 chr12 :5317394-5318394 BC065168 5' Y 4 4 4 4 
2G50 chr12:65162828-65163828 Mamdc1 5' Y 4 4 4 4 
5G90 ch r12 :78095338-78096338 AK053779 5' Y 4 4 4 4 
3063 chr12:99963951-99964951 GoIga5 5' Y 4 4 4 4 
1E25 chr13:110143397-110144508 AK053890 5' Y 4 4 4 4 
5G11 chr13:23076015-23077015 HIe 5' LlKE 4 4 4 4 
3H19 chr13:23104309-23105315 Hist1 h1c 5' Y 4 4 4 4 
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Notl site Notl site location RLGS spot intensity (methylation) 
RLGS ID position +/-500 bp (mm7) gene position CpG Island Repeat testis liver intestine brain 
1F15 chr13:24635336-24636336 Vmp S' y 4 4 4 4 
1001 chr13:33353087 -33354087 Serpinb6a S' y 4 4 4 4 
2G41 chr13:4 77 43959-4 77 44959 Id4 S' Y 4 4 4 4 
2C22 chr13:53822640-53823640 Gprin1 ? GAP 4 4 4 4 
5C30 chr13:59283846-59284846 Gas1 S' Y 4 4 4 4 
2C33 chr13:592847 46-592857 46 Gas1 S' Y 4 4 4 4 
3F70 chr14: 111327498-111328498 Gpc6 S' Y 4 4 4 4 
2G96 chr14: 12515714-12516714 SIc4a7 S' y 4 4 4 4 
3E75 chr14:27151399-27152399 Cacna2d3 S' y 4 4 4 4 
4F06 chr14:27782976-27783976 AK147415 S' Y 4 4 4 4 
1H21 chr14:58470731-58471735 AY534252 S' Y 4 4 4 4 
5F75 chr14:65536009-65537009 Gfra2 S' y 4 4 4 4 
2F57 chr14:71 095432-71 096432 Tgfb1 i4 S' Y 4 4 4 4 
2F72 chr15:64073316-64074316 BC011343 S' y 4 4 4 4 
2E14 chr15:68445727 -68446727 BB645359 S' Y 4 4 4 4 
3838 chr15:85753215-85754215 intergenic \ y 4 4 4 4 
5E02 chr15:91654853-91655853 A630029G22Rik S' y 4 4 4 4 
6G69 chr15:99073349-99074348 C1q14 S' y 4 4 4 4 
5C29 chr15:99078538-99079538 intergenic \ y 4 4 4 4 
2F31 chr15 :99081949-99082948 281 0451 A06Rik S' y 4 4 4 4 
1C13 chr16:1 0066697-10067697 AK014352 S' y 4 4 4 4 
4F59 chr16:20853694-20854694 EphB3 S' Y 4 4 4 4 
1E24 chr16:21916518-21917518 Sfrs10 S' Y 4 4 4 4 
3036 chr16:32736583-32737583 Lmln S' y 4 4 4 4 
2F53 chr16:34830959-34831959 Adcy5 S' y 4 4 4 4 
6006 chr16:8411311-8412311 AK135814 body Y 4 4 4 4 
5C25 chr16:84833713-84834713 Gabpa/Atp5j 5'/5' y 4 4 4 4 
2041 chr17:24321508-24322508 Axin1 S' y 4 4 4 4 
5011 chr17:30380436-30381436 AK010021 S' Y 4 4 4 4 
5E57 chr17:81508970-81509969 AW548124 S' y 4 4 4 4 
2047 chr18:23694400-23695400 X95227 S' y 4 4 4 4 
- ----------- ------
135 
Notl site Notl site location 
RLGSIO position +/-500 bp (mm7) gene position CpG Island Repeat 
4036 chr18:36663249-36664249 Pura 3' y 
5F70 chr18:47745768-47746768 Sema6a S' y 
2F12 chr18:51494854-51495854 AK046456 S' y 
1E23 chr18:53854762-53855762 AK133910 body Y 
2E30 chr19:45556841-45557841 Fbxw4 S' y 
6010 chr19:45572506-45573506 intergenic \ LlKE 
6008 chr19:4650792-4651792 4921506122Rik S' Y 
1G31 chrX: 1 03142779-1 03143779 2610002M06Rik S' y 
3G99 chrX:104161360-104162360 AK050539/AK086455 S'/S' y 
2G34 chrX:21797681-21798681 Klhl13 S' Y 
6016 chrX:51855137-51856137 6330419J24Rik S' Y 
1F21 chrX:53511527-53512527 Zic3 S' Y 
2F37 chrX:56286481-56287481 Sox3 S' y 
4C18 chrX:69060075-69061 075 SIc6a8 S' y 
NOTES: CpG Islands: Y = meets criteria of Takai & Jones 
LlKE = meets criteria of Gardiner-Garden & Frommer, not Takai & Jones 
N = meets neither 
Site Position: S' = 3kb upstream - 1 kb downstream of transcriptional start site 
Methylation: 
3'= 
body = 
Ig = 
RLGS 
4= 
3= 
2= 
1 = 
0.5 = 
0= 
3kb downstream - 1 kb upstream of transcriptional termination site 
anything inside 
anything outside 
approximate 
%methylation 
0% 
2S% 
SO% 
7S% 
90% 
100% 
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RLGS spot intensity (methylation) 
testis liver intestine brain 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
4 4 4 4 
Table 3.3: qAMP primer sequences used to confirm the DNA methylation status of 
id T d RLGS 1 . d 1 0 L . entlle oClan to analyze nmt3 spermatogoma. 
RLGS spot Forward Primer (5'-3') Reverse Primer (5'-3') 
1027 CTTTCGCAGGTTGTCCATCT CCTCAGCTCTTCCTCCACAG 
1F55 TGCCAACTGCTTTTCCAGAT TAAAGCATCCCAGTGGCAGT 
1G34 TAGTCCTGCGTGTGGACTGT GCGTTGCTAGGAGAGAAGGA 
1H64 CTAAGCTGCGCCTCAGACA TACTTGATGCCACCCACGTT 
2B19 CACACCTGGCCTGATTGAT CCCAGGGATGCTCCATAGT 
2C56 CATCAACCCAGGTACGAAGA GGAAGAGGAGGAGCCACAGT 
2C58 GCTCCAACCTCAGTCAGCA CACAGAGGGAGCAGGCATA 
2F21 CTGCCAAAGAATCCTTTCTGAC GCCCTACTACCTGGAGAACGA 
2F64 GGCTCAAGGCCCTAAGGTAA AGCCCCTACCCAGCCTACAT 
3B50 TGATTAGCACTCGTTGGACA CTTTGGAAACGTCTGCGATTA 
3031 GGTAGCAGAGTTGAGCCATT CTCGGACTTGTCGGCATC 
3038 CAAGCTGCATGCTAAATTCG TCAAGCAAGTGGAGCCTTTT 
3070 GCGCTCCCAAATGAAGGTTA AGCGACAAGCTCCATTCTCT 
3E07 GGCCGTACCACAGATAACCA GCGCAGTTATCCGTCTATCCA 
3E09 GTCCAGAGTGCGTCTGAAGAT TCGGAGATAGCAGCATAGCA 
3E80 CTCCCCCATTCTCCCTCAC CCTAACTTCTTGCCGTGCTC 
3E85 ACTCTCCTGCCTTGCACCT GCTGTCCACTCGGTGTCAT 
3F27 GTGGCTCTCTTTTTCCAAAGC AAACCAGGCAGGAGGGATT 
3F91 CCTTTTCCCTTTCTGCCACT AAGTTGATCCTGTGGTGATGC 
3G122 GAAGAGCATCACGATCAGCA AATGCCACTAGCCCAAGGT 
3G91 TACCTGGCTGATTGGTGATG ACTGAGAGCAAGCGAACAGG 
3G91 TACCTGGCTGATTGGTGATG ACTGAGAGCAAGCGAACAGG 
4B46 GAGAGAGAGACTGTCACCCTGTTA TTCAGGGTTGCAGCTAAAGA 
4C11 CTGGCAAGCTGTCCGATAGT CCGAGATCTTACGCAGGAGATA 
4C13 ACAGTCTTGCCCGGATTGAT GTGTGAGAAGCCGAGGAGAA 
4C31 AAGCAGGAAGTTGGCGTTTA CTTCCTCCTCCTGCTTCCA 
4C40 TCTGCAATAAGGGGCTGAAC AAAGTGGCTTGTGAGGCATT 
4C43 TTAGGGCTGCCAGGAGTAAG ACCCACGAGCATCTTTCG 
4072 GTGCGATTTGTGAACTTCGT GGGCAAGGCAGTAAACATCT 
4E15 CAGTGGCTCTCCTCACCTTC CGTGAGAGCCAAGAAACCTC 
4F97 ATCTGTGTCGGTGGTGAGGT GAAGGGATGGTAGCAAGTGG 
4G106 CCCTTTCTTCCCCCTAAGC GAGACGAGGTGAGCGTCTG 
4G110 TAAACAAACCCCACCACTGC CATGTTGCCAGGAGCTTTG 
5C54 GGCATCTGGTGAAAGCTCA CTGGGAAACGGCACTTCTT 
5058 ATTCTCCTGGGCATGACATC CAGCTGCTGCCTTCTAACTTG 
5F09 AAGGCCACTGCCTAGAACCT CGAGAGGGGGCGATATTACT 
137 
Table 3.4: qAMP Primer sequences used to determine methylation levels of non-CpG 
. 1 d h 4 10 17 d X IS an sequences on c romosomes , , an 
Position (mm7) Forward Primer (5'-3') Reverse Primer (5'-3') 
chr4:4872334-4872813 ACCCTTCAAAACCCGTGAAT GCCTGAATCTTGCTCTTTGCAT 
chr4:9927753-9928179 GAAAGGGGAACAGGGGAGTA GGCACCTAGCATCTTGGAGA 
chr4:15477713-15478091 GTGTTGGCTAATGAGGAGGA GAAGGAGAAAGGATGCTGGA 
chr4: 19850460-19850826 CTATGACTCCCCACGTCACA GTCATGCGGAAGACATCTGA 
chr4:24806042-24806420 GGAAACAGAGCTCTCTGGAA ACAGCTAACCCAATGGCTCT 
chr4:30339739-30340307 TTGAACAGCATGCCTCTCT TTTAACTGCGCTGTGGAGAA 
chr4:35145276-35146275 TCATCAAGGGCAGAGGAAAT TTTCGAGAAGGACGGAGGT 
chr4:40155437 -40155738 ACCACACAGACCTCCTCTCA CTCAAAGCAGCCACGACTGT 
chr4:452821 04-45282572 TCATCAGTGACCCCTCTTCC CTGGACCAGCTCTTCCTCAT 
chr4:50216637 -50217105 TGGCTAGGGAAGAGGTGAGA CTTCTTCCCTTGTGGCTTGA 
chr4:55202844-55203145 TTTGAGAGAAGGCAGCATGA AAGGCCTTCGTCGTTAGACA 
chr4:59969750-59970164 GTGCCACATGGTGTGGTAAA ATATGCCGTATTGCACAACC 
chr4 :65403458-65403793 CCCAGGGTAAAAAGGATCA AATCGTCTCGAACTCGCTCA 
chr4:70217560-70217910 GGGGCTTTAAATGGGAAACA TCAAGCAGGAAGAGCTGGATA 
chr4:75238764-75239513 CCCAGATACCAAGGTGTGTCT GGCTGACAGGTGAACTGAGA 
chr4:80266828-80267395 CATGTGTCCCCGTTTCTTGT CAGCTTGGTCACAACCATCA 
chr4:85800348-85800847 CACCCCATCTCCCATTTCTA AGGATCACCACGAAACAGGT 
chr4:904 73664-904 7 4084 GGACAAGGGGGCTTTCTTTCT GGGAATGGAGCTGTATGGT 
chr4:96111617-96112110 AGCTTCCCACTTTCCAACAA GCCTTTCAGCTACAGTTCCAA 
chr4: 1 00277854-1 00278187 AAAACCAACAGGCCTGAGAA TCGTCGTCAAAAAGGTCAGA 
chr4: 1 05596524-1 05596856 AGCAACAGCAGCAACTGAAC TCCCTGGTTGATCCTGTGTA 
chr4: 11 0703297 -110703796 GAGAGGAACCTGAGGCTTGA CAGCAGAGACGGGAGACAAT 
chr4:115472605-115473015 TTCATGGCATCCCTACCAGT TCTTGCTGTGACTGCATCCT 
chr4: 120466404-120466860 CTGGAAGAACATGGCAAGTGA TCCTCCCTCTGTTCTCTGGT 
chr4:125407419-125407757 ACCATGGAAAAGGAGCAACA GCCAGGTCTGGATACAAGGA 
chr4: 129975322-129975744 TCCACTGTGTTCAGAAGCAA GGAATAACCGGTCATCCAAA 
chr4: 135498472-135498890 CCCGAGGTCATGAGAAAGAA CTGTTTCCTGGGGTTGTGAT 
chr4: 140499164-140499582 TGCACTGGAACAGGACTGAG GAGGGGATGTAAACGGGAGT 
chr4: 144580754-144581253 TCTGCTAGCTCCTCCTGCTT GGAGGTGTTGTGGCTAGCTT 
chr4: 150486904-150487236 CGAACGGAAGAAAAGGACTG TGTAGTGTCTGGGAGGGACA 
chr4:155169477-155169776 AATGTGAGGGTCGTTGCACT TGTAGGCCAGCTTCCTTCAT 
chr10:3022525-3023024 GGGTAGGTGGAAGATGGAAA TCTGTGTTCCCCTCCTGTTT 
chr1 0:1 0171776-1 0172275 AGGCACTGCGTGATAAAGGT ACAGCAGACGCTGGAAGTCT 
chr10:16148635-16150301 AAACCGGTTCTGGTGGCTAT CAGCCAGTCCAAATTGTGTG 
chr10:21168346-21168845 AGTGGCCGAGTCCACTCATA GCCTCTCTAGGAAAGCCACA 
chr10:31696268-31696767 CCAGCCTTCATGCTTTATCC GGTAGCAGCCATCAGGTGAG 
chr10:36795939-36797049 CAAAACCAAGCTGGGTGAGA GTGGCTTCCTCTCTGGAAGA 
chr10:41919793-41920292 GGGCCCTTTCCACTGCTAT ACATCGATGGTGAGGTGGA 
chr10:47643544-47644043 GAGAAGGGAAAGAGCTTCACTC GGCTTTTACAGGGGAGAAATG 
chr10:52120732-52121231 CCTTCTGTGCAGAACTGCTAAT TGGCTGGGAATGATGGTAAT 
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chr10:57109907-57110406 AGGAGGCACTTCACGAGCA ACCTGGTAGCTGGGAAGGAG 
chr1 0:61 051807-61 053306 ATCCTGGGTAATGCAGCAGA GGCTAGAGAGCCAAAGAGCA 
chr10:65305221-65305970 TCAGAGAGCACAGGGAAGGT CCATTTCAGGCTAGATGTCCT 
chr10:70667883-70668382 GTCTCCCCTGAATGTTGTCT CATGAAGACAAAGAGGCACA 
chr10:75781133-75781632 GCTATGGAATGGGATGTGGT GCCCTGCCCTATTGGAGTT 
chr10:81242447-81242946 AACATCCCCGCCTCTGACT TGCTGTCTGTGTGCTCAGGA 
chr10:86594635-86595134 CCAACATACACCACTGCCTCT GGAAGAGCCTCTGCATCAAG 
chr10:91796647-91797146 TCAAACCCAGACTCAAGCAA GATGGGCAGCACTTATTTCA 
chr1 0:9694271 0-96943209 TGGCTAAGGCTTGAATACACA GAAGCTCTGCCCATGTCAAT 
chr1 0:1 01731736-101732235 CATTTTCAAGGAAGTGTTTTACAGT TGCTATCAGCTAAAGCAGCATAAT 
chr1 0: 106985289-106986955 TGCTGTGTTAAGTGGTCCAGA AGGATGTGTCTGTATCAGACGTG 
chr10:112041194-112041693 AAAAGGACATGCTAACCTGTGT GCTCTTTAATACAAGGGCAGTT 
chr10:116708169-116708668 CTCACAGTGGCAAGCACCT GACCCTGAGATGGACTTTGC 
chr1 0:121511 044-121511543 TCTGCCACCCTACCTGATCT GGAAGTGGTGCATCTTGTGA 
chr10:126312457-126312956 TTCCAGACGATGCTGAAAGA AGTTAATACCCACGGCCACA 
chr17:4233200-4233699 TCTACATGCAACAGTCCAGAGA AGTTTCTGCACAGCACAGTCTT 
chr17:10131737-10132236 GCATGTGGCCTGAATTATCA GGACCTGACATCTCCTTCCA 
chr17: 15662405-15663529 GGAAGGGAAATGGCTTCCTT TCTCCAAGTCCTCTGAGTCCA 
chr17:21803071-21803570 GGTCAGAAAGCTGCACCATA TTGTAGGCATGTGCACTGGT 
chr17:25013796-25014295 CAGACCATCACACACCCAGA CCTCAGCCCACAGGATAAAG 
chr17:30062796-30063545 CGGCAGCCTCATTACACAAT CCTTCATCAGGGGCAGCTAT 
chr17:36167472-36167971 TTGCCCTGCTATCCTGTGAT GGACCACAAGGGACCTTACA 
chr17:41678272-41678771 GGCTGACCTCAGCTCTCAGT TGCTGGTAGGAGTTGGCTTT 
chr17:46937248-469377 47 CCACACTTGGGTCCTCTGTT CCTGCACTTCCTGACACAGT 
chr17:50849373-50849872 GAGCCATGGATCCTTCAAGT TGTCAGGCCTGGACTCCTT 
chr17:54763523-54764022 TCAGGCAGAGGCCTAGAGTT GAGAGTCTCAGGCTGGCAAT 
chr17:60097848-60098347 CTGAGGAGTGAGCAAAACAAT CACAGATAATTTCCTCTGTTGG 
chr17:65306561-65307060 TGGAGACTGGTGAGCTAGAGA AAGACATGATGCTTGCCATCT 
chr17:70393712-70394211 TTAAGCAAAATCCCCCATCC AAGGCTGTGGAGGGTTTTAAG 
chr17:74730937-74731436 CCCACCGTGATTTTTACAGAA TGTGAGGAATGTTGTCAGCAA 
chr17:80208923-80209422 TTGACATTTCTTTCAGGGGACT GGCTTGTAAACTTAAACTGGAGGA 
chr17:85207048-85207547 CTCACAGCGGCTCCTGATA TTGAGGGAAGGGTGAGAGAA 
chr17:91821561-91822060 ATAACCCAAGGGGTCTGTGA AAAGACAATGAGAGGGCAAA 
chrX:4890124-4890623 GGCAGTAAGGGGACAGGTTA CCTTGACAGACCAGCTCTGAA 
chrX:9827238-9827737 AGCGCTGACTGGAAGTCATT CTCCTCCCTCACCTTTTGAA 
chrX:15319447-15319946 ACCGGTAAGTGGCAGTAAGT TTCTCCAGATGGTGCTCCT 
chrX:20292767-20293099 AGTAATAGACGGGGCCAGGA CTGCTTTGGGAGAAGTGGTCT 
chrX:35736464-35736818 TTTCCAGCGCCAATAGTTGT TGTGGTGATCACATCACTTCAG 
chrX:40656582-40656936 CTGGCATCACTGCATCTATGA CAGAGTGGTTGTGCTCCTGAT 
chrX:45749431-45750930 AAGAATCTAGGGCCCTCTTTG GTGGACCGAGACAAAGGAAA 
chrX:48789755-48790109 TCCCCAGGAACCTTCTACCT GTGTAGGAGGATGGCAGGAA 
chrX:56195598-56196098 CAGACTCCAGCAACAAAGGA CCCTTGAGAGCAAATCGAAG 
chrX:61330784-61331547 AGCACGGGCTGCTACAAA CACTGCCTCTTCTGTGTCCA 
chrX:66502472-66502918 AATTGCCCAACTGCATACAA AATGCTGGGCTTCACCAATA 
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chrX:71408206-71408702 TAGCTAGCGGGGTATGACTT CCTTGAAGGAGAACAGCATA 
chrX:76236203-76236748 TGCTCACTGTGCTACAACCA GTCCATGAGCCTCTCCCTTA 
chrX:80709428-80709859 AGTCCAGGAGCAACTGGCTA CGAGGCAGCTCAAAGGTAGA 
chrX:85404289-85404720 ATTGGGTTCATCTGGCTACA CCTGATTATCACAAGCATTCATC 
chrX:90325997-90326375 CTTTTGCCAACGGTCCTCTA CCCGAGGAAAATGAACCTGT 
chrX:95723738-95724169 TGTGTCCCGAGCATTGATTA GGGCTGAGCAAACCTTTCTT 
chrX:1 00788840-1 00789271 GACCCACATGATCAAAGTGCT AAGAAAATCCTGGCTGCTGA 
chrX:1 056451 03-1 05645481 TCAGAGCCATGGAATGTGTT TTTGGAGCTCATTCAGACCT 
chrX:110765173-110765604 GACAAATGCTATCTTTAATGGCTGT TTGAGAGAAACGCACCAAAA 
chrX:115633810-115634309 AGGATTTCGTCCAATCTCA TGTATGAAATGCACTGTCTTGT 
chrX:121249040-121249469 TGAAGGTGGAAAAATCTGCTGT TGCATGTGATACTTACTCCCTATGA 
chrX:126210018-126210447 CTTCCTTCTCTTTTGCCTTTGA GCAGAATTACTGGGAGAGAAAT 
chrX:130693473-130695722 GGCTCCTTTGCTCATCTTCT GGGTGCCTGTGTCTGATTCT 
chrX:136254525-136254954 GCCTTAGAAGCCATTATAGTTTTGTC TCTCTGAACCCTTTGAAAGCA 
chrX:141149803-141150371 CCAGCTGCTTGATTGCTTCT GCTTTTAAAGGAGGGGCTTC 
chrX:146231833-146232219 TCCTAAATACTCTTGGGGTTTGG TCAGCAATAAAAGGGGAATAG 
chrX:151368505-151369254 CCTTCAGAGACTTTCTCCCTTT GGCAGTCTGCTAGAATGTGCT 
chrX:1564081 03-156408651 CAGCCTTGCTGATCTGACAT TTGTGTCACTGCCTCCATAA 
chrX:161246279-161246665 AGCATGAGCCCACTCTTGA TGGACAGGTGTCACTTGCAT 
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APPENDIX TO CHAPTER III 
Appendix 3.1: The relationship between testis-specific DNA methylation 
and the proximity scaffold/matrix attachment regions (S/MARs). 
The organization of chromosomes within interphase nuclei is dependent 
on interactions between chromatin and a proteinatious component of the nucleus 
called the nuclear matrix. The nuclear matrix is made up of structural 
filamentous proteins that make up a nuclear scaffold and proteins that link the 
scaffold to chromatin (Gruenbaum et al., 2005). In this manner, the matrix is 
associated with the organization of chromatin into functional and non-functional 
compartments within the nucleus. Interactions between chromatin and nuclear 
matrix proteins occur in a DNA sequence-specific manner, in regions called 
S/MARs (Boulikas, 1993). S/MARs are distributed throughout the genome and 
are usually found in evolutionarily conserved non-coding DNA sequences 
(Glazko et al., 2003). 
Although the exact locations of interactions between the nuclear matrix 
and chromatin are not clearly defined, regions of high S/MAR-forming potential 
can be identified using a bioinformatic approach (Figure 3.11 a). Using this 
approach, regions of high S/MAR potential occur on average approximately 
every 20 kb. Comparing the difference between methylation of liver and testis 
DNA at non-CGI, non-repetitive sites on several chromosomes to the S/MAR 
proximity of each site reveals that there is an increased likelihood of observing a 
difference in methylation between the tissues if the sites are closer to a region of 
high S/MAR potential (Figure 3.11 b). 
This may indicate that methylation of non-S' sites may play a role in the re-
organization of chromatin architecture. Germ cells may use DNA methylation to 
modulate which S/MARs are bound to the matrix to produce an architecture that 
is different than somatic cells and is permissive for meiotic processes. 
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Figure 3.11: Testis-specific DNA methylation and S/MAR proximity. (a) The 
MAR-Wiz v1.5 output file of a 40 kb region of DNA showing the SMAR-forming 
potential of the sequence in 100 bp windows (http://futuresoft.org/mar-wiz). Any 
region showing a potential over 0.75 was considered a SMAR. The distance 
from the analyzed region to the closest SMAR was recorded. (b) The 
comparison of the difference in DNA methylation between liver and testis 
compared to the proximity of the analyzed site to the closest S/MAR. Ali data 
generated using the qAMP assay on chromosomes 4, 10, 17 and X was included 
in the comparison. The dashed vertical line represents the median S/MAR 
distance of ail analyzed sites. The average absolute difference in DNA 
methylation between sites closer or farther away th an the median distance was 
compared. There is a statistically greater likelihood of an analyzed site showing 
a difference in methylation if it is closer to S/MAR (P=0.002). Statistical analysis 
performed by Mann-Whitney rank sum test (SigmaStat v2.03). 
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Appendix 3.2: The relationship between the genomic locations of 
hypomethylated testis-specific genes and testis-specific differentially 
methylated loci. 
There is much evidence that supports a functional relationship between 
promoter-specific hypomethylation and gene expression. Although in this 
chapter we have concluded that much of the testis-specific hypomethylation is 
not likely associated directly with gene expression, it is possible that the 
expression of some testis-specific genes is associated with hypomethylated loci. 
Only three genes of the 66 analyzed demonstrated the highest level of 
expression in the tissue that was hypomethylated, and ail three occurred in the 
testis. This is an agreement with the finding that the vast majority of genes that 
are known to display this association are found in the testis and not other tissues 
(MacLean and Wilkinson, 2005). 
We find that several of the testis-specific genes that are known to be 
specifically hypomethylated in the testis are located near genomic loci that are 
found to be differentially methylated between the testis and somatic tissues 
(Figure 3.12). Half of these genes are located between 100 kb and 4 Mb from a 
locus identified by RLGS to be hypomethylated in the testis; none are associated 
with hypermethylated sites. The distances separating several of these genes 
from an observed hypomethylated site is larger th an what would be expected to 
be influenced by the activity of the gene itself. It is possible that regional 
chromatin changes that may occur on a larger scale would allow gene activity to 
be increased if the gene were located in a hypomethylated region. 
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Figure 3.12: The relationship between the locations oftestis-specific genes 
and hypomethylated genomic loci determined by RLGS. Ali testis-specific 
genes that are known to be specifically hypomethylated in the testis in mouse are 
shown (MacLean and Wilkinson, 2005). Half of these genes are located between 
100 kb and 4 Mb from a locus identified by RLGS to be hypomethylated in the 
testis. Hyper- and hypomethylated loci are shown as closed red or open blue 
triangles, respectively. 
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CONNECTING TEXT 
The primary objective of the work described in chapter III was to 
determine the status of DNA methylation in the testis. The adult testis is made 
up many distinct types of germ cells in various stages of spermatogenic 
development; the germ cells in several of these stages possess striking 
differences in their chromatin structure. Once the unique nature had been 
described, we wanted to determine if the very complicated developmental 
process of spermatogenesis is associated with changes to the unique pattern of 
DNA methylation. In chapter IV, by isolating purified populations of male germ 
cells, we determine the changes in DNA methylation that occur during 
spermatogenesis and elucidate the origins of the unique pattern of DNA 
methylation in the testis. 
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CHAPTERIV 
Developmental Acquisition of Genome-Wide DNA Methylation Occurs Prior 
to Meiosis in Male Germ Cells 
Christopher C. Oakes, Sophie La Salle, Dominic J. Smiraglia, Bernard Robaire, & 
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ABSTRACT 
The development of germ cells is a highly ordered process that begins 
during fetal growth and is completed in the adult. Epigenetic modifications that 
occur in germ cells are important for both germ cell function and post-fertilization 
embryonic development. We have previously shown that male germ cells in the 
adult mou se have a highly distinct epigenetic state, as revealed by a unique 
genome-wide pattern of DNA methylation. Although it is known that these 
patterns begin to be established during fetal life, it is not known to what extent 
DNA methylation is modified during spermatogenesis. We have used restriction 
landmark genomic scanning (RLGS) and other techniques to examine DNA 
methylation at multiple sites across the genome during postnatal germ cell 
development in the mouse. Although a significant proportion of the distinct germ 
cell pattern is acquired prior to the type A spermatogonial stage, we find that both 
de novo methylation and demethylation occurs du ring spermatogenesis, mainly 
in spermatogonia and spermatocytes in early meiotic prophase 1. Alterations 
include predominantly non-CpG island sequences from both unique loci and 
repetitive elements. These modifications are progressive and are almost 
exclusively completed by the end of the pachytene spermatocyte stage. These 
studies define the developmental timing of genome-wide DNA methylation 
pattern acquisition during spermatogenesis. 
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INTRODUCTION 
Epigenetic marks in the form of DNA methylation are involved in the 
development of germ cells and important in the maintenance of fertility. 
Catalyzed by a family of DNA methyltransferase (DNMT) enzymes, mammalian 
DNA is commonly modified by the addition of a methyl group to the 5th position of 
the cytosine ring in CpG dinucleotides. DNA methylation is thought to act by 
promoting heterochromatin formation that can lead to gene repression when 
present in regulatory regions of genes (Klose and Bird, 2006). The importance of 
DNA methylation in male germ cells has been highlighted by studies investigating 
the properties of DNMTs. DNMTs are expressed in male germ cells in a 
developmentally regulated fashion, and some are expressed as germ cell-
specific alternative transcripts (La Salle et aL, 2004; La Salle and Trasler, 2006a; 
Mertineit et aL, 1998; Shovlin et aL, 2006). Dnmt3L, a DNMT lacking catalytic 
activity, is expressed at especially high levels in the gonocytes in fetal testes 
beginning at 15.5-18.5 days post coitum (dpc) (Bourc'his et aL, 2001; La Salle et 
aL, 2004). Males lacking Dnmt3L are infertile due to a complete lack of mature 
germ cells (Bourc'his et aL, 2001; Hata et aL, 2002) and display structural 
abnormalities of meiotic chromosomes (Bourc'his and Bestor, 2004; Webster et 
aL, 2005). DNA methylation is not fully acquired in germ cells of these mice at 
several repetitive and non-repetitive sequences, including imprinted and non-
imprinted loci (Bourc'his and Bestor, 2004; Hata et aL, 2006; Kaneda et aL, 2004; 
La Salle et aL, 2007; Oakes et aL, 2007b; Webster et aL, 2005). Germ cell-
specific deletion of Dnmt3a results in infertility and a loss of methylation at 
imprinted genes but not at repeat sequences (Kaneda et aL, 2004). 
The importance of DNA methylation in male germ cells is also inferred by 
its distinct patterns of DNA methylation. We have shown that genome-wide DNA 
methylation patterns involving an array of sequence types are highly unique in 
spermatozoa compared to somatic tissues in mouse (Oakes et aL, 2007b). 
Recently, a study in humans concluded that DNA methylation in sperm is highly 
distinct from ail cells and tissues of somatic origin (Eckhardt et aL, 2006). Other 
studies have found distinct DNA methylation states in repetitive sequences 
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(Sanford et aL, 1984) and some testis-specific genes in male germ cells 
(MacLean and Wilkinson, 2005). This unique state of DNA methylation arises 
from a genome-wide reprogramming event that occurs specifically in the 
primordial germ cells (PGCs) of the developing embryo (Reik et aL, 2001). 
Between 10.5 and 12.5 dpc, patterns of DNA methylation are erased in PGCs in 
imprinted and testis-specific genes (Hajkova et aL, 2002; Maatouk et aL, 2006). 
Repetitive elements, such as the intracisternal A partiele (IAP), LlNE-1 (L 1) and 
minor satellites undergo a similar demethylation although not to the same extent 
as is seen for single-copy genes (Hajkova et aL, 2002; Lees-Murdock et aL, 
2003; Walsh et aL, 1998). In the male, DNA methylation begins to be 
reestablished around 15.5 dpc for imprinted genes (Davis et aL, 2000; Li et aL, 
2004; Ueda et aL, 2000). The repeat sequences IAP and L 1 are remethylated by 
17.5 dpc (Lees-Murdock et aL, 2003). This also coincides with the 
developmental time point where germ cells stain strongly using an antibody 
directed against 5-methylcytosine (Coffigny et aL, 1999). 
Although several studies have addressed the acquisition of DNA 
methylation during fetal germ cell development, few have investigated the 
behavior of DNA methylation patterns during spermatogenesis. 
Spermatogenesis is a weil defined, complex developmental process whereby 
morphologically distinct, haploid spermatozoa that are capable of fertilization are 
produced from diploid germ cell precursors (Russell et aL, 1990). In mammals, 
this process continually produces a supply of spermatozoa for the duration of the 
life of the adult animal. Spermatogonial stem cells occupy the seminiferous 
tubules of the testis and continually provide a pool of undifferentiated diploid ce Ils 
ca lied type A spermatogonia. These cells undergo several rounds of mitosis 
before entering meiotic prophase l, where tetraploid spermatocytes pair and 
recombine homologous chromosomes. After recombination, spermatocytes are 
reduced to haploid spermatids that undergo morphological changes from round 
spermatids to elongating spermatids and finally to spermatozoa. These 
spermatozoa exit the testis and complete their maturation process during 
epididymal transit. 
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Studies of the paternally methylated imprinted gene, H19, shows that 
although initial acquisition occurs before birth, complete levels of DNA 
methylation are not achieved until the pachytene spermatocyte phase of 
spermatogenesis (Davis et al., 1999). The two other known paternally 
methylated imprinted genes, Rasgrf1 and Gt/2, similarly acquire most of their 
DNA methylation in the prenatal window, but have yet to acquire the levels found 
in spermatozoa (Li et al., 2004). Other data show that sorne sequences have 
fully acquired their DNA methylation status before the beginning of 
spermatogenesis, including sorne repetitive elements, such as IAP, L 1 and 
satellite sequences (Bourc'his and Bestor, 2004; Lees-Murdock et al., 2003; 
Walsh et al., 1998). The hypomethylated state of Pgk-2, a testis-specific gene 
expressed in spermatocytes, is also established prior to spermatogenesis (Geyer 
et al., 2004). Although limited data point to the acquisition of DNA methylation 
patterns beyond the fetal development window, a comprehensive study of the 
timing and the range of sequences involved has not been done. 
Restriction landmark genomic scanning (RLGS) is a highly reproducible 
technique that is used to investigate genome-wide patterns of DNA methylation 
in a variety of sequences. In combination with a recently developed second 
generation virtual RLGS resource (Smiraglia et al., 2007) that uses genomic 
sequence to produce simulated RLGS profiles, individual genomic loci that 
display alterations of DNA methylation can be identified. In this study, we 
produce a non-biased, detailed view of the patterns of DNA methylation in a 
variety of sequences as male germ cells progress though spermatogenesis. We 
find that both de novo methylation and demethylation occurs during 
spermatogenesis in a sequence-specifie manner. Most importantly, we establish 
that, in addition to prenatal acquisition, patterns of DNA methylation at multiple 
sites across the genome are acquired postnatally and are complete prior to 
meiosis in male germ cells. 
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MATERIALS AND METHODS 
Isolation of purified spermatogenic cells 
Adult male C57BU6 mice were obtained from Charles River Laboratories 
(St-Constant, Quebec). Ali animal studies were conducted in accordance with 
the principles and procedures outlined in the Guide to the Care and Use of 
Experimental Animais prepared by the Canadian Council on Animal Care. 
Purified populations of type A spermatogonia, early pachytene and pachytene 
spermatocytes, and round and elongated spermatids were obtained from the 
testes of mice using the sedimentation velocity method (Bellve et aL, 1977a). 
Type A spermatogonia were obtained from 8-day post partum (dpp) mice with an 
average purity of 86% (n=2, 100 mice pooled per cell separation). Early 
pachytene spermatocytes were obtained from 17 dpp mice with a purity of 75% 
(n=1 cell separation, 100 mice pooled). Pachytene spermatocytes (avg. 
pu rity=85%) , round spermatids (avg. purity=95%) and elongated spermatids 
(avg. purity of nucleated cells=97%) were obtained from 70 dpp mice (n=3, 12 
mice pooled per cell separation). Spermatozoa were isolated from the cauda 
epididymidis of 70 dpp mice (n=3, 12 mice pooled per purification, avg. 
purity=99%) as described previously (Alciviar, 1989). Primitive type A 
spermatogonia were isolated from the testes of 6 dpp GOF18deltaPE-Oct4/GFP 
(Yoshimizu et aL, 1999) mice that have been bred into C57BU6 background for 
3+ generations. Germ cells were isolated using fluorescence-assisted cel! 
sorting (FACS) as described in (La Salle et aL, 2007) (n=3, 3-4 mice pooled per 
purification). The qAMP method was used (see below) to determine the level of 
inter-strain variability in DNA methylation levels. Primitive type A spermatogonia 
were isolated from the testes of 6 dpp GOF18deltaPE-Oct4/GFP bred to CD1 
mice and methylation levels for approximately 20 randomly chosen genomic loci 
were found to be similar «15% variation) to GOF18deltaPE-Oct4/GFP mice bred 
into C57BU6. Liver, intestine and brain tissues were isolated from adult C57BU6 
mice. Genomic DNA was isolated using proteinase K and phenol followed by 
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dialysis for the RLGS and Southern blotting experiments or the DNeasy Tissue 
Kit from Qiagen (Germantown, MD, USA) for qAMP analysis. 
RLGS and spot identification 
RLGS was done as described previously (Okazaki et aL, 1995). 
Densitometry of RLGS spots was done by exposing the RLGS gel to a 
phosphorimager screen from Kodak (Rochester, NY, USA). Images were 
analyzed using the ImageQuant v5.1 software from GE Healthcare (Piscataway, 
NJ, USA). Spot density values were obtained by comparing a spot of interest to 
approximately 10-15 surrounding spots of unchanged intensity. In order for a 
spot to be identified as having altered DNA methylation, the alteration had to be 
consistent in ail RLGS profiles of the same cell type and spot densitometry had to 
reveal a difference of greater than 25%. Genomic location of spots was identified 
using a virtual RLGS resource (Smiraglia et aL, 2007). Ali identified spots were 
confirmed by the BAC mixing gel method (Oakes et aL, 2007b). CpG islands 
were defined as done previously (Gardiner-Garden and Frommer, 1987) and 5' 
regions were defined as being within 1 kb of the transcriptional start site or within 
200 bp of a CpG island that was found within the first exon or up to 5kb from the 
transcriptional start site. Spermatogenic cell type-specifie gene expression data 
were obtained from the Mammalian Reproductive Genetics data base 
(http://mrg.genetics.washington.edu/). 
DNA methylation analysis using qAMP 
The qAMP method was done as described previously (Oakes et aL, 2006). 
Briefly, genomic DNA is digested in separate reactions with either no enzyme 
(sham digest), methylation sensitive restriction enzymes (MSREs) and the 
methylation-dependent restriction enzyme, McrBC. Primers are designed to 
flank restriction sites of interest and individually-digested DNA samples are 
amplified using real-time PCR. Shifts in Ct value (~Ct) between the sham- and 
enzyme-digested samples are used to calculate the percentage of methylation at 
the various CpG sites within the amplified region (MSREs: %methylation=100(2-
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L'>Ct); McrBC: %methylation=100(1-2-L'>Ct). Ali ~Ct values are the means of 
triplicate reactions. Due to the curved relationship between ~Ct and percent 
methylation, MS REs are more accurate in the low % methylation range «50%) 
and McrBC is more accurate in high % methylation ranges (>50%). Primers 
used to analyze genomic regions identified by RLGS are as follows: AK137601, 
5'-CTCCCCCATTCTCCCTCAC 5'-CCTAACTTCTTGCCGTGCTC; Polg, 5'-
CAGACCTCCACGTCGAACA 5'-CAGAGCCTGCCTT ACTTGGA; Abt1, 5'-
CCATGGGCGTGTTATGTAGA 5'-TGCTTGATGGGATGTTCATT; Ibtk, 5'-
ACTCTCCTGCCTTGCACCT 5'-GCTGTCCACTCGGTGTCAT; Tcf3, 5'-
GCAAGGGCCTGGATAGGA 5'-GCTACCCACTCCGAGCAA. Primers used to 
analyze differentially methylated regions (DMRs) of imprinted genes are as 
follows: H19, 5'-AAAAGCAGAAGGCAGGACAC 5'-
ATGTTCCAGAGACAGCCAAAG; H19 (McrBC), 5'-
AGCCGTTGTGAGTGGAAAGA 5'-CATAGCGGCTTCGGACATT; Rasgrf1, 5'-
CTGCACTTCGCTACCGTTTC 5'-CAGCAGCAGCAGTAGCAGTC; Gt/2, 5'-
CCGTGAACTAGCGAGGAGGT 5'-AT AATGCAGCCCTTCCCTCA. ln the 
chromosome-wide survey, a region was considered to be different if at least one 
of the enzyme digests detected a reproducible difference of 15% or greater in 
each replicate (n=2 for both primitive type A spermatogonia and spermatozoa), 
and that the enzyme used to detect the difference was within its accu rate percent 
range. The difference in both enzyme digests had to be in the same direction or 
unchanged. Primers used to analyze regions on chromosome 7 are listed in 
Table 4.4 primers for chromosomes 4, 10, 17 and X are listed in Table 3.4. 
Primers were designed using the Primer3 software (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). Genomic sequence data was obtained trom the 
University of California at Santa Cruz Genome Browser, version mm7 
(http://www.genome.ucsc.edu). 
Southern blotting 
Southern blots were performed as described (Trasler et al., 1990) and 
visualized by autoradiography. Minor satellite probes were constructed by PCR 
154 
amplification of mouse genomic DNA using primers 5'-
CATGGAAAATGATAAAAACC and 5'-CATCTAATATGTTCTACAGTGTGG 
(Lehnertz et aL, 2003). The ribosomal DNA (rDNA) repeat probe was 
constructed using primers 5'-CGTTATGGGGTCATTTTTGG and 5'-
CAGACCCAAGCCAGT AAAAAG to analyze Hpall sites located in the proximal 
promoter of the rDNA repeat. The IAP probe has been used previously (Michaud 
et aL, 1994; Walsh et aL, 1998). DNA was digested completely with either Mspl 
or its methylation-sensitive isoschizomer Hpall. The membrane was stripped 
and reprobed according to the manufacture's recommended conditions (Hybond, 
GE Healthcare). 
RESULTS 
Detection of alterations of DNA methylation during spermatogenesis using RLGS 
RLGS investigates genome-wide patterns of DNA methylation by 
separating genomic DNA that has been digested with the methylation-sensitive 
restriction enzyme, Notl, by two-dimensional gel electrophoresis. In the mouse, 
Notl sites occur in a variety of sequence types. To determine if the pattern of 
genome-wide DNA methylation in spermatozoa is acquired during 
spermatogenesis, RLGS profiles of purified populations of type A spermatogonia, 
pachytene spermatocytes from two developmental time points (early and mid-Iate 
pachytene) as weIl as post-meiotic round and elongating spermatids were 
generated (Figure 4.1 a). The intensity of a total of 19 RLGS spots is observed to 
be different between these ce" types; 11 demonstrate increased methylation (de 
novo methylation) and 8 are demonstrate decreased methylation (demethylation) 
during spermatogenesis, as indicated by a loss or a gain of spot intensity, 
respectively (Figure 4.1 b). The majority of the changes in individual spot 
intensities, in de novo methylation and demethylated directions, occur between 
type A spermatogonia and early pachytene spermatocytes. The intensity of 
some spots continues to change between early and mid-Iate pachytene, and 
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always occurs in the same direction. With the exception of one spot, ail spots do 
not gain or lose measurable amounts of methylation after the pachytene stage. 
Other th an the progressive changes that occur between type A spermatogonia 
and spermatocytes, no de novo or demethylation events are observed in any of 
the cell types tested. Virtual RLGS analysis (Smiraglia et aL, 2007) reveals that, 
in the analyzable window of the RLGS gel, there are 2954 potential RLGS spots 
that originate from approximately 2600 Notl sites (Table 4.1). This indicates that 
only a small fraction «0.7%) of the assayable Notl sites display modified DNA 
methylation during spermatogenesis, leaving greater than 99% unchanged. 
Germ cell-specificity of spots that show altered methylation during 
spermatogenesis 
T 0 determine if the spots that display altered methylation during 
spermatogenesis have a methylation status that is unique to male germ cells, the 
intensityof changed spots was examined in three somatic tissues: liver, intestine 
and brain (Figure 4.2a). Thirteen of the 19 spots were hypermethylated (absent) 
in ail three somatic tissues studied, and none of them were hypomethylated in ail 
three tissues. A minority (6/19) of spots that are hypomethylated in somatic 
tissues demonstrate tissue-specifie patterns of methylation (Figure 4.2b). Spots 
that were de novo or demethylated during spermatogenesis demonstrated equal 
levels of germ cell-specificity, indicating that the unique hypomethylated state of 
these loci is not related to the methylation states in a particular phase of 
spermatogenesis. The dissimilarity between spermatozoa and somatic profiles 
(Oakes et aL, 2007b), versus the relative similarity between type A 
spermatogonia and spermatozoa, indicates that the bulk of germ ce II-specifie 
methylation pattern is acquired prior to the type A spermatogonia stage. 
Identification of spots that show alterations during spermatogenesis 
Identification of the genomic location of spots of interest was 
accomplished by using a second-generation virtual RLGS resource to identify 
candidate loci (Smiraglia et aL, 2007), and confirming the identity of each spot 
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using the BAC mixing gel method (data not shown). Using these methods, we 
identified 5/11 spots that were de nova methylated and 3/8 spots that were 
demethylated during spermatogenesis (Table 4.2). Spots are found on several 
chromosomes, are located within a variety of positions relative to known genes 
and within various sequence types (Le. CpG islands (CGls), repeats, etc.). Ali 
sites are in the vicinity of expressed sequences; either in the 5' region, body, or 
3' end of genes. Only 2/8 identified spots are within CGls. Interestingly, these 
two sites are found only 42 kb apart on chromosome 7, one within the 5' CpG 
island of the Polg (mitochondrial DNA-directed polymerase) gene and a mRNA, 
A K032343 , located upstream. Due to the GC-rich nature of the Notl recognition 
site, 75% of the approximate 8000 Notl sites found throughout the mouse 
genome are found within CG\. Although the group size is small, 2/8 (25%) is less 
than the expected proportion and may suggest that altered DNA methylation 
occurs more commonly in non-CGI sequences. Most interestingly, ail three 
identified sites that are demethylated during spermatogenesis are found in small 
solitary long terminal repeats (L TRs) that belong to the mammalian retroposon-
like (MaLR) and endogenous retroviral-K (ERVK) families of the L TR class of 
repetitive sequences, whereas ail identified de nova methylated sites are in 
unique sequences. 
Male germ cells possess a global gene expression profile that is highly 
unique from somatic tissues (Shima et al., 2004). These transcripts are found to 
be highly regulated during spermatogenesis. DNA methylation has been 
proposed to function as a transcriptional regulator by causing gene repression 
when present in 5' regulatory sequences (Klose and Bird, 2006). To investigate 
if the status of DNA methylation in specifie spermatogenic ceil types correlates 
with transcriptional activity, the DNA methylation status of ail identified RLGS loci 
located in 5' regions of known genes was compared to known levels of gene 
expression in these same cell types. Gene expression data were obtained from 
the Mouse Reproductive Genetics Database. Approximately 400 spots have 
been identified on mouse RLGS profiles that are located within the 5' regions of 
transcribed sequences (Smiraglia et al., 2007). Of these, expression levels have 
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been determined for 166 known genes in type A spermatogonia, pachytene 
spermatocytes and round spermatids (Shima et al., 2004). Despite greater than 
90% (140) of these genes demonstrating a greater than 1.5-fold difference in 
expression between spermatogenic cell types (66% show greater th an 2-fold 
expression differences), greater th an 99% (165/166) show no detectable change 
in methylation status (Table 4.3). In addition, for the only spot belonging to a 5' 
region that does demonstrate a change in methylation, Polg, increased 
methylation is correlated with an increase in expression, the opposite of what 
would be expected. 
Quantitative DNA methylation analysis of selected identified loci 
T 0 determine whether changes that are observed by RLGS at Notl sites 
are representative of the DNA methylation status of neighboring CpGs, sites 
within small regions (-200 bp) flanking the Notl sites were chosen for analysis by 
the qAMP method. To confirm and expand upon the results found in type A 
spermatogonia, an additional cell type, primitive type A spermatogonia, was 
analyzed. These cells are derived from a time point two days earlier in 
spermatogonial development (6 dpp). Notl sites that are found in various 
positions relative to genes were chosen for analysis: 3' end (Tcf3), body region 
(lbtk) , 5' upstream region (AK137601), and 5' CGI (Polg). Percent methylation 
values at Notl sites determined using RLGS correspond to the value determined 
by qAMP in each of the cell types investigated (Figure 4.3). Neighboring CpG 
sites generally showed similar levels of methylation to the Notl site and gained or 
lost methylation in a similarly progressive manner. Exceptions to this are Hpall 
sites found in Tcf3 and Polg, where no increase in methylation is detected, 
demonstrating that heterogeneous methylation occurs between neighboring 
CpGs in various cell types examined. Sorne small differences are observed 
between primitive type A and type A spermatogonia, especially at the Notl site in 
the Polg gene. De novo methylation and demethylation changes are found to be 
virtually complete by the pachytene spermatocyte stage, supporting the RLGS 
findings. 
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Acquisition of DNA methylation at paternally methylated imprinted DMRs 
Imprinted genes acquire a parent-specifie pattern of methylation during 
germ cell development. Previously, the H19 gene was shown to possess an 
incomplete level of methylation in spermatogonia, specifically on the maternai 
allele, which was later completed by the pachytene stage (Davis et aL, 1999). 
There are two other weil described regions that possess paternally methylated 
DMRs. Unfortunately, none of the paternally methylated DMRs are present on 
our RLGS profiles. To determine if DNA methylation is being acquired during 
spermatogenesis, the qAMP method was used to investigate DMRs in the Dlk1-
Gt/2 region (Takada et aL, 2002) and the Rasgrf1 gene (Yoon et al., 2002). The 
previously defined H19-lgf2 region (Tremblay et aL, 1995) was used as control. 
This analysis reveals that the majority of CpGs investigated have acquired their 
full methylation status by the primitive type A spermatogonial stage; however, a 
sm ail am ou nt of methylation is acquired up to the pachytene stage (Figure 4.4). 
The Hhal enzyme digest of the Rasgrf1 DMR displays the largest percentage 
increase of DNA methylation during spermatogenesis. There are three Hhal 
sites in the amplified region of Rasgrf1; if only one of the three is unmethylated, 
the strand will not amplify and c,ontribute to the percentage of unmethylated 
strands. This particular digest reveals that a small proportion of CpGs are 
unmethylated in the Rasgrf1 DMR in type A spermatogonia and that by the 
pachytene stage, DNA strands gain their fully methylated status. Changes in 
DNA methylation at other sites were minor. 
Chromosome-wide survey of non-CpG island unique sequences 
RLGS analysis has a strong bias towards CGls; however, a higher 
proportion of non-CGI sites were shown to display altered patterns of DNA 
methylation during spermatogenesis. To determine the prevalence of DNA 
methylation changes occurring at non-CGI sites, small groups of CpGs (regions) 
were chosen for quantitative analysis by the qAMP method at approximately 5 
Mb intervals across chromosomes 4, 7, 10, 17 and X. These regions were 
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chosen at random other than not being proximal (>10 kb) to a CGI, or the 
transcriptional start site of a known gene. Regions were also chosen to be solely 
within non-repetitive sequences. Analysis of 125 total regions in primitive type A 
spermatogonia and spermatozoa reveals differences in DNA methylation in a 
region-specifie manner (Figure 4.5). Regions displaying high, intermediate 
(partial), and low levels of DNA methylation are detected, revealing that a full 
range of methylation levels can be found in germ cells in a site-specifie manner. 
Differences were observed in 12 regions on 4 of 5 chromosomes. The number 
and/or extent of methylation differences were observed to be similar between the 
autosomes and the X chromosome, chromosomal position (telomeric versus 
centromeric), G- and R-banding patterns and flan king GC content (data not 
shown). Interestingly, ail 12 regions that showed a difference were gaining 
methylation during spermatogenesis. Differences are in the same range «60%) 
as previously detected at RLGS sites. 
A closer examination of the changes to six of the 12 sites reveals that, like 
other changes observed, methylation acquisition during spermatogenesis is 
complete by the pachytene stage (Figure 4.6). Several of the changes are 
specifie to the CpGs investigated by a particular restriction enzyme, indicating 
that heterogeneous methylation exists at these sites. Further examination of the 
methylation of these regions in primitive type A spermatogonia shows that most 
CpGs investigated have methylation states that are similar to type A 
spermatogonia; however, significant increases are observed at sites in two of the 
six regions. 
Examination of repetitive sequences 
The observation that ail demethylated sequences identified by RLGS were 
of repetitive origin suggests that changes might be occurring in repetitive 
sequences during spermatogenesis. We chose to analyze three different types 
of repeat sequences that have been previously determined to have different 
levels of methylation: the minor satellite repeat, the ribosomal DNA repeat, and 
IAP, an interspersed L TR-containing endogenous retroviral sequence (Figure 
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4.7). Equal amounts of DNA isolated from type A spermatogonia to spermatozoa 
were digested with Hpall, along with somatic tissues as control. Differences are 
observed to occur between somatic and germ cells for both the minor satellite 
repeat and IAP; however, no changes are observed to occur during 
spermatogenesis for these classes of repeat sequences. No change in the 
methylation status of full-length IAP repeats is also found by a comparison of real 
and virtual RLGS profiles. Several hundred IAP and early transposon (ETn) 
repeats of the L TR class of repeat sequences are distinctly visible on virtual 
RLGS profiles (Oakes et al., 2007b). The spots corresponding to these repeat 
sequences are not observed in any spermatogenic cell type, indicating invariable 
hypermethylation during spermatogenesis (data not shown). 
DISCUSSION 
We have examined a wide variety of sequence-types to determine the 
development of DNA methylation patterns during spermatogenesis. Our findings 
demonstrate that de novo and demethylation events occur in a sequence-specifie 
manner. Through the use of several methods, we have shown that sequences 
which undergo changes in methylation during spermatogenesis include CGI and 
non-CGI sequences that are found within various positions within known genes 
or in intergenic sequences. These modifications occur in a specifie 
developmental window during spermatogenesis. Both de novo and 
demethylation events occur in the early phases of spermatogenesis, and, 
regardless of the direction of the change or the sequence type, are complete by 
the end of the pachytene stage. During spermatogenesis, the reported de novo 
DNA methyltransferase enzymes, DNMT3a and DNMT3b, display their highest 
levels of expression in spermatogonia (La Salle and Trasler, 2006a; Shima et aL, 
2004), and are probable candidates to facilitate de novo methylation events in 
early germ cell types. Germ cells in the early phases of spermatogenesis 
undergo frequent DNA replication, thus, demethylation may occur passively. 
Demethylation does not occur in spermatogenic cell types that are not replicating 
DNA. Sequences that acquire de novo methylation during spermatogenesis are 
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generally non-repetitive. Demethylated sequences are observed in solitary l TR 
fragments, a category of small, divergent interspersed repeat sequences that are 
the remnants of transposition events involving full-Iength l TR repeats. The 
specifie fragments identified are from MalR and ERVK families of repeats, 
sequences that have previously been found to be expressed in oocytes and early 
embryos (Peaston et al., 2004). Although the numbers of identified demethylated 
sequences are low, it is interesting to observe this dichotomy between the 
behavior of small repetitive and non-repetitive sequences. This difference is 
probably confined to a subset of repeat sequence types, as no other types of 
repeats tested demonstrated this behavior. 
We also find that DNA methylation changes are only present in a minor 
proportion of the sequences investigated. Using RlGS, where 75% of ail sites 
examined are within CGls, only 0.7% (19/2954) of Not! sites were observed to 
change during spermatogenesis. The survey of non-CGI, non-repetitive 
sequences across five chromosomes revealed a higher 9.6% (12/125) proportion 
of sequences that were changing during spermatogenesis. A few possibilities 
exist to explain this discrepancy. Firstly, non-CGI sequences demonstrate a 
higher level of variability between tissues (Oakes et al., 2007b) and a similar 
phenomenon may be present between developing spermatogenic cells. 
Because only a fraction of Not! sites in the mouse genome are in non-CGI, non-
repetitive sequences (Fazzari and Greally, 2004), fewer changes are expected to 
be observed using RlGS. Secondly, due to the random nature of spot positions 
on two-dimensional RlGS profiles, spots displaying altered intensity can be 
overlapped or obscured by others and would be missed. Thirdly, the qAMP 
method is more sensitive to small-scale changes (error range ±5%) (Oakes et al., 
2006) than is RlGS. For these reasons, the fraction of loci found to be changed 
using RlGS would be considered to be an underestimate. However, even with 
these caveats considered, it remains clear that changes occur only in a limited 
proportion of the sequences examined. 
Some small differences are observed between primitive type A and type A 
spermatogonia. One explanation is that these differences are developmental, 
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although we cannot exclude the possibility that some of these small differences 
are representative of the differences in purity levels of these cells. Evidence of 
developmental differences is supported by progressively decreased levels of 
methylation in AK137601 (Figure 4.3) and by methylation levels increased 
beyond the 20% level that would be predicted by somatic contamination (Po/g, 
Figure 4.3 & Figure 4.6). Type A spermatogonia have an average purity of 85%, 
whereas primitive type A spermatogonia isolated by flow cytometry are more 
highly purified. Contaminating cells in type A spermatogonia, isolated by 
sedimentation velocity, are likely to be immature Sertoli cells. 
Previously, acquisition of DNA methylation during spermatogonial 
development has been demonstrated at DMRs of paternally methylated imprinted 
genes (Davis et al., 1999; Lees-Murdock et al., 2003). To compare our approach 
with previous findings, we investigated the developmental acquisition of 
methylation at the H19 DMR. Our results indicate that a low amount of DNA 
methylation is acquired during the phases up to the pachytene stage in paternally 
methylated DMRs. Because the Hhal restriction enzyme in the Rasgrf1 amplified 
region has the most restriction sites of ail of the MSREs used, this region is the 
most sensitive for detecting DNA strands that are incompletely methylated. This 
particular measurement reveals that complete methylation is achieved by the 
pachytene stage. Based on the allele-specific differential acquisition of DNA 
methylation at H19 (Davis et al., 1999), we predict that unmethylated CpGs 
would most likely be found on aile les of maternai origin. 
The prevailing view of the primary biological role of DNA methylation 
involves the promotion of heterochromatin formation in gene promoter regions 
leading to a transcriptional repression. The global transcriptional profile of 
individual spermatogenic cell types is highly distinct, especially in the pachytene 
spermatocyte and round spermatid cell types where a burst of unique transcripts 
are produced presumably to facilitate meiotic and spermiogenic processes 
(Shima et al., 2004). Although the expression of a limited number of testis-
specific genes has been shown to be correlated with testis-specific 
hypomethylation of 5' regions (Sanford et al., 1984), a primary role for DNA 
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methylation in the global direct control of spermatogenic cel! type-specifie levels 
of gene expression is not supported by our data. Of 166 genes examined, no 5' 
region was shown to be hyper- or hypomethylated in a cell type where 
expression was repressed or increased, respectively. Furthermore, changes in 
DNA methylation during spermatogenesis were more commonly found away from 
the regulatory (5') regions of genes. These results do not challenge the 
prevailing view that DNA methylation and gene expression are mechanistically 
linked, rather they point to potential alternative functions for DNA methylation in 
germ cells. In addition, there are several explanations that could contribute to 
the lack of correlation, including RNA stabilization. There is evidence to suggest 
that changes in DNA methylation play a role in establishing an epigenetic state in 
the early stages of germ cel! development that is permissive for transcription to 
occur at a later stage (Geyer et al., 2004). It is likely that other regulatory 
mechanisms, such as transcription factor regulation, are responsible for the 
variability observed in transcript levels between spermatogenic cell types. 
An alternate role for these modifications of DNA methylation is their 
involvement in the organization of a germ ce II-specifie chromatin configuration. 
Alternate roles for DNA methylation have been described, and include silencing 
of repetitive elements and chromatin stability/organization (Bestor and Tycko, 
1996). The results of the present study indicate that the bulk of the unique germ 
ce II-specifie pattern that is achieved by meiosis has already been established in 
primitive type A spermatogonia. Thus, one possible explanation is that these 
changes represent the final modifications of an epigenetic program that is 
important to the organization of a specialized, genome-wide chromatin 
configuration necessary for passage through meiosis. There are a few 
observations that support this hypothesis: firstly, the majority of modifications are 
non-5'. The involvement of non-5' methylation in meiotic chromosomal 
organization is suggested by the abnormal chromosomal structures in Dnmt3L-
null spermatocytes (Bourc'his and Bestor, 2004). These germ cells fail to gain 
normal methylation patterns at interspersed repetitive and intergenic/intronic loci 
(Bourc'his and Bestor, 2004; La Salle et al., 2007; Oakes et al., 2007b). 
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Although the numbers of pre-meiotic Dnmt3L-nuli germ cells are decreased, they 
do not completely fail until meiotic entry, indicating that male germ cell DNA 
methylation patterns are more essential for meiosis than mitosis (La Salle et al., 
2007). Secondly, very few changes were observed to occur after meiosis, 
despite highly dynamic chromatin modulations in spermatid stages. Thirdly, most 
changes that occur are partial (20-60%) changes, indicating that sorne 
methylation has been acquired in prior stages at the se sites. Finally, changes 
are generally restricted to sites with germ ce II-specifie (non-somatic) methylation 
states, supporting a connection to the distinct, post-meiotic patterns. An example 
of this connection is that the three identified loci that are demethylated during 
spermatogenesis are of the same family of repetitive sequences as 21 others 
identified on mouse RLGS profiles, 19 of which are already hypomethylated in 
germ cells despite being hypermethylated in somatic tissues (Oakes et al., 
2007b). It is reasonable to believe that the selective demethylation of these 
repeat sequences during spermatogenesis reflects a requirement for male germ 
cells to have sequences of this type hypomethylated. 
ln summary, we find that in addition to the acquisition of DNA methylation 
that occurs in prenatal male gonocytes, patterns continue to be acquired during 
spermatogenesis in a sequence-specifie manner. These studies raise the 
possibility that male germ cells may be especially sensitive to potential 
'epimutations'; further studies will be required to test if these processes render 
male germ cells particularly sensitive to environmental influences. 
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Figure 4.1: Examination of RLGS profiles from purified spermatogenic cell 
types. (a) RLGS profiles are produced by digestion of genomic DNA with the 
methylation-sensitive enzyme, Notl; these cleavage sites are radiolabeled and 
DNA fragments are separated by two-dimensional gel electrophoresis. Visible 
spots reveal hypomethylated sites, absent spots are hypermethylated. 
Enlargements of RLGS profiles produced from type A spermatogonia, early and 
mid-Iate pachytene spermatocytes, round and elongated spermatids and 
spermatozoa are shown. Selected enlargements are representative of areas 
throughout the two-dimensional RLGS profile. Spots that are de novo 
methylated and demethylated relative to type A spermatogonia are indicated by 
open and black arrows, respectively. The identified genes that contain the 
differentially methylated spots are shown. (b) RLGS densitometry of spots that 
are de novo methylated and demethylated during spermatogenesis. Cell-type 
specifie spot intensity of spots was determined by comparing the intensity of 
spots of interest with unchanged, surrounding spots. Percent methylation values 
are determined by the inverse of the relative density. 
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Figure 4.2: Determination of the methylation state of spots that are 
differentially methylated during spermatogenesis in somatic tissues. (a) 
Enlargements of seleeted portions of RLGS profiles produeed from type A 
spermatogonia, spermatozoa, liver, intestine and brain are shown. 
Hypomethylated spots that are differentially methylated during spermatogenesis 
are indieated by black arrows. The known genes associated with the 
differentially methylated spots are shown. (b) A eomparison of the methylation 
status of individual spots that are differentially methylated during 
spermatogenesis with their methylation status in somatie tissues. The number of 
spots that are differentially methylated during spermatogenesis that are 
hypermethylated in 3/3, 2/3, 1/3, or 0/3 somatie tissues, demonstrating that spots 
that are differentially methylated during spermatogenesis are largely germ eell-
specifie. 
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Figure 4.3: Oetailed examination of differentially methylated loci using the 
qAMP method. DNA is digested using methylation-sensitive restriction enzymes 
and the methylation-dependent enzyme, McrBC. Primers are designed to flank 
the Not! site along with neighboring restriction sites (assayable CpGs) and are 
amplified using real-time PCR. The positions of the assayed regions relative to 
known genes are shown. Ali genomic sequences are orientated from centromere 
to telomere in gene diagrams. The percent methylation at different CpG sites (or 
groups of sites) determined by independent enzyme digests is shown in primitive 
type A and type A spermatogonia, pachytene spermatocytes and spermatozoa. 
N, Not!; Hh, Hhal; Hp, Hpall; M, McrBC. 
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Figure 4.4: Examination of paternally methylated imprinted DMRs. Primers 
were designed to flank restriction enzyme sites within the DMRs of H19-lgf2, 
Rasgrf1 and Dlk1-Gtl2. The location of the primers used to assay the regions 
and the restriction enzyme sites examined are shown for each DMR. Ali 
genomic sequences are orientated from centromere to telomere in gene 
diagrams. The percent methylation at different CpG sites (or groups of sites) 
determined by inde pendent enzyme digests is shown in primitive type A and type 
A spermatogonia, pachytene spermatocytes and spermatozoa. N, Notl; Hh, 
Hhal; Hp, Hpall; M, McrBC. 
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Figure 4.5: Chromosome-wide analysis of non-CG l, non-repetitive 
sequences. Using the qAMP method, Hhal and McrBC sites were randomly 
chosen for examination at approximately 5 Mb intervals across chromosomes 
4,7,10,17 and X. Chosen sites were within non-repetitive sequences and >10 kb 
from a CpG island or the transcriptional start site of a known gene. Percent 
methylation values for the two digests were averaged to give a single value for 
primitive type A spermatogonia (light blue dash) or spermatozoa (dark blue 
dash). Regions that demonstrated a change in methylation during 
spermatogenesis are indicated (red arrows). 
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Figure 4.6: Oetailed analysis of differentially-methylated CpGs identified in 
the chromosome-wide analysis. Percent methylation determined by Hhal and 
McrBC individual restriction enzyme digests are shown for primitive type A (P-Ag) 
and type A (Ag) spermatogonia, pachytene spermatocytes (Pa) and spermatozoa 
(Sp). 
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Figure 4.7: DNA methylation of repetitive elements during 
spermatogenesis and in somatie tissue. Genomic DNA was digested with 
Mspl (Iane 1) or Hpall (ail other lanes) and hybridized to probes specifie for the 
minor satellite, ribosomal DNA and IAP repeats. Each blot was produced by 
stripping and hybridizing the same membrane to each respective probe. Ag, type 
A spermatogonia; EP, early pachytene spermatocytes; Pa, pachytene 
spermatocytes; Rd, round spermatids; El, elongated spermatids; Sp, 
spermatozoa; T, testis; L, liver; l, intestine; B, brain. 
Q. Minor satellite repeat: Q. Ribosomal DNA repeat: Q. IAP 
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Table 4.1: RLGS spot summary 
Methylation during spermatogenesis 
hypermethylated during spermatogenesis 
hypomethylated during spermatogenesis 
unchanged 
total* 
*derived from virtual RlGS profile 
# of 
spots 
11 
8 
2935 
2954 
Table 4.2: Characteristics of identified loci 
Methylation during RlGS Gene Notl site CpG Spermatogenesis spot position island 
Hypermethylated 5ax2 Tcf3 3' N 
Hypermethylated 19x8 Polg 5' Y 
Hypermethylated 4C13 AK032343 body y 
Hypermethylated 3ex8 Ibtk body N 
Hypermethylated 2F36 Abt1 body N 
Hypomethylated 3ex3 AK137601 5' N 
Hypomethylated 2G75 Armc3 body N 
Hypomethylated 4dx1 A K035353 body N 
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% of 
total 
0.37 
0.27 
99.4 
100 
Repeat 
(family) 
non-repetitive 
non-repetitive 
non-repetitive 
non-repetitive 
non-repetitive 
lTR (MalR) 
lTR (ERVK) 
lTR (ERVK) 
Genome 
position 
chr6:72645454 
chr7:75333081 
chr7:75377378 
chr9:85800773 
chr13:22791131 
chr1 :36371367 
chr2:19315058 
chr4:9701990 
Table 4.3: DNA methylation of ail identified 5' RLGS loci compared to developmental expression in male germ 
cells (Shima et al. 2004) 
Gene Expression 
RLGS Notl site CpG Gene Methylation during Type-A Pachytene Round Type-AI Type-AI 
Spot position (mm7) island symbol spermatogenesis spermatogonia spermatocytes spermatids Pachytene Round 
>2.0 -fold increase or decrease in gene expression between type-A spermatogonia, pachytene spermatocytes and round spermatids: 
4809 chr3:121195825 Y Cnn3 unchanged 868.5 52.5 26.3 16.54 33.02 
4F21 chr10:81353988 Y Aes unchanged 675.2 60.9 30.1 11.09 22.43 
3825 chr3:30907176 Y Skil unchanged 108.2 5 8.8 21.64 12.30 
2C06 chr1:182004461 Y Enah unchanged 189.9 45.4 11.4 4.18 16.66 
5833 chr7:59688248 Y Klf13 unchanged 188.2 29.8 12.5 6.32 15.06 
6E41 
2816 
1F40 
3010 
4011 
1F06 
6G05 
4E34 
6809 
3055 
4C12 
3805 
1006 
4C18 
4E47 
2G31 
2C39 
2G14 
3F33 
1C12 
4057 
3F63 
2E44 
2C33 
3815 
chr10:74622936 
chr7:3491 0692 
chr11 : 1 02426346 
chr5:42554991 
chr14: 1 00327082 
chr9:65490698 
chr10:79496639 
chr5: 103650201 
chr3:76062107 
chr17:54484543 
chr10:70950199 
chr9:88582905 
chr13:48354380 
chrX:69060578 
chr6:91199044 
chr7: 139888509 
chr4:47367145 
chr6:23775774 
chr16:96463994 
chr4:136735561 
chr4:28933944 
chr12:71861462 
chr16:46275446 
chr13:59285249 
chr13:31173603 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
Gnaz 
C80913 
Ubtf 
Cpeb2 
Spry2 
Spg21 
Hcn2 
Pkd2 
Golph4 
Jmjd2b 
Ipmk 
Syncrip 
Phf2 
SIc6a8 
Nup210 
Cdkn1c 
Tgfbr1 
Cadps2 
Hmgn1 
Cdc42 
Epha7 
Hif1a 
Pvrl3 
Gas1 
Foxc1 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
145.5 
77.6 
489.3 
66.9 
835.9 
315 
24.8 
273 
42.6 
156.6 
135.9 
248 
248.6 
38 
383.4 
136.7 
10.1 
253.6 
3143.8 
689.6 
4.7 
1068.3 
27.9 
223.4 
2.8 
180 
10.6 
11.3 
73.3 
404.2 
158.7 
70.9 
2.4 
48.2 
11.3 
18.6 
17.1 
60.7 
1737.9 
6.1 
62.7 
23 
1.8 
47.6 
609.5 
176.4 
24.4 
206.9 
70.6 
45.9 
3.4 
21.3 
5.8 
40.1 
35.9 
79.9 
30.2 
4 
28.9 
4.9 
81.4 
79.2 
34.7 
266.5 
7 
123.7 
157.6 
5.2 
93.4 
592.6 
131.1 
4.7 
207.5 
14.2 
46 
0.7 
13.73 
6.87 
6.68 
0.17 
5.27 
4.44 
10.33 
5.66 
3.77 
8.42 
7.95 
4.09 
0.14 
6.23 
6.11 
5.94 
5.61 
5.33 
5.16 
3.91 
0.19 
5.16 
0.40 
4.87 
0.82 
6.83 
13.38 
12.20 
1.86 
10.46 
10.43 
6.20 
9.45 
8.69 
1.92 
1.72 
7.15 
0.93 
5.43 
3.10 
0.87 
1.94 
2.72 
5.31 
5.26 
1.00 
5.15 
1.96 
4.86 
4.00 
Pachytenel 
Round 
2.00 
2.02 
0.57 
3.98 
2.38 
0.50 
1.95 
1.83 
11.26 
1.99 
2.35 
0.60 
1.67 
2.31 
0.23 
0.22 
1.75 
6.52 
0.87 
0.51 
0.15 
0.35 
0.51 
1.03 
1.35 
5.19 
1.00 
4.97 
1.00 
4.86 
Gene Expression 
RLGS Notl site CpG Gene Methylation during Type-A Pachytene Round Type-AI 
Spot position (mm7) island symbol spermatogenesis spermatogonia spermatocytes spermatids Pachytene 
4069 chr10:82305166 Y Nf yb unchanged 246.9 70.9 50.9 3.48 
4E04 chr4:43537404 N Tpm2 unchanged 75 18.8 15.7 3.99 
5G11 chr13:23076518 N Hfe unchanged 46.6 36.8 10.1 1.27 
3C02 chr18:5759245 Y Zfhx1a unchanged 214 47.6 72.9 4.50 
3A04 chr19:28951323 Y Jak2 unchanged 51.1 11.4 23.3 4.48 
1016 chr7:33589283 Y Zfp537 unchanged 227.8 51.5 92.9 4.42 
2G96 chr14:12516217 Y SIc4a7 unchanged 440.3 216.4 101.3 2.03 
6007 chr10:90641565 Y Apaf1 unchanged 83.4 19.3 33.6 4.32 
5C23 chr5:47309019 Y SIit2 unchanged 154.9 38.4 96.5 4.03 
4F59 chr16:20854197 Y Ephb3 unchanged 24.8 13 6.2 1.91 
4E70 chr11 :75254073 Y Hic1 unchanged 119.5 121 30.3 0.99 
5G21 chr7:61228791 Y Tjp1 unchanged 570.2 245.2 144 2.33 
3E54 chr10:67139468 Y Egr2 unchanged 296.1 96.3 77.4 3.07 
1014 chr3:34457763 Y Sox2 unchanged 15.6 4.1 10.1 3.80 
1 E20 chr8:68540083 Y Hapln4 unchanged 25.7 90.7 23.9 0.28 
3A03 chr4:8617986 Y Chd7 unchanged 54.2 14.7 17.8 3.69 
4028 chr10:126812970 Y Mars unchanged 602.9 292 163.7 2.06 
2C27 chr9:61396680 Y Tle3 unchanged 240.9 73 66.6 3.30 
1G11 chr9:31111394 Y Aplp2 unchanged 708.6 856.3 242.6 0.83 
1E24 chr16:21917021 Y Sfrs10 unchanged 557.4 1274.9 367.3 0.44 
2C55 
4E02 
1F27 
2G41 
5H105 
4C22 
4803 
5F57 
4029 
1C10 
3F19 
2E39 
1022 
4827 
6E43 
chr18: 15032382 
chr8: 118546524 
chr2: 180543938 
chr13:47744462 
chr11 :99047138 
chr16:91456904 
chr12:106313454 
chr15:76793102 
chr8:69847664 
chr19:38537602 
chr5: 1 05053964 
chr17:32034148 
chr7: 1 05875598 
chr13:95424603 
chr6:87925903 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
Ss18 
Usp10 
Psma7/Ss1811 
Id4 
Rara 
1110rb 
Yy1 
Recql4/Lrrc14 
Nr2f6 
Tbc1d12 
Zfp326 
Rps18 
Rab6ip1 
Foxd1 
Cnbp1 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
325.4 
226.8 
310.3 
53.9 
67.3 
203.8 
151.4 
175.6 
254.4 
73.4 
133.1 
4823.6 
382.7 
24.5 
1001.3 
181 
205.5 
147.7 
123 
173 
27.8 
74.9 
161.5 
60.2 
90 
188.7 
93.3 
1963.6 
222.2 
13.4 
772.8 
94.2 
66.1 
90.5 
51.1 
20.2 
61.5 
49 
63 
104.8 
69.5 
49.1 
2177.8 
155.9 
10.1 
416.5 
1.58 
1.54 
2.52 
0.31 
2.42 
2.72 
0.94 
2.92 
2.83 
0.39 
1.43 
2.46 
1.72 
1.83 
1.30 
Type-AI 
Round 
4.85 
4.78 
4.61 
2.94 
2.19 
2.45 
4.35 
2.48 
1.61 
4.00 
3.94 
3.96 
3.83 
1.54 
1.08 
3.04 
3.68 
3.62 
2.92 
1.52 
3.45 
3.43 
3.43 
1.05 
3.33 
3.31 
3.09 
2.79 
2.43 
1.06 
2.71 
2.21 
2.45 
2.43 
2.40 
Pachytenel 
Round 
1.39 
1.20 
3.64 
0.65 
0.49 
0.55 
2.14 
0.57 
0.40 
2.10 
3.99 
1.70 
1.24 
0.41 
3.79 
0.83 
1.78 
1.10 
3.53 
3.47 
2.18 
2.23 
1.36 
3.39 
1.38 
1.22 
3.30 
0.96 
0.86 
2.72 
1.90 
0.90 
1.43 
1.33 
1.86 
Gene Expression 
RLGS Notl site CpG Gene Methylation during Type-A Pachytene Round 
Spot position (mm7) island symbol s(>l!r'matogenesis spermatogonia spermatocytes spermatids 
4F52 ehr11 :90747562 Y Stxbp4/Cox11 unchanged 681.6 460.5 287.2 
1 F21 ehrX:53512030 Y Zie3 unchanged 40.8 17.2 60.5 
5F59 ehr9:47491956 Y Igsf4a unchanged 407.6 174.6 40604 
5G109 ehr11:98136023 Y Rpl19 unchanged 2148.7 924.6 1101.5 
4B07 ehr3:144463229 Y Hs2st1/Sep15 unchanged 56.2 25.5 36.3 
6004 
5042 
2F64 
7G10 
3E74 
1E22 
3C09 
1E05 
3B16 
3C10 
1F14 
3C20 
2F69 
5F77 
6C29 
4058 
5E05 
2F79 
3E60 
2C31 
3E75 
5E61 
3C27 
5G45 
6030 
3F06 
5F75 
5F70 
5H01 
4065 
ehr5:31167823 
ehr5:51939647 
ehr14:581 04671 
ehr12:84079990 
ehr7:130181507 
ehr10:22488086 
ehr9:87831 050 
chr1 : 191691206 
chr6:8736466 
ehr2:84558866 
ehr8:12371081 
ehr15:69012599 
chr12:70016617 
chr9:96005241 
chr6:124991072 
chr5:271 03826 
chr19: 11498970 
chr15:82438623 
chr16:18170697 
ehr3:57976910 
ehr14:27151902 
chr11 :120052116 
chr2:74499528 
chr11:106721954 
chr7: 118894584 
chr1 :87054948 
chr14:65536512 
ehr18:47746271 
ehr11 :120782221 
ehr5: 120894922 
y 
y 
y 
N 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Fosl2 
Lgi2 
Gata4 
Tgfb3 
Ohx32/Fank1 
Tbpl1 
Tbx18 
Reor3 
Ica1 
Zdhhc5 
Sox1 
Khdrbs3 
Gpr135 
Atp1 b3 
Cops7a 
Insig1 
Stx3 
Ndufa6 
Gp1bb 
Pfn2 
Cacna2d3 
Baiap2 
Evx2 
Tex2 
Rbbp6 
Ecel1 
Gfra2 
Sema6a 
Aspscr1 
Brap 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
53 
317.6 
192.1 
177.1 
8.1 
95.6 
3.3 
62.1 
10704 
9.7 
11.6 
26.7 
24.5 
1242 
114.6 
2.3 
4 
64.9 
4.5 
222.7 
4.1 
180.2 
7.8 
103.2 
405.7 
145.3 
63.2 
11.1 
1.2 
274.1 
182 
24.5 
174 
94.7 
89.1 
3570.7 
1237.9 
9 
386 
9304 
3804 
29.1 
128.5 
19.8 
1058 
414.9 
2.1 
13.9 
151.1 
15.5 
740.3 
3.7 
405.5 
17.2 
155.6 
269 
310.8 
58 
16 
3 
584.8 
71.6 
153.6 
96.7 
92.8 
4619.2 
1841.9 
42.2 
239.9 
565.3 
56.5 
61.5 
105.1 
94.3 
4685 
294 
7.3 
10.6 
224.2 
8.5 
658.8 
11.8 
574.5 
24.2 
305.6 
78004 
420.9 
165.5 
31.6 
1.8 
675.4 
Type-AI 
Pachytene 
1048 
2.37 
2.33 
2.32 
2.20 
2.16 
1.83 
2.03 
1.99 
0.00 
0.08 
0.37 
0.16 
1.15 
0.25 
0040 
0.21 
1.24 
1.17 
0.28 
1.10 
0.29 
0043 
0.29 
0.30 
1.11 
0044 
0.45 
0.66 
1.51 
0047 
1.09 
0.69 
0040 
0047 
Type-AI 
Round 
2.37 
0.67 
1.00 
1.95 
1.55 
0.74 
2.07 
1.99 
1.91 
0.00 
0.05 
0.08 
0.26 
0.19 
0.17 
0.19 
0.25 
0.26 
0.27 
0.39 
0.32 
0.38 
0.29 
0.53 
0.34 
0.35 
0.31 
0.32 
0.34 
0.52 
0.35 
0.38 
0.35 
0.67 
0041 
Pachytenel 
Round 
1.60 
0.28 
0043 
0.84 
0.70 
0.34 
1.13 
0.98 
0.96 
0.77 
0.67 
0.21 
1.61 
0.17 
0.68 
0047 
1.22 
0.21 
0.23 
1.41 
0.29 
1.31 
0.67 
1.82 
1.12 
0.31 
0.71 
0.71 
0.51 
0.34 
0.74 
0.35 
0.51 
1.67 
0.87 
Gene Expression 
RLGS Notl site CpG Gene Methylation during Type-A Pachytene Round 
Spot position (mll1ZL island ~mbol sperl11atogenesis spermatogonia spermatocytes spermatids 
5C25 chr16:84834216 Y Atp5j/Gabpa unchanged 397.1 663.6 976.3 
3E34 chr6:99781479 Y Gpr27 unchanged 197.1 335.6 475.8 
4829 chr10:79764334 Y ORF61 unchanged 426.5 1017.1 712.6 
4E27 chr9:68685762 
2G93 chr15:85817232 
2048 chr4:6380904 
2C41 chr8:68982926 
5038 chr7: 141322497 
2F90 chr4: 11118407 
1 gx8 chr7:75333081 
3bx5 chr13:109808317 
y 
N 
Y 
Y 
Y 
Y 
Y 
Y 
Rora 
Ppara 
Nsmaf 
Fkbp8 
Fgf15 
Ccne2 
Polg 
Odx4 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
hypermethylated 
unchanged 
7.4 
30.4 
95.4 
328.4 
4.7 
21.6 
53.2 
609.5 
16.6 
52.9 
50.1 
655.7 
3.8 
42.9 
75.5 
1810.9 
16.2 
65.2 
102.5 
669.3 
7.7 
28.6 
36.8 
1656.3 
Type-AI 
Pachytene 
0.60 
0.59 
0.42 
0.45 
0.57 
1.90 
0.50 
1.24 
0.50 
0.70 
0.34 
2.0-1.5 -'old increase or decrease in gene expression between type-A spermatogonia, pachytene spermatocytes and round spermatids: 
3F56 chr12:47397383 Y Foxg1 unchanged 2.3 3.7 1.9 0.62 
3829 chr11:108024329 N Cacng5 unchanged 182.6 95.3 112.3 1.92 
5C10 chr17:25808890 Y Nudt3 unchanged 413.6 624 326.8 0.66 
3028 chr12:71498554 Y Tmem30b unchanged 9.5 8.4 5.1 1.13 
5C17 chr12:52831 045 Y Cfl2 unchanged 69.9 38.4 51.3 1.82 
2845 
1G37 
2840 
2C19 
4E24 
2823 
6G25 
6C22 
6C25 
4045 
5A03 
4036 
4G27 
2C09 
2E30 
7010 
1001 
chr16:17638759 Y 
chr13:101060069 Y 
chr11 :119150635 Y 
chr6:85541630 Y 
chr11 :70296139 Y 
chr11 :43394228 N 
chr16:20282499 Y 
chr13_ran:397372 Y 
chr10:27855771 Y 
chr2:71372755 N 
chr7:32007761 Y 
chr18:36663752 Y 
chr11 :98131652 Y 
chr4:99049166 Y 
chr19:45557344 Y 
chr1 : 189454671 Y 
chr13:33353590 N 
Prodh 
Erbb2ip 
Cbx8 
Egr4 
SIc16a11 
011 Ertd730e 
Chrd 
Zfp131 
Ptprk 
0lx1 
Cebpa 
Pura 
Cacnb1 
Foxd3 
Fbxw4 
Smyd2 
Serpinb6a 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
44.5 
115.3 
5.9 
373.2 
92.1 
120.1 
9.7 
151.9 
98.4 
14.4 
182.2 
211.3 
520.4 
5.4 
64.9 
19.4 
426.9 
183 
27.2 
64 
3.3 
394.5 
52.7 
70.4 
12.5 
162.8 
73.5 
20.4 
111.9 
141.3 
324 
3.4 
77.5 
20.5 
815.3 
24.7 
112.3 
5.8 
224.7 
60.5 
126.4 
7.4 
96.6 
59.8 
12.4 
120 
130.7 
463.2 
6.1 
48.8 
13.2 
705.4 
1.64 
1.80 
1.79 
0.95 
1.75 
1.71 
0.78 
0.93 
1.34 
0.71 
1.63 
1.50 
1.61 
1.59 
0.84 
0.95 
0.52 
Type-AI 
Round 
0.41 
0.41 
0.60 
0.46 
0.47 
0.93 
0.49 
0.61 
0.76 
1.45 
0.37 
1.21 
1.63 
1.27 
1.86 
1.36 
1.80 
1.03 
1.02 
1.66 
1.52 
0.95 
1.31 
1.57 
1.65 
1.16 
1.52 
1.62 
1.12 
0.89 
1.33 
1.47 
0.61 
Pachytenel 
Round 
0.68 
0.71 
1.43 
1.02 
0.81 
0.49 
0.98 
0.49 
1.50 
2.05 
1.09 
1.95 
0.85 
1.91 
1.65 
0.75 
1.10 
0.57 
0.57 
1.76 
0.87 
0.56 
1.69 
1.69 
1.23 
1.65 
0.93 
1.08 
0.70 
0.56 
1.59 
1.55 
1.16 
Gene Expression 
RLGS Notl site CpG Gene Methylation during Type-A Pachytene Round Type-AI Type-AI Pachytenel 
Spot position (mm7) island symbol spermatogenesis spermatogonia spermatocytes spermatids Pachytene Round Round 
3063 chr12:99964454 Y GoIga5 unchanged 158.9 118.8 221.1 1.34 0.72 0.54 
4E72 chr11 :11638307 Y Zfpn1a1 unchanged 13.7 20.8 24.9 0.66 0.55 0.84 
2C29 chr13:40659482 Y Elovl2 unchanged 33.9 59.2 51.6 0.57 0.66 1.15 
3E55 chr1 :37782382 Y Mgat4a unchanged 71.9 67.1 115.7 1.07 0.62 0.58 
5A19 chr13:57902535 Y Ntrk2 unchanged 3.7 6.3 5.3 0.59 0.70 1.19 
7F24 chr19:15834161 Y Gnaq unchanged 30.2 50.1 51.4 0.60 0.59 0.97 
4027 chr6:52127688 Y Hoxa2 unchanged 34.8 59 43.4 0.59 0.80 1.36 
4054 chr10:107795510 Y Pawr unchanged 92.7 81.5 137.9 1.14 0.67 0.59 
4G04 chr2:76250268 Y Osbpl6 unchanged 5.8 9.8 8.9 0.59 0.65 1.10 
5E17 chr19:10069558 y Syt7 unchanged 14.7 22.8 24.8 0.64 0.59 0.92 
2607 chr3:17780620 Y 6hlhb5 unchanged 26.3 24.9 41.7 1.06 0.63 0.60 
3F18 chr19:3895560 Y Nudt8 unchanged 12.1 15 20.2 0.81 0.60 0.74 
5052 chr5:71955539 Y Zar1 unchanged 177.5 203 291.7 0.87 0.61 0.70 
4G102 chr10:43391874 Y Cd24a unchanged 110.9 80.9 132.4 1.37 0.84 0.61 
2617 chr8:90951656 Y Irx5 unchanged 49 37.3 60.9 1.31 0.80 0.61 
6G41 chr10:80545053 Y Oot11 unchanged 474 599.7 758.1 0.79 0.63 0.79 
5F52 chr1 :132036873 Y Pctk3 unchanged 59.6 83.4 89 0.71 0.67 0.94 
<1.5 -fold increase or decrease in gene expression between type-A spermatogonia, pachytene spermatocytes and round spermatids: 
3C21 chr19:6323991 Y Nrxn2 unchanged 8.4 9.1 11.5 0.92 
2025 chr19:43334330 Y Cnnm1 unchanged 57.9 78.4 62.5 0.74 
2F28 chr4:109053461 Y Faf1 unchanged 64.6 81 80.5 0.80 
1G51 chr9:49773820 Y Ncam1 unchanged 55.7 69.2 64 0.80 
1 F15 chr13:24635839 Y Vmp unchanged 18 16.4 20.3 1.10 
3A01 chr10:128147538 N Zfpn1a4 unchanged 62 73.2 76.7 0.85 
3F09 chr3:45324659 Y Pcdh10 unchanged 15 13.6 16.7 1.10 
1E30 chr15:102996927 Y Hoxc5 unchanged 22.7 26 20.6 0.87 
2F37 
2F53 
3H19 
5G43 
1F02 
2D41 
6G67 
3E07 
chrX:56286984 
ehr16:34831462 
ehr13:23104812 
chr3:104581892 
ehr2:74512389 
chr17:24322011 
ehr7:60359889 
ehr11 :22924443 
y 
y 
y 
y 
y 
y 
y 
y 
Sox3 
Adey5 
Hist1 h1e 
Rhoe 
Hoxd13 
Axin1 
Apba2 
U2af1-rs1 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
16.6 
16.1 
13.5 
145.1 
4.5 
256.4 
39.8 
105.9 
184 
13.1 
17.6 
14.3 
101.3 
4.5 
253.5 
32.4 
97 
14.5 
13.3 
13.6 
103.8 
4.1 
189.4 
30.9 
89.8 
1.27 
0.91 
0.94 
1.43 
1.00 
1.01 
1.23 
1.09 
0.73 
0.93 
0.80 
0.87 
0.89 
0.81 
0.90 
1.10 
1.14 
1.21 
0.99 
1.40 
1.10 
1.35 
1.29 
1.18 
0.79 
1.25 
1.01 
1.08 
0.81 
0.95 
0.81 
1.26 
0.90 
1.32 
1.05 
0.98 
1.10 
1.34 
1.05 
1.08 
Table 4.4: qAMP primer sequences for the analysis of chromosome 7 
Position (mm7) Forward Primer (5'-3') Reverse Primer (5'-3') 
chr7:4108913 CCAGACAGGATTTTGGTGTG CTGCAGACATTCACCCTCCT 
chr7:6746813 CCCTGGGATCTGGAATCTAA GTCGGTCTCAGTGGCAATTT 
chr7:14306726 GCCAGGGAGAACATCTGACA GGGTCAGCCTCTGTGCTAAT 
chr7:21977178 ATCACAGTCAACGCTCTGGA GAAGCCAGGTAGGGTTGAAA 
chr7:24130951 CTGCACTGAAGCCCACATAC GGGTGAGGTCTTGCTGTGTT 
chr7:28023804 TCTTCAAACCCACTGGCACT CAGCGACAGACAGATCTCCA 
chr7:34071401 CCGCTCTTTAGTGTGCCTCT CTTCATCAAGTGGCTGCTGA 
chr7:40447675 CCATTTTCAAAGCCTGCAT AGCAAGTTGTCCTCCAGCA 
chr7:46339059 CCTCCTCCTTGGACACTTCT AAGACACTGGGTAATCCGTCA 
chr7:50861196 GCGTCCAACAATATACCATTGA GGATAAGCATCCAGGGCTAA 
chr7:56864697 GTGCACACACACAACCTTGG AGTACAGGGGCAGATGATGG 
chr7:61 063773 GGGTCCAAGTGGAACAGCTA ACTGATGTCATTGCCCTGCT 
chr7:66063823 GAGTGGTGGGGATCCAAATA AGTTCCATTTCCCACACCAG 
chr7:71 097048 GAAATCTCCCAAGGCCTGAT CCCATTTTGGGTTTCTTGAG 
chr7:76285711 TCAGGTCCAGGTCTGAGGAT GTGGGGCTGTCACTTGAGTT 
chr7:83048811 TCAGAAATGGCAATCACCAA ACATTGACAGCGAGAACAGATT 
chr7:88111373 AATCTTGAGTGCCAGGCTGA CCCCTCCCCACATATTCCTA 
chr7:93098898 CTGTCACAGATCAGCAAGCA AACGAGCAGGCAGAGCTATT 
chr7:97669003 CTCCGAGCCCTAGTCTCTGT AGCGGAACACCCATTAACAT 
chr7: 1 02854935 CTTTATGCCTACTCCATTTTGC TTGCTTTCCTCTTGGATGTCT 
chr7: 108398636 CCGGGCAATAATTACAGCAT TCAGGTCTTCTCTCCCCTTG 
chr7: 112379886 CACAGAGCTAGAGCTGTCTCAAA AACATTCCAGCATTCCAAGC 
chr7:117545186 GGCAATATTGATGGCTGTGA AGTGGGAAATGCAGGCTTCT 
chr7: 124654460 TGAAGGTCTCAGCTGTGGAG CAGTGGTGCCAACCTGAGT 
chr7:128659310 GGTGATCAAGCTACAGACACGA AGTGATAAGCGACCACAGCA 
chr7:133765185 AGCAAACCTTGATGGGACAT CATTGCCAGTGTGCTTGAAA 
chr7:138855398 CCTCTGTGAGAAAGAGGGTCA AAGGCTGAACCAGCCAGACT 
CONNECTING TEXT 
The studies described in chapter IV determine that patterns of DNA 
methylation are being acquired during spermatogenesis. Previous studies 
performed in our laboratory have demonstrated that the administration of the 
hypomethylating drug, 5-aza-2'deoxycytidine (5-azaCdR), to adult mice and rats 
causes a disruption of spermatogenesis. 5-azaCdR inhibits DNA 
methyltransferase activity in a dose-dependent manner. As animal models of 
DNA hypomethylation caused by genetic ablation of DNA methyltransferases 
result in a cessation of sperm production, 5-azaCdR becomes a very useful tool 
to partially perturb DNA methyltransferase activity and determine the resulting 
sperm-specific effects. Previously determined effects of the drug include 
decreased sperm production, abnormalities in the development of embryos sired 
by treated animais and, at higher doses, a reduction in global levels of sperm 
DNA methylation. In chapter V, we describe the effects of perturbing DNA 
methyltransferase activity to the health of germ cells in greater detail and 
determine the genome-wide status of DNA methylation in sperm from 5-azaCdR 
treated animais. 
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CHAPTERV 
Adverse effects of 5-aza-2'-deoxycytidine on spermatogenesis include 
reduced sperm function and selective inhibition of de novo DNA 
methylation 
Christopher C. Oakes, Tamara L.J. Kelly, Bernard Robaire & Jacquetta M. 
Trasler 
Manuscript submitted to The Journal of Pharmacology 
and Experimental Therapeutics 
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ABSTRACT 
The anti-cancer agent, 5-aza-2'-deoxycytidine (5-azaCdR, Decitabine), 
causes DNA hypomethylation and a robust, dose-dependent disruption of 
spermatogenesis. Previously we have shown that altered testicular histology 
and reduced sperm production in 5-azaCdR-treated animais is associated with 
decreased global sperm DNA methylation and an increase in infertility and/or a 
decreased ability to support pre implantation embryonic development. The goal 
of this study was to determine potential contributors to 5-azaCdR-mediated 
infertility including alterations in sperm motility, fertilization ability, early embryo 
development and sequence-specific DNA methylation. We find that although 
sperm from 5-azaCdR-treated animais displayed decreased motility, altered 
morphology and produced embryos that were less likely to survive to the 
blastocyst stage, the major contributor to infertility was a marked (56-70%) 
decrease in fertilization ability. Sperm DNA methylation was investigated using 
Southern blot, restriction landmark genomic scanning (RLGS), and quantitative 
analysis of DNA methylation by real-time PCR (qAMP). Interestingly, 
hypomethylation was restricted to genomic loci that have been previously 
determined to acquire methylation during spermatogenesis, demonstrating that 
5-azaCdR selectively inhibits de novo methylation activity. Similar to previous 
studies, we show that mice that are heterozygous for a non-functional Dnmt1 
gene are partially protected against the deleterious effects of 5-azaCdR; 
however, methylation levels are not restored in these mice, suggesting that 
adverse effects are due to other mechanism(s) in addition to DNA 
hypomethylation. These results demonstrate that clinically relevant doses of 5-
azaCdR specifically impair de novo methylation activity in male germ cells; 
however, genotype-specific differences in drug responses suggest that adverse 
reproductive outcomes are mainly mediated by the cytotoxic properties of the 
drug. 
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INTRODUCTION 
DNA methylation is an essential modification of mammalian DNA and 
occurs at 60 to 80 percent of CpG dinucleotides in the genome. DNA 
methylation is known to play important roles in several cellular processes and is 
often associated with transcriptional repression and increased genomic stability 
(Bird, 2002). In cancer, deregulation of DNA methylation is often observed (Das 
and Singal, 2004; Egger et aL, 2004). DNA methylation is catalyzed by a family 
of DNA methyltransferase enzymes (DNMTs). The principal enzyme, DNMT1, 
primarily maintains established methylation patters during DNA replication; 
whereas, patterns are established by the de nova methyltransferases DNMT3a 
and DNMT3b (Li et aL, 1992; Okano et aL, 1999). 
5-AzaCdR is currently used clinically as an anti-cancer agent for the 
treatment of myelodysplastic syndromes and other types of cancer due to its 
ability to demethylate tumour-suppressor genes and cause replication-dependent 
cytotoxicity. Following incorporation into replicating DNA, DNMTs become 
irreversibly bound to 5-azaCdR as a covalent adduct (Gabbara and Bhagwat, 
1995; Santi et aL, 1984; Taylor and Jones, 1982). Hypomethylation occurs 
during subsequent rounds of DNA replication because the depleted cellular pool 
of DNMTs is insufficient to maintain established genomic methylation patterns. 
Adducts are cytotoxic and induce apoptosis (Juttermann et aL, 1994) in a p53-
dependent manner (Schneider-Stock et aL, 2005). Notably, decreases in 
methylation can occur at non-cytotoxic concentrations of 5-azaCdR that do not 
significantly impair DNA synthesis (Glazer and Knode, 1984; Haaf, 1995; Mondai 
and Heidelberger, 1980). Use of 5-azaCdR inhibits ail known methyltransferases 
(Weisenberger et aL, 2004). 
Mounting evidence points to an important role for DNA methylation in the 
process of male germ cell development. Within the male germ line, germ cell-
specifie methylation patterns are initiated before birth and are completed during 
spermatogenesis by the pachytene phase of meiosis 1 (Davis et aL, 1999; La 
Salle and Trasler, 2006b; Oakes et aL, 2007a). Methylation patterns in male 
germ cells are highly distinct from those found in somatic tissues (Eckhardt et aL, 
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2006; Oakes et al., 2007b). Expression of various DNMTs is highly regulated 
throughout spermatogenesis (Benoit and Trasler, 1994; Jue et aL, 1995; La Salle 
and Trasler, 2006a; Trasler et aL, 1992), and inactivation of the DNMTs through 
gene-targeting results in male infertility (Bourc'his et aL, 2001; Kaneda et al., 
2004). Due to the embryonic lethality and/or sterility in DNMT-deficient mice, the 
use of 5-azaCdR becomes a useful alternative to further investigate the role of 
DNA methylation in germ cells. 
Previous studies on the effects of 5-azacytidine in rats (Doerksen et aL, 
2000; Doerksen and Trasler, 1996) and 5-azaCdR in mice (Kelly et aL, 2003) 
have demonstrated that treatment results in a robust disruption of 
spermatogenesis. Spermatogenesis is distinctively sensitive to the effects of the 
drug as these adverse reproductive effects occur at doses where body weights 
and haematological parameters remain unaffected (Kelly et al., 2003). 
Treatments used in these studies were of sufficient duration to expose 
developing germ cells from the spermatogonial stem cell stage through 
spermatogenesis and epididymal transit. 5-AzaCdR treatment resulted in several 
reproducible effects. Treatment caused a dose-dependent decrease in testis 
weights, lowered sperm counts and an increased level of abnormalities in 
testicular histology. Interestingly, mating of treated mice with control females 
resulted in increased preimplantation loss (reduction of the number of 
implantation sites minus the number of oocytes ovulated). An increase in 
pre implantation loss could be the result of either a failure of sperm from 5-
azaCdR-treated animais to fertilize oocytes or a reduction in the survival of 
embryos during preimplantation development. Furthermore, global DNA 
methylation analysis reveals a dose-dependent decrease in DNA methylation in 
sperm from treated animais. 
ln this study, we determine the cause of the 5-azaCdR-dependent 
preimplantation loss by performing a detailed analysis of sperm function and 
preimplantation development. The relationship of these effects to drug-
dependent alterations in sperm DNA methylation is determined by using a variety 
of techniques that assess sequence-specific levels of DNA methylation. 
190 
Previous studies have indicated that the treatment of mice that have reduced 
levels of DNMT1 results in a greater level of DNA hypomethylation and less 
cellular toxicity compared to wild-type mice in somatic tissues (Juttermann et aL, 
1994; Laird et aL, 1995). We have also previously found that in Dnmt1c/+ mice, 
animais that are heterozygous for a targeted mutation in the catalytic do main of 
DNMT1 (Lei et aL, 1996), some of the adverse spermatogenic effects of 5-
azaCdR are attenuated in comparison to Dnmt1+/+ males (Kelly et aL, 2003). 
Genotype-dependent responses in the extent of the hypomethylation in sperm 
DNA and the level of adverse spermatogenic effects between Dnmt1+/+ and 
Dnmt1c/+ animais allude to the roles played by cytotoxic adducts versus abnormal 
DNA methylation. Thus a further aim of the current study was to examine the 
effects of 5-azaCdR in Dnmtr/+ and Dnmt1c/+ mice. 
MATERIALS AND METHODS 
AnimaIs 
Male Dnmtt+/+ and Dnmt1c/+ mice, heterozygous for a deletion within the 
catalytic domain of the primary mammalian DNA methyltransferase, DNMT1 (Lei 
et aL, 1996), were bred and raised in our own facilities (McGiII University -
Montreal Children's Hospital Research Institute) on a C57BU6 background. 
Male mice of both genotypes were obtained through crosses of Dnmt1c/+ males 
and C57BU6 females; PCR genotyping of mice was performed as described 
(Kelly et aL, 2003). Adult virgin C57BU6 and CD1 females were obtained from 
Charles River, Canada (St. Constant, Canada). Ali mice were maintained on a 
12:12 hour light/dark cycle and were provided with food and water ad libutum. 
Animal experiments were carried out according to the principles and procedures 
detailed in the Guide to the Care and Use of Experimental Animais, by the 
Canadian Council on Animal Care. 
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Treatment 
Dnmt1+/+ and Dnmt1c/+ males (age 7 to 10 weeks) were randomly 
assigned to one of two treatment groups (Saline: Dnmt1+/+, n = 13; Dnmt1c/+, n = 
15. 5-AzaCdR: Dnmt1+/+, n = 14; Dnmt1c!+' n = 15). Males were treated 3 times 
a week for 7 weeks, by intraperitoneal injection (IP), with either saline or 0.1 
mg/kg 5-azaCdR to expose male germ cells throughout their development. 
Throughout the treatment, males were weighed twice per week. After 7 weeks of 
treatment, males were mated with four virgin superovulated CD1 females (age 8 
weeks) and then sacrificed. The testes, epididymides, seminal vesicles and 
spleen were removed, weighed, snap-frozen and stored at -80°C. A section of 
liver was also removed and frozen. Spermatozoa from the caudal epididymides 
were isolated and purified as described (Alcivar et aL, 1989) with modifications 
(Kelly et aL, 2003), and were stored at -80°C. 
Mating and Embryo Culture 
Adult female CD1 mice aged 8 weeks were superovulated by 
administration of 5 lU of pregnant mare serum gonadotropin (PMSG; Sigma) 
followed by 5 lU of human chorionic gonadotropin (hCG; Sigma) 48 hours later. 
To obtain fertilized embryos, each male (n = 7-9/treatment group), after 7 weeks 
of treatment, was mated, overnight, with 1 superovulated virgin CD1 female per 
night for 4 nights, for a total of 4 females per male. The next morning females 
were examined for the presence of a vaginal plug. One-cell embryos and 
unfertilized oocytes were isolated at 27 hours post-hCG and cumulus cells 
removed by hyaluronidase treatment (1 mg/ml) (Sigma) in HEPES-buffered M2 
medium (Sigma). Oocytes were examined for the presence of two pronuclei 
indicating that fertilization had taken place. Oocytes were classified as fertilized, 
unfertilized or fragmented; the majority of fragmented oocytes could not be 
evaluated as to fertilization status, and thus, were not subcategorized. Fertilized 
embryos were washed three times, using a mouth-controlled drawn-out glass 
pipette, and placed into pre-equilibrated bicarbonate-buffered kSOM medium 
(Erbach et aL, 1994) with gentomycin, under oil, and cultured under an 
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atmosphere of 5%02 , 5%C02 , in nitrogen at 37°C in a humidified modular 
incubator (Billups-Rothenberg, Del Mar, CA). Embryos were examined daily, on 
a heated stage, and scored for development through to the blastocyst stage. 
Data are presented on a per male basis; to avoid skewing of data males were 
removed from ail data sets if less than 10 eggs, in total, were collected from 
females mated to that male; only two males were removed, one saline Dnmt1+/+ 
male and one 5-azaCdR-treated Dnmt1c/+ male. 
Sperm Motility Analysis 
Sperm motility of treated Dnmt1+/+ and Dnmt1d + male mice (n = 6/group) 
was analysed using an IVOS semen analyser (Hamilton-Thome Research, 
Beverly, MA) with parameters determined by the Jackson Laboratory (courtesy of 
Hamilton-Thome). Ali dishes and si ides were kept at 3rC during ail steps. 
Briefly, the cauda epididymidis was tied off, both proximally and distally, removed 
from the epididymis and rinsed in 3 ml of warmed M199 medium with Hank's 
salts (Sigma, St. Louis, MO) supplemented with 0.5% w/v BSA, pH 7.4 (GIBCO, 
Mississauga, ON) in a 35 mm Petri dish at 3rC. The cauda epididymidis was 
then moved to a new Petri dish containing 3 ml of warm supplemented M199 
medium, minced and the epididymal tissue removed. Sperm were allowed to 
disperse for 5 minutes. The sperm suspension was diluted 1: 10 in warm 
supplemented medium prior to motility analyses such that concentration did not 
impair motility. The diluted suspension (20j.l1) was loaded into a pre-warmed 2X-
CEL Sperm Analysis Chamber (80j.lm deep) (Hamilton-Thome Research). 
Movement characteristics analysed were: percent motility - motile sperm divided 
by the sum of the motile and immotile sperm within the analysis field; percent 
progressive motility - progressively motile sperm divided by the sum of motile 
and immotile sperm within the field; average path velocity (VAP) - the average 
velocity of the smoothed cell path; progressive/straight line velocity (VSL) - the 
average velocity measured in a straight line from the beginning to end of the 
track; curvilinear velocity (VCL) - the sum of the distances moved in each frame 
along the sampled path divided by the time taken to cover the track; amplitude of 
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lateral head displacement (ALH); beat cross frequency (BCF) - the frequency 
with which the sperm track crosses the sperm path; straightness (STR) - the 
departure of the cell path from a straight line and; linearity (LIN) - the departure 
of the cell track from a straight line. 
Tracks were digitally recorded at 60Hz under 4X dark-field illumination. 
Analysis was completed using the following IVOS settings: stage temperature, 
37°C; frames acquired, 30; frame rate, 60 Hz; minimum contrast, 30; minimum 
cell size, 4 pixels; magnification, 0.81; cell intensity, 75; static size, 0.13-2.43; 
static intensity, 0.10-1.52. Five slides were analysed for each mouse and each 
slide was sam pied five times such that a minimum of 300 sperm were analysed 
per slide. The mean of the five slides was calculated for each mouse. 
DNA Methylation Analysis 
DNA was extracted from purified spermatozoa using proteinase K followed 
by phenol extraction for Southern blot and RLGS analysis as described 
previously (Okazaki et aL, 1995). Southern blots were done as described 
previously (Trasler et aL, 1990) and visualized by autoradiography. Major and 
minor satellite probes were constructed by PCR amplification of mouse genomic 
DNA using primers described previously (Lehnertz et aL, 2003). The probe for 
the intracisternal A-particle (IAP) has been used previously (Michaud et aL, 1994; 
Walsh et aL, 1998). Three to four replicate RLGS profiles were generated for 
each treatment group. Each profile was visualized by autoradiography for 
identification of changed spots and phophorimager screen for spot densitometry 
analysis. Visu al assessment of changes in spot intensity was confirmed by 
densitometric analysis by comparing the intensity of the spot of interest in 
comparison to the intensity of 8-10 surrounding spots of unchanged intensity. Ali 
spots showing differential intensity were observed to be changed in ail replicates 
except one spot in a Dnmt1c/+ saline-treated profile. The genomic location of 
spots of interest was determined by using either the mouse RLGS cloning library 
method (Yu et aL, 2004) or a second-generation virtual RLGS resource 
(Smiraglia et aL, 2007). Loci identified using virtual RLGS were confirmed by 
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obtaining the corresponding BAC clone (Roswell Park Microarray Core Facility, 
Buffalo, NY) and running RLGS mixing gels. The methylation status of paternally 
methylated imprinted DMRs and RLGS spots was determined by using the qAMP 
methylation assay (Oakes et aL, 2006). Briefly, DNA is digested with various 
methylation-sensitive restriction enzymes (MSREs) and a methylation-dependent 
restriction enzyme, McrBC, followed by amplification using real-time PCR. Shifts 
in Ct value (~Ct) between the sham- and enzyme-digested samples are used to 
calculate the percentage of methylation at the various CpG sites within the 
amplified region (MS REs: %methylation=100(2-t,CI); McrBC: 
%methylation=100(1-2-t,C'). Ali ~Ct values are the means of triplicate reactions. 
Primers are designed to flank CpG/restriction sites of interest. Primers used 
were described previously (Oakes et aL, 2007a). 
Statistical Analysis 
Statistical analysis was performed using SigmaStat 2.03 software (SPSS, 
Chicago, IL). Significant differences (p<0.05) between treatment groups with 
respect to the various motility parameters, morphological characteristics, 
fertilization ability, and percent methylation were detected using two-way 
ANOVA, with a post-hoc Tukey test. Embryo data are expressed on a per male 
basis and were evaluated for significance using three-way ANOVA, with a post-
hoc Tukey test. 
RESULTS 
General Results 
Mice were treated with 5-azaCdR for 7 weeks, a sufficient period for the 
exposure of developing germ cells throughout the entire window of 
spermatogenesis (from spermatogonial stem cell to spermatozoa) and 
epididymal transit. As observed in a previous study (Kelly et aL, 2003), treatment 
with 5-azaCdR elicited no obvious changes in behaviour and weight, although 
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initial and final body weights of the Dnmt1+/+ and Dnmt1c/+ genotypes were 
significantly different (p<0.05) (Table 5.1). Again, testis weights were 
significantly decreased in treated males, regardless of genotype (p<0.001), and 
similar to our previous studies, the extent of reduction was considerably less in 
Dnmt1c/+ males than in Dnmt1+/+ males (p<0.05). However, testis weight decline 
was greater for both genotypes than in our previous study (Kelly et al., 2003). 
Sperm Moti/ity, Morph%gy and Fertilization Ability 
To assess the effects of 5-azaCdR-treatment on sperm movement, 
multiple motility characteristics were assayed by computer assisted sperm 
analysis (CASA) using a Hamilton-Thorne IVOS sem en analyser. Both the 
proportion of sperm found to be motile (sperm motility) and the fraction that were 
progressively motile were significantly lowered in sperm from 5-azaCdR-treated 
Dnmt1+/+ males, but the extent of the decrease was less in sperm from Dnmt1c/+ 
males (Figure 5.1 a; Table 5.2). The curvilinear velocity (VCL), a measure of total 
movement of sperm, was reduced in both treated groups. While several other 
parameters concerning various aspects of sperm motility were significantly 
reduced in 5-azaCdR-treated Dnmt1+/+ males, significant reductions were 
observed in only two parameters (VCL and ALH) in Dnmt1c/+ mice. CASA 
analysis also allows for a measurement of the morphology the analyzed sperm. 
The average sperm head size (area) from 5-azaCdR-treated Dnmt1+/+ males 
was smaller and be abnormally shaped (Le. elongated), indicated by a change in 
the ratio of the minor axis to major axis (Figure 5.1 b). These abnormalities in 
morphology were found only in sperm from Dnmt1+/+ males. 
T 0 determine if the ability of sperm from 5-azaCdR-treated males to 
fertilize oocytes is reduced, each male was mated to four superovulated females 
(total matings = 132), and embryos were collected at the one-cell stage. The 
presence of a vaginal plug on the morning after mating indicated successful 
copulation, and the copulation rate was similar for ail treatment groups; only 
females with vaginal plugs were used for embryo collection. Approximately 500 
oocytes on average were scored per treatment group. An oocyte was 
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considered fertilized if two pronuclei were present. Whereas the incidence of 
fragmented oocytes/embryos was low «5%) and was similar in ail groups, the 
proportion of fertilized oocytes was dramatically reduced by 70% and 56% 
(p<0.001) after matings with treated Dnmt1+/+ and Dnmt1c/+ males, respectively 
(Figure 5.1 c). These results show that although a significant proportion of sperm 
remain motile after treatment, the majority of these sperm are unable to 
successfully fertilize oocytes. 
ln Vitro Embryonic Development 
T 0 assess the ability of embryos sired by treated males to progress 
normally through pre-implantation development, fertilized oocytes were placed 
into culture and scored daily for survival to advanced preimplantation stages. 
Embryo viability was calculated as the percent of embryos that survived from the 
previous stage. As Figure 5.2 iIIustrates, there was no change in the progression 
of embryos throughout preimplantation development, with the exception of 
survival to the blastocyst stage. At this point, approximately 50% of embryos 
from saline-treated groups survived; however, the proportion of surviving 
embryos sired by treated Dnmt1+/+ males was significantly reduced by an 
additional 25% (p<0.05). No such decrease was observed for embryos sired by 
treated Dnmt1 c/+ males. These results demonstrate that the ability of the paternal 
genome from 5-azaCdR-treated Dnmt1+/+ animais to support normal embryonic 
growth is reduced; in contrast, blastocyst development was similar to saline-
treated controls for the Dnmt1c/+ mice. 
DNA Methylation Analysis of Repetitive Elements 
Previous analysis of sperm from 5-azaCdR-treated animais has 
demonstrated a dose-dependent reduction in global levels of DNA methylation in 
rats (Doerksen et al., 2000) and mice (Kelly et al., 2003). In mice, only a dose 
higher (0.15 mg/kg, 3x/wk IP) than the lower dose (0.1 mg/kg, 3x/wk IP) used in 
this study resulted in a significant reduction in global sperm DNA methylation, 
despite adverse spermatogenic effects observed at the lower dose in both 
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previous and current work. The global assessment of DNA methylation may not 
be sensitive enough to detect sequence-specific changes in DNA methylation at 
the lower dose. To address the possibility that aberrant DNA methylation of 
sperm from treated males is associated with the 5-azaCdR-dependent effects, 
we investigated methylation status of three types of repetitive elements in sperm 
from 5-azaCdR-treated males using Southern blotting. Although the methylation 
status of the major and minor satellite repeats (structural elements mainly found 
in centromeric regions), and the interspersed L TR-containing retroviral element, 
IAP, have different average levels of methylation in sperm, no difference was 
detected in sperm from 5-azaCdR-treated males (Figure 5.3). 
DNA Methylation Analysis of Paternally-Methylated Imprinted Regions 
Imprinted genes display an allele-specific pattern of DNA methylation that 
is acquired in a sex-specific manner in germ cells. Loci that display this property 
are termed differentially methylated regions (DMRs). There are three imprinted 
genes with weil characterized DMRs that are methylated in sperm. We 
investigated if 5-azaCdR treatment cou Id affect the ability to maintain these 
patterns. Using primers that target restriction sites within the DMRs of H19-lgf2 
(Tremblay et aL, 1995), Dlk1-Gt/2 (Takada et aL, 2002), and Rasgrf1 (Yoon et aL, 
2002), we used the qAMP assay to determine the percent methylation in these 
regions. No changes were observed for H19-lgf2 or Dlk1-Gt/2; however, 
digestion of DNA with the Hhal restriction enzyme reveals a significant reduction 
in the percentage of methylation in sperm from 5-azaCdR-treated animais in both 
Dnmt1+/+ and Dnmt1c/+ groups (Figure 5.4). The methylation at these sites is also 
reduced in the Dnmt1c/+ saline-treated group. Because the Hhal digest of the 
Rasgrf1 DMR contains the most methylation-sensitive restriction enzyme sites of 
ail the digests tested and only one of the three Hhal sites is required to be 
unmethylated for the enzyme to cleave the DNA strand, it is the most sensitive in 
detecting a reduction in methylation (Figure 5.4a). Interestingly, previous studies 
using the same approach have determined that the Hhal digest of Rasgrf1 was 
the sole digest to reveal a substantial gain in methylation during 
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spermatogenesis compared to the other DMRs investigated (Oakes et al., 
2007a). 
Genome-Wide Analysis of Single-Copy Sequences using RLGS 
RLGS investigates genome-wide patterns of DNA methylation by 
separating genomic DNA that has been digested with the methylation-sensitive 
restriction enzyme, Notl, by two-dimensional gel electrophoresis. 
Hypomethylated sites generate spots that are visible on RLGS profiles; a change 
in spot intensity is inversely proportional to the methylation status of individual 
loci in the genome. In the mouse, Notl sites occur in a variety of sequence types, 
including unique and interspersed repetitive sequences. Previously, RLGS 
analysis found that the methylation status of 19 spots is modified during 
spermatogenesis (Oakes et al., 2007a). To further examine the relationship 
between 5-azaCdR-dependent alterations in sperm DNA methylation and the 
acquisition of patterns of DNA methylation during spermatogenesis, RLGS 
profiles were generated from sperm from each treatment group (n=2-4/group). 
This analysis reveals that a subset of spots are consistently hypomethylated in ail 
profiles from both Dnmt1+/+ and Dnmt1c/+ 5-azaCdR-treated groups (Figure 5.5; 
Table 5.3). A total of 9 spots were observed to change with treatment, and ail 
were hypomethylated. Ali changed spots in these groups are hypomethylated in 
ail profiles investigated. One spot, belonging to a Notl site upstream of the 
AK032343 gene, was observed to be hypomethylated in 1/3 profiles generated 
from a Dnmt1c/+ saline-treated animal. The vast majority (>99%) of the total 
number of spots (both hyper and hypomethylated) remain unaffected. Using a 
second-generation virtual RLGS resource (Smiraglia et al., 2007) to assess the 
amount of hypermethylated Notl sites visible on real RLGS profiles, reveals that 
greater th an 1000 hypermethylated 'spots' are not hypomethylated with 5-
azaCdR treatment. Included in these hypermethylated sites are -240 and -60 
spots originating from the IAP and Etn (early transposon) interspersed repeats, 
respectively (Oakes et al., 2007b). Hypomethylation of these repeats is highly 
visible on RLGS profiles and was not observed in any profile from any group 
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(data not shown). This result is consistent with the Southern blot analysis of IAP 
(Figure 5.3). We also investigated if changes were specifie to sperm or were 
also hypomethylated in somatic tissues from 5-azaCdR-treated animais. We 
found that ail of the sites observed to be hypomethylated in sperm did not 
change in brain or liver (Table 5.3; Figure 5.6). 
Most interestingly, of the 11 spots that in our previous study were shown 
to gain appreciable levels of methylation between the type A spermatogonial and 
sperm stages, 8 of them were consistently hypomethylated in sperm from 5-
azaCdR-treated animais (Table 5.3). Only 1/9 5-azaCdR-dependent 
hypomethylated spots was not observed to acquire methylation during 
spermatogenesis. The eight spots that are normally hypomethylated during 
spermatogenesis were unaffected by treatment. Combined with the knowledge 
that the methylation status of >99% of spots are unchanged both during 
spermatogenesis and in sperm from 5-azaCdR-treated animais, our results 
indicate that maintenance methylation and demethylation processes proceed 
normally in the presence of the drug, despite a selective inhibition of de novo 
methylation activity in germ cells. 
Analysis of 5-azaCdR-Responsive Single-Copy Sequences using qAMP 
The genomic location of 5/9 RLGS spots that are hypomethylated in 
sperm from 5-azaCdR-treated animais were determined previously (Oakes et al., 
2007a). Identified Notl sites that show altered methylation are found near or 
within genes and within non-repetitive sequences, but show varied locations 
within genes and variable CpG island status (Table 5.4). To further define the 
specificity and extent of the hypomethylation effect observed in sperm from 5-
azaCdR-treated animais and the relationship to the inhibition of de novo 
methylation, we used the qAMP assay to quantitatively measure the percentage 
of methylation in sperm from 5-azaCdR-treated mice. The qAMP assay allows 
for the examination of DNA methylation at multiple neighbouring CpGs in addition 
to the Notl site. We chose to examine the methylation of three loci that were 
detected by RLGS to be hypomethylated at their respective Notl sites, Tcf3, Abt1 
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and Ibtk (Figure 5.7a). These three loci were chosen due to the varied location 
of the Notl sites within their respective gene (3', 5' and body regions, 
respectively). We found that ail restriction enzyme digests detect a significant 
reduction in the percentage of methylation in response to treatment with 5-
azaCdR (n=5-6 mice/group) (Figure 5.7b-d). This indicates that the change in 
methylation status observed by RLGS at Notl sites is representative of changes 
present in neighbouring CpG sites. The magnitude of the reduction in 
methylation is less in the methylation-dependent McrBC digests, due to this 
particular digest being less sensitive to demethylation (Oakes et al., 2006). 
Slightly less methylation is observed in Dnmt1d + animais; however, the reduction 
is sm ail relative to the effect of 5-azaCdR. In many cases, 5-azaCdR reduces 
the level of methylation in sperm from treated animais to levels that are similar or 
close to the levels previously found in type-A spermatogonia. Analysis of a fourth 
locus, a region shown to be hypomethylated during spermatogenesis located 
upstream of the AK137601 gene, is largely unaffected by treatment, 
demonstrating that hypomethylation is observed to proceed normally in the 
presence of 5-azaCdR (Figure 5.7e). These data, taken together with the RLGS 
data, indicate again that de novo methylation activity is selectively inhibited, while 
maintenance activities and demethylation events that occur during 
spermatogenesis are unaffected. 
DISCUSSION 
ln this study, we have determined several novel effects of 5-azaCdR 
treatment on male reproductive physiology and the epigenetic integrity of male 
germ cells. We find that although sperm from 5-azaCdR treated animais display 
somewhat decreased motility, altered morphology and decreased 
pre implantation embryonic development, embryo loss most likely results from a 
sharply decreased ability of sperm to complete fertilization. Interestingly, the 
investigation of sperm DNA methylation using a variety of quantitative techniques 
reveals that hypomethylation is restricted to genomic loci that have been 
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previously determined to acquire methylation during spermatogenesis, indicating 
that de nova methylation activity is selectively inhibited. We also show that 
Dnmt1c/+ mice are partially protected from the adverse physiological effects of 5-
azaCdR; yet, levels of DNA methylation in sperm are as low or lower th an levels 
found in sperm from Dnmt1+/+ mice. 
Previous studies have shown that mating 5-azaCdR treated males with 
untreated females results in an increase in preimplantation embryo loss (Kelly et 
aL, 2003). This cou Id be the result of a failure of the sperm to fertilize or reduced 
survival of preimplantation embryos sired by 5-azaCdR-treated fathers. In this 
study, we have observed a greater than 50% reduction in the ability of the sperm 
of 5-azaCdR-treated males to successfully fertilize oocytes versus saline-treated 
males. The magnitude of the reduction in fertilization ability in the present study 
was similar to the level of preimplantation loss observed in previous studies; 
whereas, in contrast, in the current study, the decrease in the survival of embryos 
developing from the 2-cell to the blastocyst stage following treatment was 
minimal. Furthermore, the level of preimplantation loss and the reduction in the 
fertilization ability is similar in both Dnmt1 c/+ and Dnmt1+/+ animais; whereas 
decreased survival of pre implantation embryos is specifie to only Dnmt1+/+ 
animais. These results suggest that the primary cause of the 5-azaCdR-
dependent preimplantation loss noted in our previous study is mainly due to the 
inability of sperm to successfully fertilize the oocyte. The slight reduction 
observed in sperm number and motility is unlikely to be the primary reason for 
the failure of the sperm to fertilize, as the reduced parameters are within the 
range sufficient to maintain normal fertility. Changes in sperm head morphology 
are also unlikely to be the cause as measurable changes occur only in Dnmt1+/+ 
animais. The primary cause for the failure to fertilize is most likely an additional 
parameter of sperm function not addressed in these studies, which may include a 
failure of the acrosome reaction, capacitation or sperm-egg recognition. 
Changes to sperm head shape and area in wild-type animais signify a 
perturbation in chromatin packaging, indicating that 5-azaCdR may affect sperm 
chromatin organization or the mechanisms that direct morphological changes to 
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the nucleus during spermatogenesis. This may or may not be related to 5-
azaCdR-dependent changes in DNA methylation, as very few loci throughout the 
genome were observed to be hypomethylated. Treatment with 5-azaCdR is also 
associated with a decreased capacity of the paternal genome to support 
embryonic growth several days post-fertilization in wild-type animais. These 
results support the idea that the sperm chromatin quality is affected as a result of 
5-azaCdR treatment. Furthermore, previous work in combination with these 
studies demonstrates that, despite the problems associated with fertilization and 
embryonic development, embryos that are sired by 5-azaCdR-treated fathers can 
progress into later stages of development (Doerksen and Trasler, 1996). Other 
studies have shown that DNA methylation in the male pronucleus is erased 
shortly after fertilization (Oswald et aL, 2000); however, the full extent of this 
reprogramming event is not known. Future studies will be required to determine 
if 5-azaCdR-dependent alterations in DNA methylation are present in developing 
embryos and if adverse effects are present in offspring. The fact that acquisition 
of DNA methylation in male germ cells occurs during adulthood, added with the 
knowledge that germ cell methylation can be influenced, raises the possibility 
that exogenous epigenetic insults could potentially be passed on to the progeny. 
Recent studies have shown that the treatment of animais with the antiandrogenic 
fungicide, vinclozolin, results in a trangenerational disease phenotype that is 
associated with the trangenerational transmission of epigenetic abnormalities 
(Anway and Skinner, 2006; Chang et aL, 2006). 
Investigation of the genome-wide methylation status of individual 
sequences in sperm DNA from treated animais reveals that male germ cells are 
able to maintain methylation patterns at repetitive elements and single-copy 
sequences in the presence of 5-azaCdR. This demonstrates that at the doses 
used here, not enough DNMT1 is covalently trapped to inhibit the maintenance of 
previously established patterns of methylation. This is supported by the finding 
that levels of DNMT1 are highest in the gonads of adult mice (Numata et aL, 
1994; Singer-Sam et aL, 1990; Trasler et aL, 1992). Furthermore, Dnmt1c/+ germ 
cells are still able to maintain methylation patterns at these sequences in the 
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presence of 5-azaCdR despite having only half the normal amount of functional 
enzyme. Previously, we have established that in addition to maintaining 
established methylation patterns, developing germ cells possess de novo 
methylation activities (Oakes et aL, 2007a). We find that the ability of germ cells 
to acquire methylation at CpG sites which normally gain methylation during 
spermatogenesis is selectively inhibited by 5-azaCdR treatment. Almost ail CpG 
sites we have previously demonstrated to gain methylation during 
spermatogenesis are hypomethylated in sperm from 5-azaCdR treated animais. 
Two mechanisms have been reported to mediate the effects of 5-azaCdR. 
Firstly, adducts can induce apoptosis via a p53-dependent mechanism. 
Secondly, covalent trapping of a sufficient amount of DNMT proteins results in 
replication-dependent hypomethylation in surviving cells. Figure 5.8 details how 
treatment with 5-azaCdR could potentially result in germ cell cytotoxicity and the 
selective inhibition of de novo methylation, while in the Dnmt1c/+ background, 
sorne adverse effects are attenuated but de novo methylation activity is not 
restored. In spermatogonia, both maintenance and de novo methylation occur 
during mitotic divisions (Figure 5.8a). In the presence of 5-azaCdR, sorne 
cytosine residues are replaced creating potential sites for the formation of DNA-
protein adducts (Figure 5.8b). At the dose used in this study, enough adducts 
are formed to result in the reduction of approximately half of the germ cell 
population (Kelly et aL, 2003), while the other half survive but contain adducts in 
their DNA causing adverse effects to reproductive physiology. Due to the fact 
that the level of Dnmt1 expression is 5 t010-fold higher compared to Dnmt3a or 
Dnmt3b in spermatogonia (Shima et aL, 2004) and 5-azaCdR has a more 
prominent effect on Dnmt3a or Dnmt3b compared to Dnmt1 (Oka et aL, 2005), 
maintenance activity is maintained in the presence of 5-azaCdR while insufficient 
de nova methylation activity causes a loss of methylation at CpG sites that 
normally receive methylation during spermatogenesis. In Dnmt1c/+ animais, 50% 
of DNMT proteins have a mutation in their catalytic domain which prevents the 
association with incorporated 5-azaCdR (Figure 5.8c). Due to the higher levels 
of Dnmt1 expression in germ cells, DNMT1 proteins are the major contributors to 
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adduct formation. Fewer adducts are formed in the Dnmt1d + background, 
leading to less germ cell death and less adverse effects in surviving cells. 
Sufficient functional DNMT1 remains to maintain methylation patterns. Because 
de novo methylases are not mutated, their potential for adduct formation is not 
changed, causing the same level of sequestration and loss of de novo 
methylation activity. 
To our knowledge, this is the first evidence of selective inhibition of de 
novo methylation activity by 5-azaCdR. The ability of 5-azaCdR at high doses to 
induce replication-dependent demethylation of hypermethylated loci in vitro is 
weil documented. The examination of a developmental process where known 
hypermethylation events occur at distinct CpG sites in the genome has allowed 
for this novel property of the drug to be identified (Oakes et aL, 2007a). 
Extrapolation of the number of CpG sites shown to be gaining methylation during 
spermatogenesis to the total number of CpG sites located in similar sequences 
(12x106 non-repetitive, non-CpG island CpGs; (Fazzari and Greally, 2004)) 
suggests the possibility of greater than one million CpGs potentially affected by 
5-azaCdR treatment. 
Is DNA hypomethylation the cause of the 5-azaCdR-dependent adverse 
effects on sperm function and embryonic development? Interestingly, some of 
the adverse effects of 5-azaCdR examined previously, such as testis weight, 
sperm counts and abnormal seminiferous tubule morphology, as weil as effects 
examined in this study, such as sperm motility, morphology and the ability to 
support embryonic development are improved in Dnmt1c/+ animais. Despite the 
protective effects of the Dnmt1c/+ genotype, losses of DNA methylation are not 
attenuated in the germ cells of these animais; rather, DNA methylation is equally 
diminished or slightly lower at some CpG sites examined. This suggests that 
mechanisms, such as DNA-protein adduct formation, are more prominent in the 
mediation of these effects than DNA hypomethylation. However, some 
parameters, like fertilization ability, are equally effected by 5-azaCdR in Dnmt1d + 
and Dnmt1+/+ animais, indicating that hypomethylation may potentially have a 
role in mediating some of the effects. 
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FIGURES 
Figure 5.1: Effects of chronic 5-azaCdR treatment on sperm motility and 
velocity, sperm head morphology and fertilization ability. (a,b) Sperm 
motility and head morphology parameters were measured using computer 
assisted sperm analysis (CASA). (c) Fertilization ability was determined by 
isolating one-cell embryos and unfertilized oocytes after mating. Open bars 
represent Dnmt1+/+ males, grey bars represent Dnmt1c/+ males, and diagonal 
striped bars represent males treated with 5-azaCdR. Data are shown on a per 
male basis. Error bars represent ±SEM, asterisks indicate a significant 
difference between 5-azaCdR and saline treatment in genotype-matched groups, 
p-values for each parameter are indicated. 
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Figure 5.2: Viability of embryos sired by 5-azaCdR-treated males through 
the stages of preimplantation development. Percentages represent the 
survival of embryos from the previous stage. Open bars represent Dnmt1+/+ 
males, grey bars represent Dnmt1c/+ males, and diagonal striped bars represent 
males treated with 5-azaCdR. Data are shown on a per male basis. Error bars 
represent ±SEM, asterisks indicate a significant difference between 5-azaCdR 
and saline treatment in genotype-matched control groups. 
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Figure 5.3: DNA methylation analysis of repetitive elements in sperm using 
Southern blot. Sperm DNA isolated from Dnmtr/+ and Dnmt1c/+ males treated 
with either saline or 5-azaCdR was digested with either Mspl to reveal the fully 
unmethylated pattern or Hpall to determine the amount of methylation in each 
sample. Equal amounts of DNA were loaded into each lane and hybridized to 
probes for the IAP interspersed repeat and the major and minor satellite 
centromeric repeat sequences. Although varying amounts of methylation can be 
found in these sequences in sperm, a measurable decrease in methylation is not 
induced by 5-azaCdR treatment. 
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Figure 5.4: Quantitative DNA methylation analysis of paternally methylated 
imprinted DMRs in sperm using qAMP. Sperm DNA isolated from Dnmt1+/+ 
and Dnmt1c/+ males treated with either saline (sai) or 5-azaCdR (aza) was 
digested with either Notl (N), Hhal (Hh), Hpall (Hp), or McrBC (M) and amplified 
using real-time PCR. (a) Primer binding sites and the locations of flanked 
restriction sites are displayed for each DMR. (b-d) Percent methylation values at 
restriction sites in the DMRs of H19, Dlk1-Gt/2, and Rasgrf1. Only the Hhal 
digest of the Rasgrf1 DMR reveals a decrease in the percentage of methylation, 
decreasing in response to both 5-azaCdR treatment (asterisks) and the Dnmt1c/+ 
genotype (daggers). Error bars represent ±SEM, n=6-8 animais/group. 
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Figure 5.5: Genome-wide DNA methylation analysis of multiple loci using 
RLGS. RLGS determines the methylation status of approximately 3000 unique 
Not! sites located throughout the mouse genome by producing two-dimensional 
spots profiles by gel electrophoresis. A visible spot indicates a hypomethylated 
site. (a) Enlargements of small areas of RLGS profiles that display three of nine 
spots that are hypomethylated in response to 5-azaCdR treatment. (b) 
Measurement of the relative density of the three spots displayed in (a) reveals a 
decrease in DNA methylation in sperm from 5-azaCdR-treated (5-aza) versus 
saline-treated (sai) animais. 
a 
b 
Dnmtt'+I+' saline-treated 
Ab11: 
100 
80 
c: 
:B 
"'60 ;;, 
J:: 
~4O 
0'< 
20 
o 
treatment: 
Dnmt1: (+/+) 
DnmI11.i+} 5-azaCdR-treated 
unknown: 
100 
80 
c: 
~ 
<II 60 ;;, 
J:: 
~ 40 
0'< 
20 
o 
treatment: 
Dnmt1: (+1+) 
213 
"-hypomethylated 
". ~ 
<if. 
Dnml1'd+} saline-Ireated Dnmt1,<r+} 5-azaCdR-trealed 
(cI+) 
c: 
0 
~ ;;, 
J:: 
Qi 
E 
0'< 
AK032343: 
100 
80 
60 
40 
20 
0 
treatment 
Dnmt1: (+/-t) 
Figure 5.6: Enlargements of RLGS profiles showing that hypomethylation is 
observed in sperm and not in liver or brain. Hypomethylation of the Notl site 
found in the Abt1 gene is visible on sperm RLGS profiles from 5·azaCdR-treated 
animaIs from Dnmt1+/+ and Dnmt1c/+ animaIs but not in liver or brain profiles from 
the same animaIs. 
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Figure 5.7: qAMP analysis of the percentage of DNA methylation at 
restriction sites within hypomethylated loci determined by RLGS in sperm 
and a comparison to the level of methylation previously found in 
spermatogonia. (a) The genes that harbour a Notl (N) site that is 
hypomethylated by 5-azaCdR treatment, primers binding sites and the location of 
surrounding Hhal (Hh), Hpall (Hp), or McrBC (M) sites are shown. (b-d) qAMP 
analysis of hypomethylated loci within Tcf3, Abtt and Ibtk reveals 
hypomethylation at ail restriction sites examined. Horizontal grey lines on bar 
graphs show the percentage of methylation previously determined in type A 
spermatogonia (Oakes et al., 2007a). (e) qAMP analysis of a loci that is 
demethylated during spermatogenesis, AK13760 1, iIIustrates that 5-azaCdR 
does not impede demethylation du ring spermatogenesis. Error bars represent 
±SEM, n=5-6 animais/group. Statistically significant differences between 5-
azaCdR treatment vs. saline treatment in genotype-matched animais (asterisks) 
and between Dnmt1 c/+ vs. Dnmtt+/+ genotypes in treatment-matched animais 
(daggers) are shown. 
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Figure 5.8: Diagram iIIustrating potential mechanisms that underlie 
changes in DNA methylation and adverse reproductive effects in 5-azaCdR-
treated germ cells. (a) DNMT1 maintains established patterns of DNA 
methylation in spermatogonia; de novo DNA methyltransferases act on CpG sites 
programmed for methylation. (b) 5-AzaCdR incorporation causes adducts 
DNMT-DNA adducts, sequestering enough de novo DNA methyltransferase 
activity to prevent their action; sufficient DNMT1 is present to maintain 
established patterns of methylation. A high level of adducts in sperm DNA cause 
cell death and abnormalities in surviving cells. (c) A heterozygous mutation in 
the catalytic domain of DNMT1 prevents half of the pool of DNMT1 from forming 
adducts. Fewer adducts lead to a reduction in cell death and an attenuation of 
adverse effects in sperm. 
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TABLES 
Table 5.1: Effect of chronic 5-azaCdR treatment on Dnmt1+/+ and Dnmt1c/+ 
mean bodya and reproductive organ weightsb• 
Dnmt1+/+ Dnmt1c/+ 
Saline 5-azaCdR Saline 
Final body weight 26.07 ± 0.53 26.45 ± 0.61 24.27 ± 0.77* 
Testes 6.78 ± 0.21 3.87 ± 0.11* 6.57 ± 0.19 
Seminal Vesicles 2.71 ± 0.10 2.80 ± 0.15 3.36 ± 0.20 
a weight in 9 (± SEM) 
b Relative weight of paired organs (mg/g body weight) (± SEM) 
* p<O.05, vs. saline-treated Dnmt1+/+ 
t p<O.05, vs. saline-treated Dnmt1c!+ 
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5-azaCdR 
23.85 ± 0.58 
4.40 ± 0.11 t 
3.11 ± 0.14 
Table 5.2: Effects of chronic 5-azaCdR treatment on Dnmt1+/+ and Dnmt1c/+ 
sperm motility parameters (as measured by CASA). 
Dnmtl+/+ 
Sperm Parameter 
Saline 
VCL (~m/s) 243.93 ± 4.91 
(track speed) 
VSL (~m/s) 88.61 ±3.13 
(progressive velocity) 
VAP (~m/s) 125.22 ± 3.42 
(path velocity) 
STR (%) 69.65 ± 0.67 
(straightness) 
LIN (%) 37.49 ± 0.50 
(Iinearity) 
Rapid Sperm (%) 52.76 ± 4.39 
Medium Sperm 
6.65 ± 0.52 
(%) 
Slow Sperm (%) 0.34 ± 0.12 
Statie Sperm (%) 40.07 ± 4.15 
BCF 27.36 ± 0.58 (beat cross 
frequency) 
ALH 
(amplitude of lateral 13.24 ± 0.11 
head movement) 
Area 45.64 ± 3.07 
Elongation 46.37 ± 0.97 
.. 
*slgnlflcantly dlfferent vs. saline, ~O.05 
"'p=O.059 vs. saline Dnmt1c/+ 
Dnmt1CT+ 
5-azaCdR Saline 5-azaCdR 
. 
191.54 ± 9.88* 231.04 ± 4.88 203.04 ± 3.66 
68.17 ± 5.88* 84.74 ± 1.76 77.48 ± 2.39 
99.68 ± 5.40* 118.16 ± 2.51 105.61 ± 2.09$ 
65.80 ± 2.78 70.82 ± 0.95 71.76 ± 1.22 
36.29 ± 1.62 38.04 ± 0.68 39.48 ± 0.65 
37.23 ± 5.09* 47.48 ± 4.73 39.04 ± 2.26 
7.75 ± 0.92 7.76 ± 1.21 8.56 ± 2.16 
0.30 ± 0.06 0.56 ± 0.14 0.44 ± 0.17 
54.55 ± 5.07* 44.06 ± 4.87 51.12 ± 4.13 
27.30 ± 0.53 28.84 ± 0.89 29.17 ± 0.94 
. 
10.98 ± 1.29* 12.67 ± 0.17 11.28 ± 0.22 
35.41 ± 2.62* 43.57 ± 1.37 41.57 ± 1.40 
50.65 ± 1.11 * 47.04 ± 0.26 48.28 ± 0.71 
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Table 5.3: Tally of RLGS spots showing altered methylation in sperm. 
5-azaCdR & 
Spot Dnmt1(c/+l 5-azaCdR Dnmt1(c/+l Type-A 
Meth)!lation Liver Brain Sperm Liver Brain Sperm Liver Brain Sperm spermatogonia* 
Hypermethylated 0 0 0 0 0 0 0 0 0 8 
Hypomethylated 0 0 1 0 0 9 0 0 9 11 
Unchanged:;: 2954 2954 2953 2954 2954 2945 2954 2954 2945 2935 
*number of spots showing altered methylation in type-A spermatogonia versus spermatozoa (Oakes, et al. 2007a) 
tnumber of spots that show identical alterations in methylation between 5-aza & spermatogenesis RLGS studies 
:;:derived from virtual RLGS profiles 
OverlaDt 
0 
8 
NA 
Table 5.4: Characteristics of identified RLGS spots that are hypomethylated by 
5-aza-2' -deoxycytidi ne. 
Genome RLGS Notl site CpG 
position spot Gene position island Repeat 
chr6:72645454 5ax2 Tcf3 3' N non-repetitive 
chr7:75333081 1 gx8 Polg 5' Y non-repetitive 
chr7:75377378 4C13 A K032343 body Y non-repetitive 
chr9:85800773 3ex8 Ibtk body N non-repetitive 
chr13:22791131 2F36 Abtt body N non-repetitive 
CHAPTERVI 
DISCUSSION 
DISCUSSION 
6.1 DNA Methylation of the Male Germ Cell Genome 
It was proposed more than thirty years ago that epigenetic modifications in 
DNA methylation functioned in the control of developmental processes (Holliday 
and Pugh, 1975; Riggs, 1975). Due to the significant role played by germ cells in 
development, several early studies attempted to address the status of DNA 
methylation in the se cells (Ariel et al., 1991; Ariel et al., 1994; Kafri et al., 1992; 
Monk et aL, 1987; Sanford et al., 1984; Sanford et aL, 1987; Trasler et al., 1990). 
The use of a variety of different methods both to purify germ cells and to 
measure methylation, combined with the enormous complexity and size of the 
mammalian genome, has led to discrepancies between studies and to confusion 
in the literature. Without a comprehensive study providing a clear ove ra Il view of 
DNA methylation in germ cells, the prevailing view in the literature is that the 
status of DNA methylation between somatic and germ cells is similar (Ariel et al., 
1991; Reik et aL, 2001; Rollins et al., 2006). The studies described in this thesis 
have assessed DNA methylation in germ cells at a level of detail not previously 
achieved. Many of the findings challenge current dogma about DNA methylation 
and germ cells. 
6.1.1 Global versus Sequence-Specifie Detection of DNA Methylation 
Previous attempts to determine the overall methylation status of male 
germ cells involved the study of either global methylation or a limited number of 
sequences. Due to the sequence-specifie nature of DNA methylation patteming; 
extrapolation of data generated on a few sequences is of low value in the 
interpretation of overall methylation. Global assays suffer from low sensitivity and 
do not determine the methylation status of specifie sequences. In previous 
studies of global DNA methylation levels, we have found the levels of methylation 
in somatic and male germ cell genomes are relatively similar on a global scale. 
Using a thin layer chromatography (TLC) assay, that asses ses the percentage of 
DNA methylation of CCGG sites (-1.5 million sites in the mouse genome that are 
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approximately evenly distributed to both unique and repetitive sequences 
(Fazzari and Greally, 2004», we find that sperrnatozoa are only 6-7% 
undermethylated compared to liver in both mice (C. Oakes, unpublished data) 
and rats (Oakes et aL, 2003). High-perforrnance liquid chromatography, (HPLC) 
the other technique commonly used to assess global levels of DNA methylation, 
measures a ratio of total genomic cytosine versus 5mG; thus, the sensitivity is 
too low to detect small differences in overall DNA methylation. 
The primary finding of this thesis is that there are striking differences in 
DNA methylation between male gerrn cells and somatic cells. The discrepancy 
between this result and the prevailing view can be explained in part by the 
methods used previously and by the difference in DNA methylation between 
somatic and gerrn cells being a reorganization of methylation, rather than an 
overall change affecting ail sites equally. Differences may affect a large 
proportion of the genome, but the extent is masked on a global scale by 
simultaneous hyper- and hypomethylation in different regions of the genome. In 
addition, we found high levels of methylation in interspersed repetitive elements 
of high copy number in both somatic and gerrn cells by RLGS and Southem blot 
experiments. Significant differences in methylation in the unique sequence 
portion of the genome are masked because of the substantial proportion of CpGs 
in the genome that are found in these repeats. 
Despite the overall levels of DNA methylation being similar between 
somatic and male gerrn cells, the slightly lower level of DNA methylation found in 
sperrnatozoa by previous TLC assays is consistent with the findings presented in 
this thesis using other techniques. Using RLGS, qAMP analysis and Southern 
blot experiments, gerrn cells have overall lower amounts of methylation in 
comparison to somatic tissues. In locus-specifie experiments, the total number of 
loci that have a lower amount of methylation in male gerrn cells is greater than 
the number of loci that have a higher amount. One explanation for there being 
an overall lower amount of methylation in male gerrn cells may relate to the 
overall level of GC content in the genome. Analysis of the frequency distribution 
of isochores in mammals· (Costantini et aL, 2006), reveals that the genome is 
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composed of more low GC regions than high GC regions. If low GC regions are 
hypomethylated in germ cells as equally as high Ge regions are 
hypermethylated, it would be expected to find overaillower levels of methylation 
in germ cells, consistent with the findings of these four independent methods. 
6.1.2 Germ Cell DNA Methylation and the Evolution of Genomic Cytosine 
Content 
These findings also challenge a predominant, widely-held theory that 
describes how germ ce II-specifie DNA methylation is responsible for sculpting the 
mammalian genome into regions of high and low CpG content throughout 
evolutionary time. The basis of this theory is the reduced stability of the 5-
methylcytosine molecule versus cytosine. 5mC will undergo spontaneous 
deamination to form thymine at 2-3 times the rate compared to unmethylated 
cytosine, which will result in a 5mC-+ T transition mutation if not properly repaired 
(Shen et aL, 1994). An accumulation of these mis-repaired point mutations in the 
germ line of a species that contains DNA methylation would inevitably lead to a 
loss of cytosine content over evolutionary time. Regions containing methylated 
CpGs would lose cytosines and regions containing unmethylated cytosines would 
maintain an expected level of cytosine content. As the regional distribution of 
CpG and GC content is correlated in the genome, the basis for the chromosomal 
isochore structure may also be due to this mechanism (Fryxell and Zuckerkandl, 
2000). Theories of the evolution of GC content and isochores are controversial 
(Duret et aL, 2006), but it is generally thought that overall GC content has been 
decreasing in mammalian genomes (Belle et aL, 2004). The underlying reason 
for the correlation of regional CpG and GC depletion is unclear; however, the 
presence of non-CpG methylation in germ cells (Haines et aL, 2001; Imamura et 
aL, 2005) would permit the theory to apply to GC content generally. Previously, 
authors of one study have used the spontaneous deamination theory to conclude 
that the DNA methylation status of the germ cell genome is revealed by 
sequences enriched or depleted in CpG dinucleotides without generating any 
experimental evidence to support this assumption (Rollins et aL, 2006). 
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There are several points that support this theory. Firstly, CGls are a 
dramatic example of sequences with high CpG and GC content, and their 
constitutively hypomethylated state in both somatic and germ cells has been 
thoroughly demonstrated. Secondly, C~ T transitions at CpG sites represent 
approximately one-third of ail described mutations in humans and occur 18-fold 
more frequently than the mean of qther point mutations (Cooper and 
Youssoufian, 1988). Thirdly, it is widely-accepted that in somatic cells, 
heterochromatic regions are both depleted in CpG/GC content and highly 
methylated. Without any data to show otherwise, this pattern of methylation 
would be assumed to be the same for germ cells. 
Results from the experiments presented in this thesis clearly disagree with 
the underlying assumption that low GC regions are hypermethylated in germ 
cells. Not only are low GC regions less likely to contain methylation, regions that 
are supposed to be unmethylated because of their aboye-average GC content 
are actually more likely to be hypermethylated. This result makes spontaneous 
deamination of hypermethylated regions in the male germ line unlikely to be the 
cause of region-specifie CpG depletion. Although genome-wide patterns of DNA 
methylation are not known in female germ cells due to current technical 
limitations, female PGCs are demethylated early in germ cell development and 
methylation is not re-established until the oocyte growth phase. For the vast 
majority of the time the genome spends in the female germ line, it is likely that 
relatively little methylation is present. It seems reasonable to speculate that 
female germ cells are also unlikely to contribute to CpG depletion via 
spontaneous deamination caused by DNA methylation. 
An alternate theory to the spontaneous deamination theory that could 
explain the striking relationship between GC content, heterochromatin and DNA 
methylation involves reprogramming in PGCs. Recently, a new mechanism of 
active demethylation has been proposed that involves site-directed deamination 
of methylcytosines coupled to DNA repair (Walsh and Xu, 2006). In this 
mechanism, an endogenously encoded family of DNA mutases, the Apobec/AID 
proteins, originally described to function in defense of viral DNA through directed 
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mutation of cytosines (Sheehy et aL, 2002), is granted access to genomic DNA. 
Methylcytosines are mutated to thymine residues and are immediately repaired 
by thymidine DNA glycosylase (TDG) (Neddermann et aL, 1996) or MBD4 
(Hendrich et aL, 1999). The result is a net conversion of 5mC to cytosine 
providing the desired process of demethylation; however, in this mechanism, the 
slightest inefficiency in repair would introduce the possibility that 5mC residues 
would mutate to thymine. This process would occur every generation in both 
male and female germ lines presumably across the entire genome making the 
possibility of C--+ T transitional mutations at demethylated cytosines prominent. 
This alternate theory explains the striking relationship between GC content 
and DNA methylation in somatic cells. It has been shown that when PGCs enter 
the gonadal ridges, they retain a somatic pattern of DNA methylation at single 
COpy genes and repeats (Hajkova et aL, 2002; Maatouk et al., 2006). The 
pattern in these cells would also presumably retain the characteristic somatic 
pattern of hypermethylation of heterochromatic regions of below average GC 
content and hypomethylation of regions of high GC content. Thus, genome-wide 
demethylation of methylated heterochromatic regions would inevitably lead to a 
loss of CG content in these regions and not in above-average GC regions. 
ApobeclAID proteins also catalyze the deamination of cytosine to uracil, which 
may explain the regional association between CpG depletion and low GC 
content. The ability of PGCs to direct widespread active demethylation has been 
described (Tada et al., 1997), although the mechanism of active demethylation is 
unknown. Demethylation in these cells is likely to occur via a directed 
deaminationrr -G repair pathway as mice deficient in the only reported 
demethylase that directly removes the methyl group from cytosine, MBD2 
(Bhattacharya et al., 1999), develop normally and are fertile (Sansom et al., 
2003). 
Although these two theories are not mutually exclusive, there are a few 
lines of evidence that support the directed deaminationrr-G repair theory over 
the spontaneous deamination theory. Firstly, in a study on mouse cells, it was 
noted that C--+ T transitions occur non-randomly (Steinberg and Gorman, 1992). 
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They found that a surprisingly high number of aile les that had a C-+ T mutation 
carried an additional C-+ T transition originating from a nearby CpG nucleotide. 
When both mutations were present they were always on the same allele, 
affecting CpG dinucleotides that were always on the same DNA strand. 
Furthermore, the second mutation was never observed in the absence of the first 
mutation. These observations are very difficult to reconcile with current views of 
spontaneous deamination, as mutations in this theory should occur randomly. 
Whereas it is possible that in a mechanism that involves a local repair process, if 
repair at one CpG is not performed, a neighbouring CpG may be similarly 
affected. Secondly, male germ cells re-establish methylation in their genomes 
very soon after it is removed. This is in stark contrast to the female where DNA 
methylation is not re-established until just prior to fertilization. Thus, male germ 
cell genomes spend much more time in a methylated state than the female germ 
cells per generation. Because the Y chromosome exclusively dwells in the male 
germ line compared to the X chromosome that occupies the male germ line only 
one-third of the time, the spontaneous deamination theory would predict that the 
y chromosome would be more GC-depleted. However, these two chromosomes 
have equally depleted levels of both GC content and CpG ratios (Fazzari and 
Greally, 2004). 
6.1.3 Potential Roles for the Distinct Pattern of DNA Methylation in Male 
Germ Cens: Gene Expression versus Chromatin Organization 
Although the role of DNA methylation in the direct control of gene 
expression is controversial (Baylin and Bestor, 2002), there are a few genes that 
are clearly governed by DNA methylation in their 5' regions. Interestingly, most 
of these genes are exclusively expressed or are highest-expressing in the testis 
(MacLean and Wilkinson, 2005). This is consistent with the findings presented in 
this thesis, where the few genes that demonstrated a strong correlation between 
hypomethylation of 5' regions and increased expression were hypomethylated 
only in the testis. Surprisingly, a much higher proportion of 5' regions and CGls 
were differentially methylated between somatic tissues; however, none of these 
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demonstrated the highest level of expression in the tissue that was 
hypomethylated. Confusingly, sorne of these genes demonstrated the opposite 
correlation: several somatic-specific differentially methylated genes that 
contained CGls were morehighly expressed in the tissues in which they were 
most highly methylated. This high methylation/high expression relationship has 
recently been noted for other somatic tissues (Eckhardt et aL, 2006) and in 
cancer (Ordway et aL, 2006). Sorne testis-specific genes also demonstrate this 
inverse correlation (Choi et aL, 1997; Muller-Tidow et aL, 2001; Trasler et al., 
1990). The purpose or mechanism behind this phenomenon is unknown. 
One of the primary functions of DNA methylation is the suppression of 
transposable element activity (Bestor and Tycko, 1996; Walsh et aL, 1998). We 
find that transposable elements are gen~rally methylated in ail tissues examined. 
Interestingly, we find that a significant proportion of the sites that are 
hypomethylated in the testis are of repetitive origin. These repeat elements are 
almost exclusively from small' solitary L TRs that belong to class Il and class III 
L TR repeats. These sequences are missing key elements required for 
retrotransposition, thus would not be expected to be expressed. Many other 
types of repeats were investigated in the course of these studies, and these were 
the only repeats to demonstrate this property. 
Solitary L TRs occur in high frequency in the genome. They are remnants 
of a transposition event where homologous 5' and 3' L TRs are paired and 
recombined, removing the viral sequence as a circular piece of DNA and leaving 
behind an intact L TR. This obviously renders the retrovirus inactive; however, 
the remaining L TR retains promoter activity. Unmethylated solitary L TRs can 
thus recruit RNA polymerase and initiate transcription producing novel and 
modified transcripts. Genome-wide demethylation of solitary L TRs in germ cells 
would have a broad effect on transcription. Although the level of expression of 
these sequences in male germ cells is not currently known, these particular 
repeats are known to compose significant proportions of the total transcript 
population in female germ cells and early embryos (Peaston et aL, 2004). This 
study demonstrates that the activity of L TR elements found upstream of genes or 
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within introns produces alternative transcripts in these cells. Sorne are translated 
into novel proteins. When considering that these cells may have a non-somatic 
pattern of DNA methylation, it is unclear whether the transcription of these 
sequences is causal or secondary to a change in chromosome structure. It has 
been argued that the unmasking of these L TR-driven promoters may provide a 
global regulatory network that shifts the overall transcription profile in these cells 
(Shapiro, 2005). An alternative argument is, due to the fact that the majorityof 
these transcripts are degraded and/or blocked from translation, this transcription 
is a consequence of a primary reorganization of chromatin structure. These 
transcripts are tolerated because of the benefit an alternative chromosome 
structure provides for germ cell-specific processes. 
Due to the fact that the RLGS technique investigates randomly positioned 
Notl sites, the methylation status of a variety of sites inside and outside of genes 
is investigated. This novel approach to investigating methylation in male germ 
cells has revealed that despite the RLGS technique being biased towards 5' 
regions and CGls, we have found that there are more sites that are differentially 
methylated away from these regions th an what would be expected at random 
(P=1 x1 0-17). The methylation status of non-5' sites that are found in the vicinity 
of genes (body & 3') is not representative of the expression status of the gene. 
This. simple observation about the distribution of differentially methylated sites 
makes the argument that there are additional roles for DNA methylation other 
than gene expression. 
Non-CGI loci are most commonly differentially methylated in the testis 
compared to other tissues. Germ cells are known to retain highly specialized 
chromosomal structures that occur during meiosis and during spermiogenesis in 
the male. Compared to somatic chromosomes, meiotic chromosomes have a 
different ultra-structure (Fang and Jagiello, 1981). Somatic chromosomes have a 
distinct hetero/euchromatic structure that serves to promote transcriptional 
activity in specifie regions and repress activity in others. In addition to this 
function, meiotic chromosomes must maintain a structure that permits 
homologous pairing, recombination and reduction to haploid cells. During 
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meiosis, complex and unidentified processes direct sorne sequences to 
associate with the synaptonemal complex and others to the intervening 
chromatin loops that are not complexed with the core (Moens et aL, 1998). A re-
configuration of the methylation pattern in germ cells may be an attempt to 
position sorne genomic regions for either loop-specific or core-specific 
interactions. Another possibility is that hypomethylation of low GC regions that 
are normally heterochromatic and hypermethylation of aboye-average GC 
regions functions to provide a uniform linear configurational status of the 
chromosome. This may be necessary so that sequences are available for pairing 
along the entire chromosome and not just in less-condensed, euchromatic 
regions. 
Another possible role for the unique pattern of DNA methylation in germ 
cells involves controlling the association of chromatin with the nuclear matrix. 
The nuclear matrix is intimately associated with the organization of chromatin into 
functional and non-functional compartments of the nucleus. Interactions between 
chromatin and nuclear matrix proteins occur in regions of DNA called 
scaffold/matrix attachment regions (S/MARs) (Boulikas, 1993). S/MARs are 
distributed throughout the genome and are usually found in conserved non-
. 
coding regions (Glazko et aL, 2003). The discovery that MeCP2, a protein that 
specifically binds to methylated DNA, associates with known nuclear matrix 
proteins has provided a link between the methylation state of DNA and 
interactions with the nuclear matrix (Weitzel et aL, 1997). Data presented in this 
thesis suggest the possibility that the methylation status of potential S/MARs may 
play a role in the re-organization of chromatin architecture. 
Data presented in this thesis demonstrates a role for DNA methylation in 
male germ cells outside of 5' regions of genes. Several possible roles in 
connection with the modulation of chromatin structure have been discussed, 
such as the modulation of loop versus core interactions, nuclear matrix 
interactions and control linear configuration of the chromatin for homologous 
palnng. Future studies could specifically target sequences known to be 
associated with these phenomena and study both the DNA methylation status 
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and the chromatin marks in the form of various histone modifications. For 
example, DNA that associates with the chromatin loops versus DNA associated 
with the synaptonemal complex can be isolated individually (Moens et aL, 1998). 
The DNA methylation status and the histone modifications present could be 
determined for these two groups of sequences. Furthermore, the behavior of 
these sequences in a model of abnormal synapsis, such as the Dnmf3L-deficient 
model, could be assessed. 
It is very difficult to assess whether germ cell-specific transcription or a 
reorganization of germ cell chromatin structure is in the dominant purpose for the 
highly distinct genomic pattern of DNA methylation in male germ cells. These 
two purposes are not mutually exclusive; changes in transcription and changes in 
chromatin structure are clearly co-dependent. If promoters of testis-specific 
genes are found in regions of the genome that are hypomethylated in the testis, 
they are likely to have an increased potential for transcription. In support of this 
connection, testis-specific genes in the mouse and human genomes are found to 
be clustered at a higher frequency than by chance alone (Li et aL, 2005). 
Regional changes in chromatin structure may facilitate the clustering effect. In a 
recent study of the transcriptional profile of developing oocytes, a time where 
DNA methylation is being acquired and reorganization of chromatin is 
presumably taking place, it was found that the most significant predictor of a 
change in the transcription of a particular gene was the chromosomal region in 
which the gene was located (Pan et aL, 2005). On average, genes located within 
a particular chromosomal region demonstrated either increased or decreased 
activity concurrently. As it is unlikely that that the majority of ail of the genes in a 
particular region are required to be activated or inhibited for oocyte growth 
specifically, this suggests that regional changes in chromatin structure occurring 
in the acquisition phase of oocyte maturation is having an influence in ove ra Il 
transcription in these regions. Finally, we have found that approximately half of 
ail testis-specific genes that are hypomethylated in the testis are positioned 
within 3-4 Mb of hypomethylated sequences found by RLGS. As transcriptional 
activation in the testis of these specific genes are unlikely to influence the 
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chromatin structure of DNA several Mb distant, large-scale regional changes may 
be influencing the transcriptional capacity of these genes in the testis. 
6.2 Establishment of DNA Methylation Patterns in Germ Cells 
The findings in this thesis further define the timing of the acquisition of the 
unique pattern of DNA methylation in germ cells. Although it is regarded that 
male germ cell DNA methylation patterns continue to be acquired after birth up 
until the pachytene phase of spermatogenesis, progressive acquisition of DNA 
methylation has reliably been shown for a single locus, the imprinted gene H19 
(Davis et aL, 1999; Ueda et aL, 2000). Furthermore, in these studies it is only a 
proportion of methylation on the maternai allele that has not fully been 
established prior to spermatogenesis. The two other patemally-methylated 
imprinted genes, Rasgrf1 and Gt/2, have been studied and may not have 
acquired their fully-methylated status before birth (Li et aL, 2004); however, it is 
not clear whether the acquisition of DNA methylation occurs during 
spermatogenesis. Ali other sequences studied have acquired the methylation 
status by birth that is achieved by the pachytene spermatocyte stage. This begs 
three questions: 1) to what extent are patterns of DNA methylation being 
acquired during spermatogenesis? 2) Are only imprinted genes acquiring DNA 
methylation during spermatogenesis, or are other sequences involved? 3) What 
is the relationship between the amounts of methylation being acquired during 
spermatogenesis and the amount of DNA methylation being acquired before 
birth? Until now, ail these questions remained largely unexplored. 
Studies completed in this. thesis provide data that addresses ail three 
questions. Clearly, acquisition of DNAmethylation occurs at several sequences, 
supporting and extending the previous findings on H19. Aiso in a similar fashion 
to the previous finding, these changes are almost always complete by the 
pachytene spermatocyte stage. Data presented in this thesis also shows that 
pattern acquisition involves demethylation of specifie sequences, a result not 
previously shown. We have shown that there are regions of the genome beyond 
imprinted genes that progressively acquire DNA methylation in male germ cells. 
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Although it has not been exhaustively tested to ensure that these regions 
displaying novel DNA methylation patterns are not imprinted in ail tissues, 
patterns of methylation of these regions in Iiver, intestine, brain, testis and 
spermatozoa do not show the characteristic methylation behavior of imprinted 
regions. We have also shown that only a minority of sequences in the genome 
participate in pattern acquisition during spermatogenesis, determined by the 
similarities of DNA methylation between spermatogonia and spermatozoa. 
Depending on the method used, partial acquisition of DNA methylation is 
detected in less than 10% of sequences. Although the data presented in this 
thesis are vastly more extensive than the studies done previously, only a minority 
of the genome is interpreted. Future studies employing tiling array technology 
will be able to interpret a larger proportion of the genome. 
6.2.1 The Purpose for the Timing of Pattern Acquisition 
Although the numbers of identified sites are low, there seems to be a 
connection between the types of modified sequences in spermatogenesis and 
the unique state of DNA methylation in the testis as compared to somatic tissues. 
The changes are both more Iikely to occur in non-CGI, non-5' regions. Also, a 
few of the solitary L TR sequences, a group of sequences that are that are 
hypomethylated in the testis, are in the process of demethylation during 
spermatogenesis. This supports the theory that these changes may represent 
the final modifications of changes to the chromatin structure before entry into 
meiosis (discussed in chapter IV). 
The majority of modifications of DNA methylation are made during the 
fetal developmental window compared to those made during spermatogenesis. 
Establishment of DNA methylation patterns during fetal development precedes 
the creation of the spermatogonial stem cell population. Due to the heritability of 
established DNA methylation patterns, this strategy would necessitate the 
establishment of patterns at only a single time during development instead of 
during each wave of spermatogenesis. This strategy is more efficient and less 
prone to error, as exogenous influences such as exposure to toxins and 
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fluctuations in nutrient availability could affect the ability to continually establish 
patterns during adult life. This may be partly the reason why other than the 
limited number of sequences that gain their methylation early in 
spermatogenesis, other spermatogenic processes, such as meiotic divisions and 
spermiogenesis, are not associated with modification to DNA methylation 
patterns. 
A few studies on the testis-specific gene, Pgk-2, have observed a post-
meiotic hypermethylation event (Ariel et aL, 1991; Kafri et aL, 1992) that was 
later recognized to specifically occur during epididymal transit (Ariel et aL, 1994; 
Geyer et aL, 2004). Although this gene was not included in our study, we do not 
observe any modifications to the pattern of DNA methylation in this late 
developmental window. Based on the sequences investigated here, the 
occurrence of a global epigenetic reprogramming event occurring in the post-
meiotic stages of spermatogenesis (Geyer et aL, 2004) is not supported byour 
data. 
6.3 Perturbation of DNMT Function and Male Germ Cell DNA Methylation 
Recent studies have established that the perturbation of DNMT function 
specifically in male germ cells results in catastrophic effects. Knock-out of 
Dnmt3L and the germ cell-specific conditional knock-out of Dnmt3a results in a 
complete loss of male germ cells in adult mice (Bourc'his et aL, 2001; Hata et aL, 
2002; Kaneda et aL, 2004). Although this underscores the importance of DNA 
methylation in male germ cells, the lack spermatogenesis in these models makes 
studying the germ cells from these models problematic. In this thesis, we have 
taken two approaches to ascertain the effect of perturbations DNMT function to 
germ cell methylation. Firstly, as described in chapter III, we have taken 
advantage of the difference in the timing of the defect and the resulting effect in 
the Dnmt3L model. The Dnmt3L gene is highly expressed during late fetal 
development; however, Dnmt3L-deficent germ cells survive through this 
developmental window until they undergo apoptosis after birth during the 
spermatocyte stages of spermatogenesis (Bourc'his and Bestor, 2004). Isolation 
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of spermtogonia from Dnmt3L-deficient post-natal mice allows for the atlainment 
of germ cells that have been perturbed by the absence of the DNMT3L protein, 
but have not yet begun to undergo the secondary effects associated with cell 
death. A second strategy, described in chapter V, is the treatment of male mice 
with 5-azaCdR, a general inhibitory agent of DNMT function. Although sufficient 
doses of this drug can cause a full disruption of spermatogenesis (Doerksen et 
aL, 2000; Doerksen and Trasler, 1996; Kelly et aL, 2003), the use of a lesser 
d,?se permits for the production of spermatozoa; yet, the spermatozoa have 
developed in the presence of the drug. These studies allow for the assessment 
of the effects of DNMT perturbation on sperm function, sperm quality and ability 
of sperm to support embryonic growth. In addition, alterations in germ cell DNA 
methylation that are associated with perturbations of DNMT function can be 
measured. 
6.3.1 Dnmf3L-Deficient Male Germ Cells 
ln Dnmt3L-deficient germ cells, patemally-methylated imprinted genes are 
hypomethylated to varying extents; however, it is unclear how methylation 
changes at these few loci could result in such catastrophic, genome-wide effects. 
Two studies have produced additional data showing that male germ cells 
deficient in Dnmt3L demonstrate demethylation of interspersed transposable 
elements (Bourc'his and Bestor, 2004; Hata et aL, 2006). This has led the 
authors to conclude that the genome-wide meiotic structural failure is the result of 
the expression of these elements that leads to a destabilization of the genome. 
The non-homo logo us synapsis that characterizes meiotic prophase in Dnmt3L-
deficient spermatocytes may result from: 1) a perturbation of meiosis-speciflc 
gene expression; 2) single-strand or double-strand breaks produced during 
replicative retrotransposition; and/or, 3) iIIegitimate interactions between 
dispersed repetitive loci that were unmasked by demethylation (Maloisel and 
Rossignol, 1998). The studies presented here, in combination with other recent 
findings (La Salle et aL, 2007), clearly demonstrate that in addition to the 
hypomethylation of imprinted and transposable element loci, undermethylated 
235 
loci include non-imprinted, non-repetitive sequences. This suggests a fourth 
possibility: the testicular DNA methylation pattern is not being acquired on a 
genome-wide scale, which may lead to an inability to maintain a chromosomal 
structure that permits proper homologous pairing interactions. This fourth 
possibility does not exclude the other possible reasons of the meiotic failure, as 
the failure may be a cumulative effect involving other causes, such as an 
alteration of expression of a key meiotic gene. 
6.3.2 5-AzaCdR Treatment 
. Previous studies have demonstrated that 5-azaCdR has a robust effect on 
the development of male germ cells (Doerksen et aL, 2000; Doerksen and 
Trasler, 1996; Kelly et aL, 2003). These studies compose the only series of 
experiments that have shown that perturbing DNMT function using a method 
other than gene-targeting directly affects the development and function of male 
germ cells. Data presented in this thesis furthers the knowledge of these studies, 
demonstrating that sperm produced in the presence of 5-azaCdR are of reduced 
quality. This reduced quality includes decreased motility and fertilization ability, 
abnormal morphology and a reduced ability to support embryonic growth. These 
studies firmly establish that in addition to causing a reduction in the number of 
germ cells produced, the male germ cells that survive 5-azaCdR treatment are 
functionally non-equivalent. These experiments also further demonstrate the 
interesting protective aspects of reducing the amount of functional DNMT1 levels 
in the prevention of sorne decreases in sperm function. 
Previous assessment of spermatozoa in 5-azaCdR-treated animais found 
a dose-dependent decrease in global levels of DNA methylation that was 
correlated with a dose-dependent increase in testicular abnormalities. Effects on 
germ cells were noticed at lower doses before significant decreases in global 
methylation could be detected. These results beg three questions: 1) are 5-
azaCdR-dependent modifications occurring at lower doses, but are undetectable 
using a global assay? 2) If 5-azaCdR is causing a modification of DNA 
methylation, what specific loci or sequence-types are affected? 3) Are 
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abnormalities . in germ cell function caused by alterations in germ cell DNA 
methylation or by other effects of the drug such as covalent adduct formation? 
The dose of 5-azaCdR used in this study corresponds to the lowest dose 
used in previous studies (Kelly et al., 2003). Significant differences in DNA 
methylation between treated and non-treated animais were not observed at the 
global level using the TLC assay despite adverse testicular effects detected at 
this dose in these studies and those previously done. In this study, using the 
more sensitive and comprehensive RLGS technique, sorne differences were 
observed. However, differences represented only a very minor proportion of the 
sequences investigated by RLGS, in part supporting the lack of a significant 
decrease in global methylation found by the TLC assay. Sequences known to 
remain unchanged include ail the interspersed transposable elements visible on 
the RLGS and the repetitive elements investigated using Southem blots. 
The low dose of 5-azaCdR selectively causes an inhibition of de nova 
methylation activity, resulting . in the specifie hypomethylation of loci in 
spermatozoa that normally gain methylation during spermatogenesis. The 
plethora of sites of the genome that maintain their methylation indicates that 
maintenance methylation activity, generally thought to be performed by DNMT1, 
remains sufficiently uninhibited and continues to maintain methylation. Sorne 
sites are also normally demethylated during spermatogenesis, and this process 
was found to proceed unabated. This is consistent with demethylation occurring 
via a passive mechanism, although it is not known if 5-azaCdR would inhibit an 
active demethylation processes. The selective action of the drug most likely 
occurs because de novo and maintenance activities are provided by separate 
enzymes (DNMT3a and DNMT3b versus DNMT1 ) and, for reasons that are 
unclear, de novo enzyme activity is more sensitive to the drug. 
5-azaCdR causes both DNA hypomethylation and DNMT-DNA adducts 
(Juttermann et al., 1994). These studies suggest that adduct formation 
contributes more to adverse effects to male reproduction than does DNA 
hypomethylation. The future development of DNMT inhibitory agents that do not 
cause the formation of adducts will be of great assistance in elucidating the exact 
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role played by alterations of DNA methylation in the generation adverse 
reproductive effects. 
To our knowledge, the selective nature of 5-azaCdR has not been 
previously described. This discovery was made possible by observing the effect 
of the drug in a system where developmental modifications of DNA methylation 
of specific loci are known to occur. It would be interesting to know if the selective 
action of the drug is restricted to germ cells or if it causes a similar effect in other 
tissues, namely in the hematopoetic system. The current primary indication for 
the clinical use of 5-azaCdR is for the treatment of myelodysplastic syndromes. 
Selective inhibition of de nova methylation might contribute to the drug's known 
anti-cancer properties. It is possible that the beneficial anti-cancer effects of 5-
azaCdR involve the prevention of de novo methylation of tumor suppressor 
genes in pre-cancerous cells in addition to its cytotoxic effects. 
These studies also raise the possibility that due to evolving patterns of 
DNA methylation during spermatogenesis, male germ cells may be especially 
sensitive to potential 'epimutations'. It has been demonstrated that disruptions in 
epigenetic programming of germ cells during the fetal developmental window can 
lead to effects in progeny of the next generation (Anway et al., 2005; Anway and 
Skinner, 2006; Chang et aL, 2006). This is possibly the result of an inhibition of 
the acquisition of germ cell epigenetic patterns that normally occurs in fetal 
development. Work presented in this thesis demonstrates that epigenetic 
patterns in male germ cells continue to be acquired beyond the pre-natal window; 
similar disruptions may occur in the reproductive life of the individual. This raises 
the possibility that offspring could be affected by environmental insults via 
alterations in germ cell epigenetic states. Several genomic loci are demethylated 
in the male pro nucleus shortly after fertilization (Oswald et aL, 2000) which would 
prevent the transmission of paternally-derived epimutations; however, the full 
extent of the demethylation is not known. Paternally-methylated imprinted genes 
retain their methylation status throughout preimplantation embryonic 
development (Reik et aL, 2001), demonstrating that sorne r~gions of the genome 
are not demethylated. Further studies will be required to test if environmental 
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influences experienced during the adult life of the male can affect progeny via an 
alteration in the epigenetic program of the offspring. 
Ali past and current methods used for the purpose of isolating large 
numbers of different types of spermatogonial cells require their isolation from pre-
pubertal testis during the first wave of spermatogenesis. This is due to technical 
limitations combined with the small proportion of early spermatogenic cells in the 
adult testis. There is a concern that the spermatogonial cells isolated from the 
first round of spermatogenesis, due to the immature state of the testis and the 
lack of later stages of germ cells, are distinct from spermatogonial cells in adults 
(Jahnukainen et al., 2004). As almost ail studies to date that have analyzed 
molecular aspects of these early spermatogenic cell types employ the use of pre-
pubertal mice, there is a concern that data generated on these spermatogonia 
are not representative of adult spermatogonia. Our studies suggest that pre-
pubertal and adult spermatogonia are of roughly equivalent maturity in their stage 
of acquisition of DNA methylation. The pattern of DNA methylation observed in 
spermatogonia isolated from pre-pubertal mice and the modifications that result 
from 5-azaCdR treatment of adult mice are highly correspondent. This result 
suggests that spermatogonia in adult mice retain a very similar pattern of DNA 
methylation to their pre-pubertal counterparts. This result also supports the 
concept of an early establishment of a spermatogonial stem cell population and 
that most germ cells in the pre-pubertal testis are progressing through 
spermatogenesis (Yoshida et al., 2006). 
6.5 Implications of the Findings and Future Considerations 
There are many questions that are raised by the experiments do ne in this 
thesis. Although it would be impossible to discuss ail the potential implications of 
this work, 1 will highlight and elaborate on three concepts that 1 think are the most 
important. 
6.4.1 Sequence-Specifie Targeting of DNA Methylation to Genomic Loci 
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At several times during mammalian development, distinct cell type-specifie 
epigenetic patterns are established. Data presented in this thesis in combination 
with the work of others firmly establishes that distinct patterns of DNA 
methylation occur on a genome-wide scale in various somatic, germ and 
embryonic cells. These results highlight the most fundamental unanswered 
question in the field of epigenetics: how is DNA methylation specifically targeted 
to distinct genomic loci. The enormous size and number of sequence types in 
the genome makes the task of accu rate genome-wide reprogramming 
exceedingly complex. 
There are several different possible mechanisms that may contribute to 
various extents to allow for site-specifie DNA methylation to be either maintained 
or changed during a reprogramming event. Firstly, it is possible that sorne 
tissue-specifie DNA methylation is simply the result of gene activity. In this 
mechanism, the gene products required for the function of a particular cell type 
drive the modifications to the epigenetic state of the DNA. The epigenetic 
modifications that are then established in any cell type, due to their heritable 
nature, in turn provide a stable environ ment for the long existence of a 
differentiated cell lineage. The information for the establishment of gene-specifie 
epigenetic marks is provided by higher-order gene regulatory networks, perhaps 
stimulated by cellular environmental eues or developmental timing. Site-specifie 
DNA methylation is the result of RNA polymerase, transcription factors, 
enhancers and repressor proteins complexed with DNA in a sequence-specifie 
manner. These proteins may enhance or block the access of the DNA 
methylation machinery to DNA. This is unlikely to be a primary mechanism due 
to the fact that genes and regulatory sequences compose a very small proportion 
of the total genomic sequence, and here we have demonstrated extensive 
reprogramming in non-genic regions. 
A second possible mechanism that may be involved in the direction of 
site-specifie DNA methylation involves relationship to the other epigenetic factor, 
histone modifications. The multitude of histone modifications provide a multi-
layered structure to the information encoded in chromatin. Thus, when 
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methylation is observed to be established in a sequence-specifie manner, this 
sequence specificity may be a reflection of an epigenetic state maintained by one 
or more of these other modifications. Evidence for this cornes from the allele-
specificity of the timing of establishment of DNA methylation marks on imprinted 
genes in both male and female germ cell development. Imprinted alleles that 
originate from the parent that is the opposite sex to the embryo acquire their 
methylation later than alleles that come from the parent of the same sex as the 
embryo (Davis et al., 1999; Hiura et al., 2006; Lucifero et al., 2004). In these 
studies, alleles exhibit 'epigenetic memory' of a previous programmed state. 
Although experiments have not been done to explore the mechanism of allelic 
epigenetic memory in these cases, it is possible that chromatin conformations, 
most likely dictated by histone modifications, persist through the reprogramming 
phase. It is abundantly clear that future studies will have to evaluate multiple 
epigenetic factors in order to fully understand the process of site-directed DNA 
methylation that occurs during reprogramming. 
A third interesting candidate for sequence-specifie targeting of DNA 
methylation involves small RNA molecules. The emerging field of RNA 
interference describes how small single and double stranded RNA molecules 
perform previously uncharacterized key roles in cellular biology which mainly 
include gene regulation at both transcriptional and post-transcriptional levels 
(Bayne and Alishire, 2005). Small RNA molecules can target other RNA 
molecules using sequence homology-dependent interactions which can lead to 
RNA degradation, sequestration, stabilization or translational blocking. It has 
also been shown that these RNA-dependent targeting complexes can induce 
repressive chromatin conformational changes when homologies are targeted to 
DNA sequences (Lippman and Martienssen, 2004). This has been weil 
characterized in severa 1 plant species and lower organisms. Although the 
existence of this process is currently controversial in mammals, RNA-based 
chromatin targeting based on sequence homology is an appealing mechanism 
that may prove to be a major force in site-specifie direction of DNA methylation. 
The defined timing and sequence specificity of the acquisition of DNA 
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methylation in male germ cells, as iIIustrated in the studies presented here, 
makes male germ ce Il devélopment a useful system to explore these 
mechanisms. 
6.4.2 Developmental Dimorphism between Female and Male Germ Cells: 
Relationship to Epigenetic Patterns 
The primary question that is raised by the work done in this thesis is the 
purpose of the unique pattern of DNA methylation in male germ cells. Why does 
the somatic pattern have to be changed? Slightly different versions of the same 
somatic pattern are used by several different types of somatic tissues. 
Furthermore, germ cells arrive at the gonadal ridges with a somatic pattern 
before they are reprogrammed. It would appear to be much simpler for male 
germ cells to use this pattern and to not have evolved mechanisms for the 
erasure and re-establishment of a distinct new pattern. Therefore, one must 
presume that the re-established pattern must serve an important purpose. We 
have suggested that meiosis is a plausible purpose because it is unique to germ 
cells, involves genome-wide changes in chromosomal configurations, 
modifications to the pattern occur prior to meiosis and the perturbation of the 
genome-wide pattern leads to meiotic failure. 
One way to further explore the relationship between patterns of DNA 
methylation is to study the patterns in oocytes. If the patterns were similar, it 
would further support the hypothesis that the patterns are important for meiosis. 
Although current technical limitations do not permit genome-wide analyses to be 
done on oocytes, there is a strong indication that patterns of DNA methylation in 
meiotic male and female germ cells are different. As mentioned previously, while 
male germ cells re-establish their methylation patterns preceding meiosis, female 
germ cells enter meiosis shortly after being demethylated, and do not reacquire 
methylation until later on during oocyte growth. Thus, male and female germ 
cells undoubtedly have different patterns of methylation at meiotic entry and 
during meiotic prophase 1 where the important processes of chromosomal 
condensation, pairing and recombination occur. In Dnmt3L-deficient mice, male 
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germ cells undergo meiotic failure that results from a lack of methylation 
establishment; however, at the equivalent phase of meiosis, female germ cells 
are yet to acquire methylation and proceed unabated through meiosis. 
Therefore, the question is: why can female germ cells proceed through meiosis in 
a demethylated state, whereas, in the case of Dnmf3L-deficient male germ cells, 
demethylated male germ cells fail during meiotic passage? The answer may 
relate to the dimorphism in the events that occur between male and female germ 
lines. As a result, the purpose of the configuration of the male germ cell pattern 
may not be solely meiosis. 
The purpose for the evolution of the striking dimorphism between the 
timing of male and female epigenetic reprogramming is unclear. Understanding 
the basis of this dimorphism is key to the understanding of the roles of DNA 
methylation in the germ cells of both sexes. One possible explanation of the 
differences in the timing of reprogramming and meiosis is to consider the 
functional commonalities and differences between the germ lines. The germ 
cells of both sexes need to accomplish three fundamental processes: 
1) Genomic reprogramming 
2) Recombination 
3) Functional differentiation into fertile gametes 
ln addition to these processes, males need to perform a critically important extra 
function: 
4) The production of a vast, perpetuai supply of gametes 
While females produce relatively few mature gametes throughout their 
reproductive lifespan, males will produce millions to billions fold more. This 
requirement has placed strong evolutionary pressure on the male germ line to 
evolve a more complex developmental process to facilitate this necessity. Higher 
output of male gametes is achieved through an expansion of the germ cell 
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population not seen in the female germ line. Meiosis is reductive (no new DNA is 
synthesized after the pre-Ieptotene stage); therefore, the expansion must occur 
mitotically preceding meiotic entry. Fetal testicular resources would obviously 
not be able to support such an expansion, thus, germ cell amplification must 
occur in the adult. In addition to the inclusion of an expanded mitotic window into 
male germ cell development, the perpetuai supply of male germ cell precursors 
are provided by the creation of a pool of spermatogonial stem cells that fuels the 
mitotic expansion. Thus, meiosis in the male is delayed until the testis has 
developed and a suitable pool of spermatogonial stem cells and mitosis have 
expanded the germ ceU population. 
It is possible that gamete output is the primary reason for the differences 
in the timing and reordering of the events in the male versus female germ lines 
(Figure 6.1). Although gamete differentiation is strikingly different between male 
and female, it is unclear why this would necessitate a rearrangement of events. 
Genomic reprogramming is reordered to occur before the creation of the stem 
cell pool for purposes of efficient and reliable establishment of the epigenetic 
program. A post-reprogramming mitotic expansion of the germ cell pool requires 
that the epigenetic program needs to be dually compatible for mitosis and 
meiosis; relatively little modification in DNA methylation occurs between the 
mitotic and meiotic phases. Compared to female germ cells, male germ cells 
must provide the means for maintenance of methylation patterns as weil as their 
initiation. By comparing the differences· in the complexity between female and 
male germ lines, it appears that meiosis may not be the sole purpose of the' 
epigenetic pattern in male germ cells. A detailed comparison of the patterns of 
DNA rnethylation in female and male germ cells will be of the utmost importance 
to the understanding of the roles of DNA methylation in germ cells. 
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6.4.3 The Role of the Paternal Epigenetic Pattern in Embryonic 
Development 
There is one possible role for the distinct pattern of DNA methylation in 
male germ cells that has yet to be discussed: the role of paternal epigenetic 
information in mammalian embryonic development. It is generally thought that ail 
gametic epigenetic information is erased during preimplantation development 
and de nova patterns are re-established for ail of the embryonic lineages, erasing 
any gametic patterns. The only current exceptions to this rule are the imprinted 
genes. As there are very few imprinted genes that are paternally-methylated, 
there is not much current evidence for paternal epigenetic contributions to the 
embryo. The active demethylation of the male pronucleus shortly after 
fertilization reduces the likelihood even further, preventing paternal epigenetic 
information from contributing to the development of preimplantation embryos. 
Despite the lesser possibility of a contribution to the embryo, there is sorne 
evidence to support the concept of gametic epigenetic information being 
important for the development of the extraembryonic lineages. Several studies 
have described vast differences in epigenetic patterns between the 
extraembryonic lineages derived from the trophectoderm (TE) and the embryonic 
lineages derived from the inner cell mass (ICM) of the blastocyst (Chapman et 
aL, 1984; Rossant et aL, 1986). This is likely to be the result of genomic 
reprogramming occurring selectively in the ICM and not in the TE during the 
development of the blastocyst. The methylation status of sorne DNA sequences 
in extraembryonic tissues resembles germ cell methylation patterns, such as the 
demethylation of major and minor satellite centromeric repeats (Sanford et aL, 
1984), sequences that are hypermethylated in ail other tissues tested. 
ln addition to the similarities between germ cell and extraembryonic 
methylation patterns, paternal-specific epigenetic information selectively survives 
into the extraembryonic versus the embryonic lineages. The best current 
evidence of this involves the epigenetic status of the paternal X chromosome in 
XX embryos. In ail extraembryonic lineages of the XX embryo, only the paternal 
X chromosome is inactivated. The pre-programmed inactivation arises from the 
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inactivation of the X chromosome during XV-body formation during meiosis in the 
male germ line (Huynh and Lee, 2003; Namekawa et aL, 2006). The 
transmission of the patemally pre-programmed inactivated state is of great 
importance because XX embryos that inherit a patemal X chromosome that 
carries a disrupted Xist gene, the gene responsible for the initiation of X-
inactivation in cis, are unable to inactivate a matemally inherited wild-type copy 
of the X chromosome (Marahrens et aL, 1997). This leads to a failure of X 
chromosome dosage compensation in the extraembryonic tissues. Another key 
piece of evidence supporting a patemal epigenetic contribution to the 
extraembryonic tissues relates to founding work in the field of mammalian 
epigenetics. Diploid mouse embryos with two male pronuclei (biparental 
androgenotes) develop differently than embryos with two female pronuclei 
(biparental gynogenotes) with respect to the extent of the development of 
embryonic versus extraembryonic tissues (Sarton et aL, 1984; McGrath and 
Solter, 1984). Extraembryonic tissue development is very limited in 
gynogenotes; whereas, extraembryonic lineages develop relatively weil in 
androgenotes. This clearly demonstrates that not only does patemal-specific 
epigenetic information survive the period of demethylation that occurs shortly 
after fertilization, but that the patemal epigenetic pattem is important for normal 
development. Future studies addressing the behavior of parent-specifie 
epigenetic information in early embryonic development will provide key insights 
into the understanding of genomic imprinting, cell lineage selection, and the 
mechanisms of embryonic and extraembryonic tissue development. 
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Figure 6.1: Diagram of the order of key events that occur in male and 
female germ lines. 
Female germ line: 
(simple) 
Male germ line: 
... 
birth 
1 
1 
1 
(complex) .. 
(_OnHdeprDgr~mingH reprogramnûng 1 
1 reprogramming 1 -+ 
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ORIGINAL CONTRIBUTIONS 
1. Site- and region-specifie levels of DNA methylation can accurately and 
quantitatively be determined by using a strategy of combining methylation-
sensitive and methylation-dependent restriction enzymes combined with real 
time PCR. 
2. The methylation status of testicular DNA is highly distinct, displaying eight-
fold the number of hypomethylated loci relative to somatic tissues. 
Differentially methylated loci are generally located within sequences that are 
away from CpG islands and 5' regions of genes. Several repetitive elements 
are specifically hypomethylated in the testis that originate from solitary l TR 
fragments belonging to ERVK (class Il) and MalR (class III) of the l TR family 
of repeats. 
3. Tissue-specifie hypomethylation of the vast majority of the differentially 
methylated loci identified using the RlGS technique does not correlate with 
increased levels of tissue-specifie gene expression. 
4. The methylation state of non-CpG island loci is correlated with the 
chromosomal banding pattern and the regional level of GC content. The 
relationship between DNA methylation and regional levels of GC content is 
inverted in the testis compared to somatic tissues. 
5. In the spermatogonia from Dnmt3L(-I-) mice, ail loci examined that were 
methylated in the testis failed to gain the normal levels of methylation found in 
wild-type spermatogonia and testis. Testis-specific hypomethylated loci 
remained normal in the spermatogonia from Dnmt3L(-I-) mice, indicating that 
the primary influence of Dnmt3L is to promote DNA methylation. 
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6. During spermatogenesis, a specific subset of genomic loci undergoes de 
nova methylation and demethylation; these changes occur mainly in the 
spermatogonia and spermatocyte stages. 
7. Alterations of DNA methylation during spermatogenesis predominantly 
include non-CpG island sequences; unique loci are usually hypermethylated 
during spermatogenesis and the few loci that are demethylated during 
spermatogenesis are found within solitary L TR repetitive elements. 
8.5-azaCdR administration did not cause the demethylation of IAP and the 
major and minor satellite repeats in sperm DNA; however, 5-azaCdR did 
cause the demethylation of the imprinted gene Rasgrf1 in sperm DNA. 
9. A subset of single-copy loci are demethylated in sperm from 5-azaCdR-
treated animais; these loci correspond to those that are hypermethylated 
during spermatogenesis. The lack of a change in maintenance methylation 
and demethylation suggests that 5-azaCdR selectively inhibits de nova 
methylation activity in germ cells. 
10. The partial rescue of adverse effects in Dnmrc/+) animais is associated with no 
restoration of methylation levels in sperm suggesting that 5-azaCdR defects 
are primarily mediated by the level of covalent adducts over hypomethylation. 
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